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1:00–2:30 p.m., Washington A
Fidelity and Quality Measures for First Episode
Psychosis Services
Chair: Masafumi Mizuno1, Co-Chair: Merete Nordentoft2
Speakers: Donald Addington, Peter B. Jones, Marianne Melau, David
McDaid
1Department of Neuropsychiatry, Toho University School of Medicine,
Tokyo, Japan, 2Copenhagen University Hospital, Copenhagen, Denmark
The Board of the IEPA Early Intervention in Mental Health decided at
its 2014 Annual Meeting in Tokyo to convene a Fidelity Task Force
comprised of an international group of experts to review the current
state of implementation of early psychosis services and focus on
tools such as ﬁdelity scales and performance measures that can be
used to support broader implementation of services. The Task Force
met in December 2015 to establish the framework of a paper which
was then developed and reviewed at a second meeting in April 2016.
In this symposium, we will summarize the key principles underlying
ﬁrst episode psychosis services, examine the application of ﬁdelity
scales and outcome measures to support implementation of evidence
based practices in mental health and review ﬁdelity scales developed
for ﬁrst episode psychosis services.
Talk 1
Fidelity and Quality Measures for First Episode
Psychosis Services
Donald Addington1, Maximillian Birchwood2, Peter Jones3,
Eóin Killackey4, David McDaid5, Marianne Melau6,
Masafumi Mizuno7, Kim Mueser8
1University of Calgary, Alberta, Canada, 2Mental Health and Wellbeing,
Warwick Medical School, Coventry, UK, 3University of Cambridge,
Cambridge, UK, 4Orygen, The National Centre of Excellence in Youth
Mental Health, The University of Melbourne, Parkville, Australia,
5London School of Economics and Political Science, UK, 6Copenhagen
University Hospital, Copenhagen, Denmark, 7Department of
Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan,
8Boston University, Boston, Massachusetts, USA
Aim: First Episode Psychosis Services are evidence based practices
which improve the outcome of a ﬁrst episode of psychosis and the
early stages of schizophrenia. Fidelity and outcome measures are
important tools for maintaining quality and fostering widespread pro-
gram implementation. The purpose of this paper is to review ﬁdelity
and outcome measures which can be used to broaden implementa-
tion of ﬁrst episode psychosis services and ensure quality of existing
services.
Methods: We reviewed the general principles and essential evidence
based components that underpin ﬁrst episode psychosis services in
order to establish measurement targets. We reviewed implementa-
tion of such services internationally, the availability of reliable and
valid ﬁdelity measures and outcome indicators and the economic bar-
riers to implementing both services and quality measures.
Results: Early Psychosis Services are variably offered in high-income
countries and rarely with attention to access and quality of services.
They are not available in middle and low income countries. Reliable
and feasible measures of access, ﬁdelity and outcome exist but sys-
tem wide barriers to quality assessment in mental health services
impede their application.
Conclusions: Reliable tools now exist to assess quality and access to
early psychosis services and support implementation.
Talk 2
Cost-effectiveness of Fidelity in Early Intervention
For Psychosis: How Good is Good?
Peter B. Jones1, M Radhakrishnan, P McCrone, L Lafortune,
L Everard, D Fowler, T Amos, N Freemantle, SP Singh, M Marshall,
V Sharma, M Birchwood
1Department of Psychiatry and NIHR CLAHRC EoE, Cambridge, UK
Background: International implementation of Early Intervention Ser-
vices (EIS) for psychosis requires evidence about the components
providing good value for money. Aims To assess the cost-
effectiveness of EIS according to the English Department of Health
2001 Policy Implementation Guide (PIG), and contrast this with a
new waiting time target (2 weeks) and standard (AWTTS; 50% meet-
ing the 2-week target) beginning April 2016.
Methods: National Eden Study data were assessed for cost-
effectiveness at a threshold of £20,000 per QALY after classifying
sites into three ﬁdelity groups: 75-80 % (high), 81%-90% (very high),
and 91-95 % (virtually complete). This was contextualised against the
AWTTS.
Results: The very high (middle) ﬁdelity group had a 56.3% likelihood
of being the most cost-effective followed by high ﬁdelity (35.8%) and
the virtually complete ﬁdelity services (7.9%). The AWTTS focuses on
intervention delivery (CBTp, antipsychotic drugs and family interven-
tions). Workforce requirements and stopping-the-clock only on
acceptance by team capable of delivering these interventions mean
team structure remains important.
Conclusions: Striving to maximise ﬁdelity may not be warranted in
the short-term, but dropping below a certain level of ﬁdelity may be
inefﬁcient. Implementation of policy at a national level needs to
incorporate nuance. Declaration of interest None
DOI 10.1111/eip.12395
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Talk 3
Program Fidelity of Specialized Early Intervention
Services in Denmark
Marianne Melau, Nikolai Alberts, Merete Nordentoft
Copenhagen University Hospital, Copenhagen, Denmark
Background: The Specialized Early Intervention (SEI) treatment in
Denmark, the OPUS treatment, has in a randomized clinical trial
proved to be effective compared to treatment as usual, and the dis-
semination of SEI services are increasing in Denmark. A prerequisite
for upholding positive effects and preserving the critical components
from the original concept is to ensure ﬁdelity to model adherence. A
ﬁdelity scale is an effective tool to assess elements critical to the SEI
programme tested.
Method: In order to develop a Danish ﬁdelity scale, we identiﬁed
essential evidence-based components of SEI services internationally
and interviewed experts from Danish SEI-teams, using an adapted
version of the Delphi Consensus method. An18-point scale was con-
ducted, of which 5 of the components are mandatory. The scale was
divided into two dimensions: one concerning the structure and the
other concerning the character and content of the treatment. The
assessment of the scale is based on interviews with team leaders,
with selected patients and staff members, medical records, and by
observing a team meeting. This multimodal approach makes the most
valid assessment. Alongside the assessment of ﬁdelity we will record
characteristics of each team and their speciﬁc patient populations.
Result: Fidelity data will be collected from 21 SEI teams all over Den-
mark. Data will be ready for presentation at the ﬁdelity-symposium.
Conclusion: If testing the ﬁdelity scale proves positively, it can easily
be implemented in practice and will have profound implications for
patients and their relatives by ensuring quality of the treatment they
are offered.
Talk 4
International Implementation of Early Intervention
Services: Analysis of Economic and Health System
Barriers and Facilitators
David McDaid, A-La Park, Valentina Iemmi, Martin Knapp
London School of Economics and Political Science, UK
Aims: While ﬁrst episode psychosis services have been developed in
very different health system, there are marked differences in service
availability, despite evidence on their effectiveness and cost effec-
tiveness. This presentation extends on a previous review of the
development of these services in high income country contexts, iden-
tifying economic and health system barriers and facilitators to their
implementation.
Methods: A systematic literature review was undertaken to map and
identify early intervention services around the globe. In addition,
funding mechanisms, as well as measures to enhance and monitor
access and quality were analysed. This was done through biblio-
graphic databases, triangulated with information from government
and working papers, websites and video documentation.
Results: Signiﬁcant service provision with sustainable mainstream
funding is restricted to a handful of high-income health systems;
most programmes remain reliant on research funding with limited
coverage and reach. The content and structure of services also varies
substantially, including recent efforts to address resource and capac-
ity limitations by expanding the remit and skills of existing community
mental health services rather than through creation of stand-alone
services. There has been little evaluation of the costs and effective-
ness of mechanisms to encourage implementation.
Conclusions: It is important to understand how differing health sys-
tem structures and incentives impact on the development of ﬁrst epi-
sode psychosis services. Measures to align ﬁnancial and other
incentives within and beyond the health system, as well mechanisms
to monitor ﬁdelity in service delivery may help future
implementation.
Question and Answer Period
Discussant: Mirella Ruggeri, University of Verona, Italy
Symposium Session 2
Thursday, October 20
1:00–2:30 p.m., Washington B
Management of Psychosis Without the Use of
Antipsychotic Medication
Chair: Patrick McGorry M.D., Ph.D.1,2, Co-Chair:
Brian O’Donoghue1,2
Speakers: Philippe Conus, Shona Francey, Brian O’Donoghue,
Anthony Morrison
1Orygen, The National Centre of Excellence in Youth Mental Health,
Centre for Youth Mental Health, 2Centre for Youth Mental Health,
University of Melbourne, Parkville, Australia
The establishment of Early Intervention for Psychosis Services has
led to a reduction in the delays in treatment for young people with
psychotic disorders and more specialized treatments. With the sub-
stantial reductions of the duration of untreated psychosis now seen
in many early psychosis services, based on the staging model and
stepped care principles, it may be that the immediate introduction of
antipsychotic medication may not be necessary. Additionally, a pro-
portion of young people with a ﬁrst episode of psychosis (FEP), with
decisional capacity, elect not to take antipsychotic medication. There
is a dearth of information on what other interventions may beneﬁt
this group. This symposium aims to address the important and topical
question of whether psychotic disorders can be managed without the
use of antipsychotic medication. Dr Philippe Conus will present out-
come data for those who were not treated with an antipsychotic
medication from a large, naturalistic, representative FEP cohort. Dr
Shona Francey will describe the study protocol for the STAGES
study, an RCT of intensive psychosocial interventions + - antipsy-
chotic medication in early psychosis and baseline characteristics of
participants. Dr Brian O’Donoghue will describe the safety measures
and outcomes of conducting the STAGES study. Prof Anthony Morri-
son will present ﬁndings of the ACTION trial, an RCT of cognitive
therapy in individuals with a diagnosis of schizophrenia who have
elected not to take antipsychotic medication. Prof Morrison will also
describe the progress of an ongoing RCT evaluating cognitive therapy
in comparison to antipsychotic medication or a combination of both.
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Talk 1
Can We Predict Good Outcome Among Patients
Who Refuse Medication? – Results From the
FEPOS Study
Philippe Conus1, Sue Cotton2, Benno Schimmelmann1,
Patrick McGorry2, Martin Lambert3
1DP-CHUV, Lausanne University, Lausanne, Switzerland, 2PEDIC,
University Medical Center Hamburg-Eppendorf, Germany, 3Orygen, The
National Centre of Excellence in Youth Mental Health, Centre for Youth
Mental Health, University of Melbourne, Parkville, Australia
Background: The literature suggests that some ﬁrst episode psycho-
sis (FEP) patients can have good outcome without antipsychotic med-
ication. However, there is very limited evidence on which a choice of
treatment without antipsychotic can be based.
Methods: FEPOS is a ﬁle-based study of an epidemiological sample
of 704 FEP patients treated at EPPIC, Melbourne, between 1998 and
2000. Among the 661 patients where data was available, 108 consist-
ently refused medication during the entire duration of their treatment
at EPPIC. In this paper we compared, within this sub-group, patients
who had a favourable outcome with those who did not.
Results: Patients were aged between 15-29 years (M = 21.9, SD
= 3.40) and the majority were male (70.4%, n = 76). Symptomatic
remission data was available on 105 patients; of these patients
41.0% (n = 41) had achieved remission. Functional remission data
was available on 100 patients; of these patients 33.0% (n = 33) had
achieved functional remission. Combined remission was evident in
23.0% (n = 23) of patients. Three factors were associated with symp-
tomatic remission: better premorbid functioning (based on GAF, OR
= 1.07, p = .006), higher number of years of education (OR = 1.43, p
= .020), and being employed or studying at service entry (OR = 2.59,
p = .034). Three factors were associated with functional remission:
shorter duration of prodrome (OR = 0.50, p = .043), severity of psy-
chopathology (CGI-S, OR = 0.51, p = .024), and vocational status at
service entry (OR = 4.29, p = .003).
Conclusions: While various aspects of pre-morbid functioning seem
to correlate with the possibility of a favourable outcome in FEP
patients who refuse medication, various limitations need to be taken
into account in this study.
Talk 2
A Randomized Placebo Controlled Trial of Intensive
Psychosocial Treatment Plus or Minus Anti-
psychotic Medication for First Episode Psychosis
With Low-risk of Self-harm or Aggression. The
STAGES Study: Staged Treatment and Acceptability
Guidelines in Early Psychosis
Shona Francey
Orygen, The National Centre of Excellence in Youth Mental Health,
Melbourne, Australia
Background: Ethical early intervention in psychosis requires careful
consideration of the risk:beneﬁt ratio of treatments recommenda-
tions, especially the role of interventions with signiﬁcant unpleasant
side-effects. The STAGES Study aims to investigate whether inten-
sive psychosocial treatment and close monitoring in a specialised
early psychosis service, without antipsychotic medication, constitutes
an effective treatment for a selected sub-group of young people
with FEP.
Methodology: Young people entering the Early Psychosis Prevention
and Intervention Centre (EPPIC) in Melbourne are screened for study
eligibility and are invited to participate if they meet stringent inclu-
sion criteria indicating low-risk of harm to self or others, and ade-
quate social support. Participants are randomly assigned to receive
either low dose antipsychotic medication or placebo for six months,
and all participants receive intensive psychosocial treatment in the
form of cognitive behavioural case management. Assessments of
psychopathology and neurocognitive performance, and neuroimaging
occurs regularly until two years after study entry. Clinicians, partici-
pants and research staff remain blind to treatment allocation until the
conclusion of the study.
Results: The study is ongoing with recruitment scheduled to conclude
late in 2016. Over 70 young people (mean age 18.6 years, 45% male)
with a range of psychotic disorder diagnoses have entered the study
to date, demonstrating that the study is feasible and acceptable. This
presentation will outline the study design and the baseline character-
istics of participants.
Conclusion: This challenging study promises to contribute rich data
about the impact of various treatments offered for ﬁrst episode psy-
chosis, and to further knowledge about factors affecting recovery.
Talk 3
THE STAGES Study: Medical and Safety Issues in
Conducting a Trial That Involves the Management
of Early Psychosis Without the Use of
Antipsychotic Medication
Brian O’Donoghue1,2
1Orygen, The National Centre of Excellence in Youth Mental Health,
Melbourne, Australia, 2Centre for Youth Mental Health, University of
Melbourne, Australia
Background: The STAGES study is an RCT that involves the manage-
ment of early psychosis with intensive psychosocial interventions and
participants are randomised to receive either antipsychotic medica-
tion or placebo. Participants must meet stringent inclusion criteria,
such as low risk of aggression or suicide. Additionally, the study pro-
tocol speciﬁes strict discontinuation criteria in which the study medi-
cation is stopped (participants can continue to receive the intensive
psychosocial interventions and are followed up as per protocol). This
presentation will outline the safety issues involved in conducting this
trial.
Methodology: The STAGES study is currently being conducted at the
EPPIC clinic at Orygen Youth Health. The study protocol speciﬁes
the following circumstances in which the study medication must be
discontinued: 1. an increase in suicidality 2. increase in aggression
3. signiﬁcant increase in the severity of positive psychotic symptoms
4. signiﬁcant decrease in functioning 5. request of participant 6. preg-
nancy. Criteria 1-3 are determined by the Brief Psychiatric Rating
Scale.
Results: By May 2016, 77 young people had consented to participate
in the STAGES study and 54.5% of participants were required to have
their study medication discontinued. Reasons for discontinuation
were: 24% (N = 10) increased risk, 19% (N = 8) insufﬁcient improve-
ment in psychotic symptoms, 19% (N = 8) participant request and
14% (N = 6) worsening symptoms. 7% (N = 3) were discontinued
due to side-effects. Additionally, information on the required report-
ing of adverse events will be presented.
Conclusion: The STAGES study will provide valuable insights which
will inform clinical guidelines, however strict safety measures are
required for such a study.
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Talk 4
Cognitive Therapy for People With a Diagnosis of
Schizophrenia Spectrum Disorder Not Taking
Antipsychotic Medication: A Single-blind
Randomised Controlled Trial
Anthony Morrison
School of Psychological Sciences, University of Manchester, UK
Background: There is little evidence regarding whether psychological
therapies can be effective as an alternative to antipsychotic medica-
tion. Our recent trial aimed to determine whether cognitive therapy
(CT) is effective in reducing psychiatric symptoms experienced by
people with schizophrenia spectrum disorders that have chosen not
to take antipsychotic medication.
Methods: We conducted a two-site single-blind randomised con-
trolled trial comparing CT plus treatment as usual (TAU) with TAU
only. Participants were followed-up for a minimum of 9 and a maxi-
mum of 18 months.
Results: 74 participants with schizophrenia spectrum disorders who
had chosen not to take antipsychotic medication psychosis (aged 16-
65 years; mean 31.47; SD 12.27) were recruited. 37 were assigned to
CT and 37 to TAU. Our primary outcome was the Positive and Nega-
tive Syndrome Scale (PANSS) total score. Changes in outcomes were
analysed following the intention-to-treat principle, using random
effects regression (a repeated-measures ANCOVA) adjusted for site,
age, gender and baseline symptoms. Psychiatric symptoms were sig-
niﬁcantly reduced in the group assigned to CT in comparison with
TAU, with an estimated between-group reduction in PANSS total of
-6.52 (95% CI -10.79 to -2.25, p = 0.003).
Conclusions: CT signiﬁcantly reduced psychiatric symptoms and
appears safe and acceptable in people with schizophrenia spectrum
disorders who have chosen not to take antipsychotic medication.
Progress from an ongoing RCT evaluating CT in comparison to anti-




The EU-GEI High Risk Study: Adversity, Stress
Sensitivity, Autoantibodies and Cortical Thickness
Chair: Philip McGuire, Co-Chair: Lucia Valmaggia
Speakers: Matthew Kempton, Tamar Kraan, Ulrich Reininghaus, Tho-
mas Pollak
Institute of Psychiatry, Psychology & Neuroscience, King’s College
London, UK
A key rate-limiting factor in research on people at ultra high risk
(UHR) for psychosis is that the samples in many studies are small,
partly because it is difﬁcult to recruit large numbers of subjects from
a single centre. This issue can be addressed through multi-centre
studies, and this symposium comprises the ﬁrst presentation of ﬁnd-
ings from the EU-GEI High Risk Study. This study recruited n = 369
subjects at ultra high risk for psychosis from a network of 12 centres
in Europe and Australia. A wide range of environmental factors that
have previously been associated with psychosis were evaluated
including, childhood adversity, substance use and the urban environ-
ment. MRI data were acquired on 3T scanners. Blood samples were
collected for the analysis of CNS autoantibodies, and for genetic, epi-
genetic, metabolomic and proteomic analyses. Experience Sampling, a
momentary assessment technique, was used to assess minor stressful
events, emotional reactivity, and psychotic experiences. In this sym-
posium, we will present new data on the relationship between child-
hood adversity and psychiatric symptoms, and the relationship
between childhood adversity and the subsequent onset of psychosis.
We will then report on the extent to which cannabis use and urbani-
city in UHR subjects are related to brain structure in this group. Expe-
rience sampling data will be presented, focusing on stress sensitivity
in UHR subjects, and the extent to which this is associated with cur-
rent psychopathology and clinical outcomes at follow up. Finally, we
will report on the prevalence of autoantibodies to the NMDA recep-
tor in high-risk subjects.
Talk 1
The Effect Of Environmental Risk Factors On Brain
Structure In Those At Risk Of Developing
Psychosis: Urbanicity And Early Cannabis Use
Matthew Kempton1, Maria Calem1, Stefania Tognin1,
Lucia Valmaggia1, Philip McGuire1, EU-GEI WP5 High Risk Study2
1Institute of Psychiatry, Psychology & Neuroscience, King’s College
London, UK, 2International Collaboration
Abnormalities in brain structure have been conﬁrmed in schizophre-
nia, and some of these abnormalities appear to be present before the
onset of the illness. Currently it is not clear if these early brain
abnormalities are associated with genetic or environmental risk fac-
tors. Urbanicity and early cannabis use are both recognized as impor-
tant environmental risk factors for psychosis. In this study we
examined the effects of these risk factors on cortical thickness in
those at ultra high risk (UHR) of developing psychosis. UHR partici-
pants were recruited as part of the multicenter EU-GEI (European
Union Gene-Environment Interaction) study and current and past
cannabis use was assessed with the cannabis experience question-
naire (CEQ). We used the Social Environment Assessment Tool
(SEAT) to examine participants’ perceptions of their urban neighbour-
hood which included rating the built environment, crime and disorder,
and neighbourhood co-operation. MRI data was acquired using the
ADNI-2 sequence, and processed using the FreeSurfer. 230 structural
MRI scans were acquired from participants with UHR at baseline.
Data was available from 9 different cities around the world with wide
variations in participant’s scores of their urban environment. Seventy-
four percent of UHR participants had previously used cannabis. The
effects of urbanicity and cannabis use on cortical thickness are pre-
sented with a focus on brain regions known to be abnormal in UHR
individuals. The ﬁndings discussed in this presentation may help in
unravelling the mechanism of how exposure to particular environ-
mental risk factors may contribute to the development of psychosis.
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Talk 2
The Effect Of Childhood Abuse On 1-Year
Outcome In Individuals At Ultra High Risk For
Psychosis In The EU-GEI At Risk Study
Tamar Kraan1, Eva Velthorst2, Lucia Valmaggia3, Matthew Kempton3,
Philip McGuire3, Filip Smit4,5,6, Lieuwe de Haan1,
Mark van der Gaag7,8, EU-GEI WP5 High Risk Study9
1Academic Medical Center, University of Amsterdam, The Netherlands,
2Icahn School of Medicine, Mount Sinai, NY, US, 3Institute of Psychiatry,
Psychology & Neuroscience, King’s College London, UK, 4VU University
and EMGO Institute for Health and Care Research, Amsterdam, The
Netherlands, 5Trimbos Institute (Netherlands Institute of Mental Health
and Addiction), Utrecht, the Netherlands, 6VU University Medical Center,
Amsterdam, the Netherlands, 7Parnassia Psychiatric Institute, The
Hague, The Netherlands, 8VU University, Amsterdam, The Netherlands,
9International Collaboration
Background: The association between childhood abuse and psychosis
has been widely demonstrated in previous research. However, the
effect of childhood abuse on transition to psychosis and other clinical
and functional outcomes in individuals at ultra-high risk (UHR) for
psychosis is not clear yet. The present study aimed to examine the
effect of childhood abuse on transition to psychosis and other clinical
and functional outcomes in UHR individuals of the EU-GEI study.
Methods: The sample consisted of 260 UHR subjects from the EU-GEI
study with childhood trauma data and clinical and functional follow-up
data available. Subjects were followed-up for two years. Clinical and
functional outcomes were assessed at 6 months, 12 months and
24 months. Childhood trauma was assessed at baseline.
Results: Preliminary ﬁndings show that a history of childhood
abuse was associated with an increased risk for transition to psy-
chosis (b = 1.36, p = 0.027, CI 0.15 - 2.57). Moreover, a history of
childhood abuse was associated with depression disorder (b
= 1.60, p < 0.001, CI 0.76 – 2.44), post-traumatic stress disorder
(b = 6.18, p = 0.03, CI 0.53 – 11.83), more severe anxiety symp-
toms (b = .39, p = 0.033, CI 0.03 – 0.74) and lower global func-
tioning (b = -4.20, p = 0.006, CI -7.18 – 1.21) at follow-up.
Conclusion: A history of childhood abuse was associated with various
clinical symptoms and poor global functional outcome, suggesting
that childhood abuse is a pluripotent risk factor for psychopathology
and poor global functioning in adolescence.
Talk 3
Stress Sensitivity As A Psychological Mechanism
Underlying The Development Of Psychosis: Initial
Evidence From The EU-GEI At Risk Experience
Sampling Study
Ulrich Reininghaus1, Barnaby Nelson2, Eva Velthorst3,
Matthew Kempton4, Lucia Valmaggia4, Philip McGuire4,
Inez Myin-Germeys5, EU-GEI WP5 High Risk Study6
1Maastricht University, The Netherlands, 2Orygen, The National Centre
of Excellence in Youth Mental Health, Melbourne, Australia, 3Icahn
School of Medicine at Mount Sinai, NY, USA, 4Institute of Psychiatry,
Psychology & Neuroscience, King’s College London, UK, 5KU Leuven,
Belgium, 6International Collaboration
While contemporary models of psychosis have proposed a number
of putative psychological mechanisms, how these contribute to the
development of psychotic experiences in real life remains unclear.
This study aimed to investigate whether elevated stress sensitivity,
operationalized as stronger emotional reactions to minor stressors
in daily life is an important psychological mechanism that contri-
butes to the development of psychosis in help-seeking ‘Ultra-High-
Risk’ (UHR) individuals. We used the Experience Sampling Method
(ESM) to assess minor stressful events, emotional reactivity, and
psychotic experiences occurring in the ﬂow of everyday life in UHR
individuals recruited from 3 sites (London, Amsterdam & The Hague,
Melbourne) and successfully completed ESM assessment with
80 UHR individuals. We found strong evidence of elevated stress
sensitivity in UHR subjects, indexed by strong negative emotional
reactions in response to event-related, activity-related, and social
stress in daily life. Elevated stress sensitivity was, in turn, associated
with increased odds of developing intense psychotic experiences in
daily life. Event-related stress sensitivity was signiﬁcantly elevated
in UHR subjects with more severe symptoms and lower global func-
tioning as measured with the GAF at 1-year follow-up. This is the
largest multi-centre study using novel ecological momentary assess-
ment technology conducted to date in UHR individuals. Our ﬁndings
suggest elevated stress sensitivity may be an important psychologi-
cal mechanism in the development of psychotic experiences in UHR
individuals associated with more severe symptoms and lower global
functioning.
Talk 4
Autoantibodies to the NMDA Receptor and Other
Neuronal Cell-Surface Antigens in Subjects at
Ultra-High Risk For Psychosis
Thomas Pollak1, Matthew Kempton1, Conrad Iyegbe1, James Stone1,
Anthony David1, Philip McGuire1, EU-GEI WP5 High Risk Study2
1Institute of Psychiatry, Psychology & Neuroscience, King’s College
London, UK, 2International Collaboration
Introduction: NMDAR autoantibodies have recently been identiﬁed
in different cohorts of patients with psychotic disorders, with meta-
analytical evidence indicating a higher prevalence in ﬁrst episode psy-
chosis. We sought to establish the prevalence and associations of
autoantibodies to the NMDAR and other neuronal autoantigens in a
group at ultra-high risk (UHR) for psychosis and their interaction with
other markers of neuronal and blood-brain barrier (BBB) integrity.
Methods: Sera from 52 UHR subjects in the EU-GEI study and
11 healthy controls were tested using a ﬁxed CBA: sera were incu-
bated with HEK293 cells that had been transfected to express one of
six autoantigens (NMDAR, AMPA-1, AMPA-2, CASPR2, LGI1, GABA-
B); antibody binding was assessed using indirect immunoﬂuores-
cence. Levels of S100B, a marker of BBB disruption, were assessed
using a chemoluminescence assay.
Results: 15 out of 52 (28%) UHR subjects from the EU-GEI study vs
1 out of 11 (9%) control subjects had S100B values over the cutoff
value of 0.10ug/L, suggesting potential discriminant utility in UHR.
Data will be presented on the prevalence of neuronal autoantibodies
and associations between baseline autoantibodies and S100B levels
and transition to psychosis and functional outcome in UHR subjects.
Conclusions: Preliminary data suggests that a proportion of UHR sub-
jects harbour potentially pathogenic autoantibodies and that S100B
levels are raised in some UHR subjects, suggesting a disrupted BBB
and/or concomitant neuronal/glial damage. Future work within the
EU-GEI UHR cohort will assess the longitudinal course, clinical signiﬁ-
cance, MRI correlates and predictive utility of a panel of 30+ CNS
autoimmune parameters.
Question and Answer Period





Putting Clinical High-Risk States and Staging
Models to Work: Implications for Service Delivery
Chair: Jai Shah1
Speakers: Jan Scott, Mary Cannon, Jai Shah, Ian Hickie
1PEPP-Montréal, Department of Psychiatry, McGill University, Montréal,
Canada
A key feature of contemporary staging models in youth mental health
(YMH) is the “clinical high-risk” (CHR) or 1b stage, deﬁned as one of
sub-threshold symptoms or having a ﬁrst-degree relative along with
functional impairment. While these distressing syndromes require
immediate care, the optimal setting and shape of clinical programming
for CHR states is far from clear. At present, CHR services tend to be
diagnosis-speciﬁc and afﬁliated with academic/tertiary care centres
(most prominently in psychosis). However, the recent trend towards
community-based, open-referral YMH systems has a myriad of impli-
cations, including the diagnosis and treatment of severe mental ill-
nesses (SMI) in youth and the CHR states that precede them. This
symposium considers these emerging issues in four countries cur-
rently undergoing YMH service transformations: Australia, Canada,
Ireland and the UK. Presenters will discuss different models of
expanding early intervention services to include CHR states, and their
relative advantages and disadvantages. They will explain how recent
studies have provided a novel validation of the CHR construct and its
clinical utility for SMIs, generated important understandings of the
relationship between attenuated symptoms and functioning in the
CHR state, and identiﬁed optimal timing and multimodal opportu-
nities for early intervention in stage 1b syndromes. Finally, they will
explore how these ﬁndings inform the conceptualization, identiﬁca-
tion and treatment of CHR states. Since youth with CHR/stage 1b
presentations make up approximately 50% of help-seekers to YMH
services, these issues have tremendous relevance for the structure
and orientation of YMH systems of care and their ongoing
transformations.
Talk 1
What Next After EIP? An Overview of Possible
Service Developments for the Early Stages of
Severe Mental Disorders in the UK
Jan Scott
Institute of Neuroscience, Newcastle University, Newcastle upon
Tyne, UK
Purpose: The UK has developed an extensive network of early inter-
vention in psychosis (EIP) services over the last 15 years. However,
discussions about future developments have led to the consideration
of four potential ‘extension’ models: geographic extension; extension
to all ‘at-risk’ youth; specialist service extension; and extension across
all age groups with emerging psychosis.
Materials/Methods: This talk will describe these proposals, present
the arguments used to support them, and examine the evidence for
and against each model.
Results: Some EIP service providers argue that successful systems of
care should not be changed, but that provision should be extended
across the UK. In other localities, there is a desire to extend EIP ser-
vices to encompass other clinical high risk groups and to move
towards a trans-diagnostic youth mental health service. A third group
of service providers have argued for specialist EI services for different
diagnostic groups: this approach would support the development of
services targeted at mood disorders (especially bipolar disorders),
leading to the provision of two parallel EI services. The fourth model
argues that EIP should be limited to early stage psychosis, but with-
out current any age limits, i.e. the service would accommodate
15 year olds alongside 50 year olds.
Conclusion: We conclude that the most logical extension model for
EIP is for it to evolve into a trans-diagnostic youth mental health
service, since the other proposed service models undermine one or
more of the important principles that have made EIP such a success-
ful strategy.
Talk 2
Prevalence of Prodromal Risk Syndromes Among
“Non Help-Seeking” Adolescents in the Community:
Inﬂuence of Assessment Criteria and Implications
for Service Development
Mary Cannon, Ian Kelleher
Royal College of Surgeons, Dublin, Ireland
Purpose: There is relatively little knowledge about the prevalence of
prodromal (CHR) syndromes in community settings. Thus far,
research has been conducted only in the context of individuals
attending “prodrome” services or clinics.
Methods: In order to address this issue, we assessed for psychotic
symptoms, CHR risk syndromes and other psychopathology in
212 non help-seeking adolescents in schools.
Results: Between 1.5-8% of this community based sample fulﬁlled
criteria for a CHR syndrome. The rate varied with the assessment cri-
teria used, in particular the measurement of disability: without
accounting for a global measure of functioning, the rate of prodromal
syndromes was 8%; when poor functioning was included, the rate
was 1.5%. Adolescents who met CHR criteria had a higher prevalence
of other psychopathology, including a range of neuropsychological
deﬁcits compared with adolescents without psychotic symptoms and
compared with adolescents who reported psychotic symptoms but
who did not fulﬁl criteria for a prodromal risk syndrome.
Conclusions: Further research is greatly needed on prevalence, out-
come and co-morbidity among “non help-seeking” individuals who
fulﬁl criteria for prodromal risk syndromes in the community. The rel-
atively high prevalence of CHR states in the non help-seeking general
population has resource implications for setting up “at-risk” services
in the community. Poor global functioning should be a key measure
to be considered in such services, and the presence of psychotic




Attenuated Psychotic Symptoms Prior to a First
Episode of Psychosis: Retrospective Validation and
Clinical Utility of the CHR Stage
Jai Shah1,2,3, Anne Crawford1,2, Sally Mustafa1, Ridha Joober1,2,3,
Ashok Malla1,2,3
1PEPP-Montréal, Douglas Mental Health University Institute, Montréal,
Canada, 2McGill University, Montréal, Canada, 3ACCESS Open Minds,
Montréal, Canada
Purpose: The relevance of staging models that incorporate CHR
states rests partly on a key assumption that has gone untested: that
the ﬁrst episode of severe mental illness (SMI) is preceded by a CHR
syndrome involving attenuated or sub-threshold symptoms. If few
individuals presenting with a ﬁrst episode SMI have experienced an
earlier CHR state, then the clinical utility of potential interventions
targeting CHR syndromes is signiﬁcantly reduced.
Materials/Methods: In order to address this question, we used data
from the Circumstances of Onset and Relapse Scale along with chart
reviews and detailed interviews in a representative catchment area-
based sample of 362 ﬁrst episode psychosis (FEP) patients and their
caregivers.
Results: From a list of 29 early signs and symptoms of psychiatric ill-
ness/distress, nine were identiﬁed by a group of expert psychologists
and psychiatrists as reﬂecting attenuated psychotic symptoms during
the prodromal period. A majority (238, 67.9%) of patients recalled
experiencing at least one of these nine features, suggesting that the
CHR state frequently precedes a FEP. At entry to FEP services, there
were no differences in social, demographic, or clinical variables
between those who had versus had not experienced attenuated
signs/symptoms.
Conclusions: Most FEP patients experienced an earlier, identiﬁable
CHR state, strengthening the latter’s utility and relevance for early
intervention (including prevention of SMIs). Intriguingly, early symp-
tom proﬁles may ﬂuctuate as the illness evolves and transitions into a
full-blown SMI. These ﬁndings have signiﬁcant implications for CHR
states, transdiagnostic clinical staging models, and their effective
operationalization in YMH services.
Talk 4
Implementation of Transdiagnostic Early
Intervention Services for Anxiety, Mood and
Psychotic Syndromes in Australia
Ian Hickie1, Patrick McGorry2,3, Shane Cross1,4, Jane Burns5,
Daniel Hermens1, Elizabeth Scott1
1Brain and Mind Centre, University of Sydney, Australia, 2Orygen Youth
Health Research Centre, Melbourne, Australia, 3Centre for Youth Mental
Health, University of Melbourne, Parkville, Australia, 4School of
Psychology, University of Sydney, Australia, 5Young and Well
Cooperative Research Centre, Melbourne, Australia
Purpose: Over the last decade, Australia has implemented progres-
sively primary-care based mental health assessment and psychological
treatment services (headspace) that are open to persons aged 12-25
years with any form of psychological distress. Concurrent academic
partnerships have developed a trans-diagnostic clinical staging model
which differentiates early forms of illness with no or limited impair-
ment (stages 1a and 1b) from established mood or psychotic disor-
ders (stages 2+).
Materials/Methods: Extensive neuropsychological and neurobiologi-
cal studies have identiﬁed correlates of these different stages of ill-
ness and compared the validity of staging models with more
conventional, diagnosis-based systems.
Results: A range of studies indicate that clinical staging is more
closely linked to neurobiological changes than to conventional diag-
noses. We have implemented this model within speciﬁc service envir-
onments and studied the 12 month patterns of service use, changes
in impairment and progression to later stages of illness.
Conclusions: The greatest opportunities for improving functional out-
comes appear to be associated with the 3 month period following
presentation for care. However, there is also a strong need to work
more effectively over 12 months with those who are already
impaired – independent of diagnoses. This work has major implica-
tions for further development of relevant mental health systems –
favouring a more intensive 12 month program of clinical and psycho-
social care, and tracking of outcomes for those with stage 1b anxiety,
mood, psychotic or comorbid disorders. The capacity to deliver such
programs of care may be taken to scale by smart use of adjunctive
digital technologies.
Question and Answer Period
Discussant: Patrick McGorry, M.D., Ph.D., Orygen, the National Centre
of Excellence in Youth Mental Health, Centre for Youth Mental Health,
University of Melbourne, Parkville, Australia
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New Findings from the NIMH RAISE Early
Treatment Program
Chair: John Kane1, Co-Chair: Nina Schooler2
Speakers: John Kane, Delbert Robinson, Nina Schooler, Kim Mueser
1Hofstra Northwell School of Medicine, New York, USA, 2SUNY
Downstate, New York, USA
The RAISE-ETP clinical trial was funded by the National Institute of
Mental Health and involved 404 ﬁrst episode psychosis patients receiv-
ing care at 34 community mental health centres in 21 states across the
U.S. Sites were cluster randomized to provide NAVIGATE, a manua-
lized, comprehensive specialty care program including psychopharma-
cology, individual therapy, family psychoeducation/therapy and
supported employment/education. We have previously reported on
two year outcomes which indicated statistically signiﬁcant advantages
for the NAVIGATE intervention in quality of life, retention in care, psy-
chopathology, and participation in work or school. Duration of
untreated psychosis (with a median of 74 weeks) had a strong moderat-
ing impact on treatment effectiveness. This symposium will include
unpublished data on: factors inﬂuencing rates of hospitalization, pre-
sented by John Kane; the role of supported education/employment in
contributing to enhanced participation in work or school, presented by
Kim Mueser; the impact of a computerized decision support system for
prescribers designed speciﬁcally for this project, presented by Delbert
Robinson; and an analyses of cognitive test measures as moderating
and outcome measures, presented by Nina Schooler. Robert Heinssen
will serve as discussant. This session will provide new data and further
insights from the conduct of this study.
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Talk 1
RAISE-ETP: Predictors of Hospitalization
John Kane1,2
1The Zucker Hillside Hospital, New York, USA, 2Hofstra Northwell School
of Medicine, New York, USA
Purpose: The RAISE-ETP clinical trial was funded by the National
Institute of Mental Health and involved 404 ﬁrst episode psychosis
patients receiving care at 34 community mental health centres in
21 states across the U.S. Sites were cluster randomized to provide
NAVIGATE, a manualized, comprehensive specialty care program
including psychopharmacology, individual therapy, family psychoedu-
cation/therapy and supported employment/education. We have pre-
viously reported on two year outcomes which indicated statistically
signiﬁcant advantages for the NAVIGATE intervention in quality of
life, retention in care, psychopathology, and participation in work or
school. Duration of untreated psychosis (with a median of 74 weeks)
had a strong moderating impact on treatment effectiveness. These
analyses involved the hospitalization data in order to identify factors
contributing to a higher risk of this outcome.
Materials and Methods: Multivariate analyses were conducted on
the effect of baseline measures such as duration of untreated psy-
chosis (DUP), number of prior hospitalizations, psychopathology and
quality of life on time to hospitalization.
Results: The analyses revealed that participants with duration of
untreated psychosis (DUP) of 74 weeks or longer were more likely
than those with shorter DUP to be hospitalized (hazard ratio
= 1.499), as were participants who had had more hospitalizations
before study entry (hazard ratio 2.401). Higher baseline scores on the
PANSS excited (hazard ratio = 1.089) and depressed (hazard ratio
= 1.064) factors were associated with hospitalized.
Conclusions: These results underscore the potential importance of
reducing DUP and successfully ameliorating symptoms such as
excitement and depression.
Talk 2
Psychopharmacological Treatment in the RAISE-
ETP Study: Outcomes of a Manual and Computer
Decision Support System Based Intervention
Delbert Robinson1,2,3
1The Feinstein Institute for Medical Research, New York, USA, 2Hofstra
Northwell School of Medicine, New York, USA, 3The Zucker Hillside
Hospital, New York, USA
Purpose: RAISE-ETP compared NAVIGATE, a comprehensive treat-
ment program for ﬁrst episode psychosis (FEP), to clinician-choice
Community Care (CC) treatment over a 2 year treatment period.
Symptom and quality of life outcomes were better for NAVIGATE
participants. Compared with prior comprehensive FEP interventions,
NAVIGATE medication prescription included unique elements of 1)
detailed speciﬁc ﬁrst episode psychotropic medication guidelines and
2) a computerized decision support system to facilitate prescription
decision making. We present comparisons of the psychotropic medi-
cations prescribed and the side effects participants experienced.
Methods: Prescription (medication name and daily dose) for all psy-
chotropic medications were obtained using the Service Use and
Resource Form administered monthly. At baseline, 3, 6, 12, 18 and
24 months, participants reported in a yes/no format whether they
had experienced during the past 30 days any of 21 common side
effects of antipsychotic medications.
Results: Over the 2 years, the 223 NAVIGATE participants compared
to the 181 CC participants were more likely to be prescribed an anti-
psychotic (odds ratio: 3.734; 95% CI: 1.709, 8.162) and also an anti-
psychotic that conformed to NAVIGATE prescribing principles (odds
ratio: 2.189; 95% CI: 1.084, 4.421). Despite an increased likelihood of
antipsychotic prescription, NAVIGATE participants reported experien-
cing fewer side effects (treatment by time interaction, F = 3.86,
df = 5,1143, p = 0.0018). NAVIGATE participants were less likely to
be prescribed an antidepressant (odds ratio: 0.391; 95% CI:
0.162, 0.943).
Conclusion: As part of comprehensive care, medication prescription
can be optimized for FEP, contributing to better symptom outcomes
with less side effect burden than standard care.
Talk 3
Cognitive Functioning in First Episode Psychosis
Nina Schooler1,2
1The Zucker Hillside Hospital, New York, USA, 2SUNY Downstate
Medical Center, New York, USA
Purpose: Signiﬁcant cognitive impairment is already seen in ﬁrst epi-
sode psychosis (FEP) and is recognized as an important moderator of
long-term outcomes. An important question is whether specialized
FEP treatment can improve cognitive functioning.
Materials and Methods: The RAISE-ETP study compared NAVIGATE,
an integrated comprehensive treatment, to Community Care in
404 FEP patients at 34 sites in the US. Treatment continued for up
to two years. The Brief Assessment of Cognition in Schizophrenia
(BACS) was administered at baseline, one and two years. Age and sex
adjusted T-scores for the BACS Composite and six sub-tests (Verbal
Memory, Digit Sequencing, Verbal Fluency, Token Motor, Symbol
Coding and Tower of London) were compared between treatments at
each time-point.
Results: Compared to norms for all measures, this FEP sample (mean
age 23; 75% male) performed at lower levels for Composite and sub-
tests at baseline. The Composite Score was not signiﬁcantly different
between treatments at baseline, one or two years. The only individual
test to show differences was Tower of London. Navigate participants
had signiﬁcantly better performance at baseline (p = .04) and at one-
year (p = .01).
Conclusions: These results conﬁrm ﬁndings of cognitive impairment
in FEP psychosis. Further, comprehensive and intensive clinical treat-
ment does not appreciably affect cognitive functioning. Presentation
of these initial ﬁndings will be supplemented by consideration of
moderators of cognitive measures, especially Tower of London which
taps executive functions and problem solving. Moderation of clinical
outcomes by cognition will also be presented. Addressing the cogni-
tive dysfunction in FEP remains challenging.
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Talk 4
Supported Education and Employment Outcomes in
the RAISE-ETP Study
Kim Mueser
Boston University, Boston, Massachusetts, USA
Purpose: Increasing involvement in work and school are major objec-
tives for ﬁrst episode of psychosis (FEP) programs. However, the evi-
dence for improvement in these outcomes has been mixed in
comprehensive programs that do not include supported employment
and education (SEE). Furthermore, research on FEP programs with
SEE have focused on participants who want to work or return to
school, limiting generalizability of ﬁndings to the broader FEP popula-
tion. This analysis compared the effects of an FEP program with SEE
on work, school, and public support outcomes to usual services.
Materials and Methods: FEP participants (N = 404) at 34 community
clinics participated in a cluster randomized trial that compared usual
Community Care (CC) to NAVIGATE, a comprehensive program with
≥5 hours/week per team of SEE. All NAVIGATE participants were
offered SEE regardless of their interest in work or school. Monthly
assessments over 24 months recorded days of employment, school
attendance, and participation in SEE, and employment and public sup-
port income. General Estimation Equation models were used to com-
pare CC and NAVIGATE on outcomes, and the mediating effect of
receiving ≥3 SEE visits on outcomes.
Results: NAVIGATE was associated with a greater increase in work
or school participation (p = .0486), which appeared to be mediated
by participation in SEE. No differences were observed in work or
school participation considered separately, or in earnings or receipt
of public support payments.
Conclusions: The comprehensive NAVIGATE program for FEP
approach improved involvement in work or school, and this effect
appears to be mediated by participation in SEE.
Question and Answer Period
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Migration and Ethnicity in First Episode Psychosis
Chair: Ingrid Melle1, Co-Chair: James Kirkbride2, Speakers:
Andreas Bechdolf, Ilaria Tarricone, James B Kirkbride, Akiah O Berg
1University of Oslo, Oslo University Hospital, Norway, 2UCL London,
University of Cambridge, UK
Migration background is recognized as a risk factor for developing
psychosis. Ethnicity might inﬂuence symptom proﬁles and help-
seeking behaviours. In Europe, having a migration- or ethnic minority
background is partly overlapping since a large proportion of ethnic
minorities also are ﬁrst- or second generation immigrants. The current
symposium includes studies from Germany, Italy, UK and Norway. It
explores the role of migration background for the use of early inter-
vention services, the risk of psychosis in internal versus external
migrants thus exploring the role of ethnicity, the speciﬁcity of symp-
tom dimensions across ethnic groups and ﬁnally investigation of fac-
tors that may mediate the associations between ethnicity and
symptom proﬁles.
Talk 1
Clinical Characteristics and Service use in Young
People with Migration Background in an Early
Intervention and Treatment Center
Andreas Bechdolf1,2,3,4, Susanna Zarafonitis-Müller1,
Sonja Anouk Laier1, Karolina Leopold1
1Department of Psychiatry, Psychotherapy and Psychosomatics,
Vivantes Klinikum am Urban, Early Intervention and Treatment Center –
FRITZ am Urban, Charité Medical University, Berlin, Germany,
2Department of Psychiatry, Psychotherapy and Psychosomatics,
Vivantes Klinikum im Friedrichshain, Charité Medical University, Berlin,
Germany, 3Department of Psychiatry and Psychotherapy, University of
Cologne, Cologne, Germany, 4ORYGEN, The National Centre of
Excellence in Youth Mental Health, The University of Melbourne,
Melbourne, Australia
Purpose: Migration is as a crucial risk factor in psychoses, correlating
with incidence, duration of untreated psychosis (DUP) and response
to interventions. Access to early intervention services is an essential
factor to improve the prognosis of young people with psychosis and
migration background.
Methods: We evaluated service use and characteristics of patients
with and without migration background who were treated in the
early intervention and treatment centre (FRITZ) in Berlin, Germany.
We compared characteristics of the FRITZ population with the char-
acteristics of the catchment area.
Results: Compared to the characteristics of the catchment area the
FRITZ sample presents a slightly lower proportion of people with
migration background (35.6%) and a higher unemployment rate
(45.8%). Regarding educational level 47.2% of our service users have
university qualiﬁcation, which corresponds to the characteristics of
the catchment area. Migrants in the FRITZ showed signiﬁcantly lower
insight into illness than non-immigrants. FRITZ patients with migrant
background were however better educated than non-immigrants of
FRITZ and the average for migrants in the catchment area.
Conclusions: In terms of migration the characteristics of the FRITZ
population corresponded to the characteristics of the catchment area.
In this respect FRITZ seems to be well assessable. However, low edu-
cated people with migration background seemed to be underrepre-
sented. We need more information about pathways to care and may
need to rethink our awareness campaigns in order to improve




Increased Risk of Psychosis in Internal Migration:
Results from the Bologna First Episode Psychosis
Study
Ilaria Tarricone1,2,3, Jane Boydell3, Arnisa Kokona1, Frederico Triolo1,
Lisa Gamberini1, Enrico Sutti1, Michela Marchetta1,
Marco Menchetti1,2, Marta DiForti3, Robin M Murray3,
Craig Morgan3, Domenico Berardi1,2
1Bologna Transcultural Psychosomatic Team (BoTPT), Department of
Medical and Surgical Sciences, University of Bologna, Italy, 2Department
of Mental Health and Pathological Addictions, Bologna Local Health
Trust, Bologna, Italy, 3Institute of Psychiatry, Psychology &
Neuroscience, King’s College London, UK
Purpose: Incidence of psychotic disorders is higher in many migrant
groups; however, little is known about internal migrants (IM). This
study aims to describe the incidence rates in natives to the region
(NA), IM and external migrants (EM).
Method: All patients aged 18-64 years, with First Episode Psychosis
(FEP), who made contact with the Bologna West psychiatric services,
between 2002 and 2010, were included.
Results: 187 cases were included. Age and sex adjusted IR of psycho-
sis per 100.000 per year were: 12.6 for NA, 25.3 for IM and 21.4 for
EM. The IRR was 1.93 (1.19-3.13, p = 0.007) for IM and 1.79 (1.06-
3.02, p = 0.03) for EM compared to NA.
Conclusion: Rates of psychosis were signiﬁcantly elevated in IM as
well as in EM. This result adds evidence as to the role of migration
itself (versus ethnicity) on the risk of psychosis.
Talk 3
Do Symptom Dimensions Vary between Ethnic
Groups at First Presentation to Early Intervention in
Psychosis Services? Evidence from the SEPEA
Study
James B Kirkbride1,2, Chandni Hindocha3, Yasir Hameed4,
Jesus Perez2,5, Peter B Jones2,5
1Division of Psychiatry, UCL, London, UK, 2Department of Psychiatry,
University of Cambridge, UK, 3Department of Clinical, Educational and
Health Psychology, UCL, London, UK, 4Norfolk & Suffolk Foundation
Trust, Ipswich, UK, 5Cambridgeshire & Peterborough NHS Foundation
Trust, Cambridge, UK
Purpose: The risk of experiencing psychotic disorders is higher in sev-
eral migrant and ethnic minority populations. We used data from a
large cohort of people with ﬁrst episode psychosis [FEP] to assess
whether symptom dimensions at presentation to early intervention
psychosis [EIP] services differ between these groups.
Method: Participants (N = 683, ages 16-35) with conﬁrmed ICD-10
FEP (F10-33) were recruited from 6 EIP services over a 3.5 year
period. Polychoric factor analysis identiﬁed 7 symptom dimensions
(manic, depressive, disorganised, delusional, paranoid, thought disor-
dered & hallucinatory symptoms). Linear regression analysis examined
variation in symptom dimensions between 11 ethnic groups, ﬁrst and
later-generation migrants and age-at-migration, controlling for socio-
demographic and clinical confounders.
Results: Symptom dimension between ethnic minority groups and white
British participants were similar, and patterns did not differ between gen-
erations or age-at-migration. Compared to white-British participants peo-
ple of black African origin experienced more manic (β = 0.24; 95%CI:
0.01, 0.47) and delusional (β = 0.12; 95%CI: 0.01, 0.23) symptoms, and
less depressive symptoms (β = -0.21; 95%CI: -0.36, -0.06). People of
Indian origin experienced more manic (β = 0.81; 95%CI: 0.05, 1.56),
depressive (β = 0.57; 95%CI: 0.08, 1.06) and disorganised (β = 0.43;
95%CI: 0.03, 0.84) symptoms, but less delusional symptoms (β = -0.41;
95%CI: -0.78, -0.03).
Conclusion: Most ethnic groups, regardless of generation status or
age-at-migration, present to EIP services with similar symptomatic
proﬁles in their ﬁrst episode of psychosis. Nonetheless, differing
symptom proﬁles in people of black African and Indian origins may
warrant more nuanced treatment responses, and could underlie the
relative excesses and absences of psychotic disorders observed in
these populations.
Talk 4 Psychotic Symptom Proﬁles in Immigrants
and Ethnic Minorities
Akiah O Berg, Mari Nerhus, Monica Aas, Ingrid Melle
NORMENT, K.G. Jebsen Centre for Psychosis Research, Division of
Mental Health and Addiction, Institute of Clinical Medicine, University of
Oslo, and Oslo University Hospital, Oslo, Norway
Purpose: Immigrants have heightened risks of psychotic disorders,
and it is proposed that migration experiences inﬂuence symptom pro-
ﬁles. We have explored the following questions in patients with
broadly deﬁned psychotic disorders; 1. Do migration experience
and/or ethnic minority status affect symptom proﬁles, and 2. Does
experience of childhood trauma inﬂuence symptoms in patients from
ethnic minorities, in particular auditory hallucinations?
Methods: Data for study 1 (N = 1081/16,5% ethnic minorities) and
2 (N = 454/ 15% ethnic minorities 15%) were drawn from a large
catchment area based sample of patients with broadly deﬁned DSM-
IV psychotic disorders. Current psychotic symptoms were measured
with the Positive and Negative Syndrome Scale, lifetime verbal hallu-
cinations during the SCID interview assessing and childhood trauma
with the Childhood Trauma Questionnaire, self-report version.
Results: 1) Differences in symptom proﬁles between immigrants and
Norwegians were primarily explained by socio-demographic factors
such as age, education and diagnosis. Multivariate analyses indicated
that ethnic minorities had more severe levels of delusions and difﬁ-
culties in abstract thinking. 2) Patients from ethnic minority groups
had experienced signiﬁcantly more childhood traumas, had more cur-
rent hallucinatory behaviour and lifetime experiences of auditory ver-
bal hallucinations. Multivariate regression analyses showed that
childhood trauma mediated the association between ethnic minority
status and hallucinations.
Conclusion: Migration experiences and/or ethnic minority status do
not directly inﬂuence psychotic symptom proﬁles. Higher symptom
levels appear to be mediated by differences in socio-demographic
factors and childhood trauma experiences.
Question and Answer Period





Engaging Families in Early Psychosis Care Using
CBT for Psychosis Informed Treatment
Chair: Kate Hardy1
Speakers: Shirley Glynn, Kate Hardy, Yulia Landa, Juliana Onwumere
1Stanford University, Palo Alto, CA, US
Families are integral to the care individuals with psychosis receive.
They are often the ﬁrst line of support for the individual and yet they
are frequently excluded from treatment and experience care giver
burnout and fatigue resulting in an impact on their own mental
health. This need has been recognized in the early psychosis ﬁeld,
where the young person is often still living in the family home, and
family intervention and peer support is recommended as a core com-
ponent of specialized early psychosis services. However, despite this
families still have trouble accessing specialized treatment within this
setting due in part to the lack of resources, staff trained in specialist
family interventions, and staff perceptions of working with families.
This symposium will present different models developed to engage
families in Cognitive Behavioural Therapy for psychosis (CBTp)
informed care. Each of these models draw upon CBT interventions
with the aim of supporting families to develop skills for self-care and
to support their loved ones. Data from these models will be pre-
sented along with a discussion regarding implementation to address
difﬁculties in large scale dissemination and training. In addition, the
symposium will provide research based recommendations to clinicians
and service managers for the inclusion of families in treatment in
terms of supporting their loved one and managing their own mental
health to reduce care giver burn out and ensure optimum engage-
ment and treatment response for the young person.
Talk 1
The Role of Family Intervention in the RAISE Early
Treatment Program
Shirley Glynn1, Susan Gingerich2, Kim Mueser3, Cori Cather4,
John Kane5
1UCLA Semel Institute for Neuroscience and Brain Behavior, Los Angeles,
USA, 2RAISE NAVIGATE Training Coordinator, USA, 3Center for
Psychiatric Rehabilitation, Boston University, USA, 4Massachusetts
General Hospital and Harvard Medical School, USA, 5Division of
Psychiatry Research, Zucker Hillside Hospital, North Shore–Long Island
Jewish Health System, USA
Purpose: The Recovery After an Initial Schizophrenia Episode Early
Treatment Project (RAISE-ETP) is a large multi-site US trial evaluating
the beneﬁts of coordinated specialty care on ﬁrst psychotic episode.
A key RAISE –ETP component is a comprehensive family interven-
tion. This presentation will provide an overview, rationale, and
engagement data pertaining to the RAISE-ETP family intervention.
Materials and Methods: Four hundred and four participants were
randomized to RAISE-ETP or customary care; consenting to family
participation in care was not an eligibility criteria. All RAISE-ETP par-
ticipants were offered an individual family program. Much of the con-
tent mirrored the individual resiliency training, which included
elements of cognitive-behavioural therapy for psychosis, and was
offered to all consumers in RAISE-ETP.
Results: Seventy seven percent of the RAISE-ETP consumers were
living with a relative; 68% had relatives who had at least one contact
with the RAISE-ETP team and 52% attended at least one educational
session. There was a mean (SD) of 6.39 (6.39) education sessions
attended by relatives who had any contact with treatment team.
Mothers were the primary involved relatives, and consumers were
present for 61% of the contacts. We are conducting further analyses
to identify predictors and beneﬁts of family engagement in
RAISE-ETP.
Conclusion: Family engagement was achievable but challenging. Par-
ticular obstacles to engagement included divorced and blended
families of origin, relatives who used illicit substances with the con-
sumer, relatives who were hostile towards antipsychotic medication
or mental health care, and role strain and distress in partners of indi-
viduals experiencing an initial psychotic episode.
Talk 2
Can Families Beneﬁt from Learning CBT for
Psychosis Skills?
Kate Hardy1, Lizette Aguirre-Giron2
1INSPIRE Clinic, Stanford University, Palo Alto, California, USA, 2Palo
Alto University, California, USA
Purpose: Families are often the ﬁrst line of support for young people
experiencing a recent onset of psychosis. Despite this families are
frequently excluded from treatment resulting in decreased access to
important skills needed to support their loved one and address their
own mental health needs as they help their family member navigate
mental health services.
Methods: This study evaluates the impact of training family members
in key Cognitive Behavioural Therapy for psychosis techniques over
the course of a 2 ½ day workshop. In line with a cognitive-
behavioural approach, the workshop aimed to help caregivers recog-
nize speciﬁc stressors and the impact this has on their thoughts, emo-
tions, and behaviours with a focus on developing appropriate coping
strategies to support their own mental well-being. In addition, care-
givers learned about the importance of developing collaborative rela-
tionships with their loved one through learning curious questioning
techniques, acknowledging and addressing their own assumptions
about symptoms, and applying coping skills to beneﬁt the whole
family.
Results: A total of 46 caregivers participated in the workshop. 65%
were supporting someone within the family home while the other
35% were in contact with their loved one more than 15 hours per
week. Participants reported high levels of satisfaction with the
workshop.
Conclusion: This study demonstrated the feasibility of training care-
givers in key CBT skills to address their own mental health needs and
to support their loved ones. The talk will present quantitative and
qualitative outcomes from this study and provide recommendations
for training families in these skills.
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Talk 3
Adaptation of CBT for Psychosis Training for
Family Caregivers of Youth at Risk for Psychosis
Yulia Landa1,2,3, Kim Mueser4, Michael Jacobs1, Rachel Jespersen1,2,3,
Katarzyna Wyka3,5
1Icahn School of Medicine at Mount Sinai, NY, USA, 2Mental Illness
Research, Education, and Clinical Center (MIRECC VISN 3), James
J. Peter Veterans Affairs Medical Center, Bronx, New York, USA, 3Weill
Medical College of Cornell University, New York, USA, 4Boston
University, Massachusetts, USA, 5CUNY School of Public Health,
New York, USA
Purpose: Teaching family caregivers CBT skills may serve as a protec-
tive factor for youth at-risk for psychosis, as it can help create a more
supportive family environment, and sustain therapeutic gains made in
time-limited CBT. We designed a comprehensive 15-week Group-
and-Family-based Cognitive Behavioural Therapy Program (GF-CBT)
that aims to facilitate functional recovery, decrease symptoms, and
prevent transition to psychosis in youth at-risk. To teach family mem-
bers how to apply CBT skills with their offspring, we adapted CBT for
psychosis clinician training program, and augmented it with simulated
learning (CBT skills are described, demonstrated, and role-played with
a standardized patient actor).
Materials and Methods: Six families participated in an open feasibility
trial, and 24 participate in a randomized controlled trial of GF-CBT.
Simulation scenarios and the Cognitive Behavioural Therapy Skills for
Families Scale (CBTSF-S) were developed to measure family mem-
bers’ proﬁciency at using CBT skills when communicating with youth
displaying attenuated psychotic symptoms. Qualitative interviews
about families’ experience with the program were conducted.
Results: There were signiﬁcant improvements in family members’
communication and use of CBT skills at post-treatment. Family care-
givers also reported increased understanding of their offspring’s
experiences, and greater conﬁdence in their ability to help. Family
members’ empathy, as perceived by youth, also increased, and youth
reported increased willingness to share with them distressing emo-
tional experiences. Gains were largely maintained at the three-month
follow-up.
Conclusion: Teaching CBT skills to family caregivers of youth at-risk
for psychosis is feasible, and can beneﬁt young individuals prone to
psychosis and their families.
Talk 4
CBT for Psychosis: Can Informal Carers Play a Role?
Juliana Onwumere1, Rosanna Michalczuk2, Stephanie Learmonth1,
Elizabeth Kuipers1,3
1Institute of Psychiatry, Psychology & Neuroscience, King’s College
London, UK, 2Royal Holloway University, London, UK, 3Biomedical
Research Centre, South London and Maudsley NHS Foundation Trust,
London, UK
Purpose: Many individuals with psychosis, particularly during the ﬁrst
episode, will live with or maintain close contact with relatives
(i.e. informal carers). There is a large body of evidence conﬁrming the
key role played by carers in supporting the recovery and wellbeing of
relatives with psychosis, and facilitating their timely access to rele-
vant services and care. Cognitive Behavioural Therapy for psychosis
(CBTp) is an evidence based psychological talking therapy included in
treatment guidelines across Europe and the USA. However, despite
the independent contributions of CBTp and carer support to optimis-
ing patient outcomes, little is known about carer involvement in indi-
vidual CBTp interventions.
Materials and methods: The current study employed focus group
methodology to explore the views of 22 psychological therapists,
working in early intervention and long-term psychosis populations,
about including carers in CBTp interventions.
Results: Thematic analyses of interview data identiﬁed six distinct
key themes comprising therapists’ positive and negative experiences
of including carers in interventions; confusion about what therapy
model was being used when carers were included in interventions;
support needed for therapists who included carers in sessions, and
ﬂexibility around the timing of when to include carers.
Conclusion: Carers may have an important role to play in therapy.
The talk will provide an overview of the key themes and review treat-




Gender Differences in Emerging Psychosis
Chair: Anita Riecher-Roessler1, Co-Chair: Anna Meneghelli2
Speakers: Anna Meneghelli, Anita Riecher-Rössler, Inez Myin-Ger-
meys, Paolo Brambilla
1Psychiatric University Clinics Basel, Switzerland, 2Ospedale Niguarda
Ca’ Granda Milan, Italy
Sex differences in schizophrenic psychosis have often been
described, especially regarding the age of onset and the course of the
disease. Little is known, however, regarding sex differences in emer-
ging psychosis, i.e. the prodromal phase of psychosis and its ﬁrst epi-
sode. In this symposium, we present data on sex differences from
different studies and centres, regarding age at onset, duration of
untreated illness, psychopathology, level of functioning, neurocogni-
tion, as well as stress reactivity, psychoendocrinology and neuroimag-
ing. We will show how sexual dimorphism impacts on brain
maturation trajectory from adolescence to adulthood. We will also
show that there are not many signiﬁcant differences between men
and women regarding psychopathology and neurocognition, and if
there are any, they seem to reﬂect general rather than patient-
speciﬁc differences between men and women. On the other hand,
stress reactivity seems to show distinct gender differences. The ﬁnd-
ings presented can shed some new light on the pathogenetic
mechanisms of emerging psychosis.
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Talk 1
Sex Differences in People at Ultra High-Risk of
Psychosis
Anna Meneghelli1, Antonio Preti2
1Ospedale Niguarda Ca’Granda, Milan, Italy, 2University of Cagliari,
Sardinia, Italy
Aims: Sex-related differences in the clinical expression and outcome
of schizophrenia have long been recognized. This study set out to
evaluate whether sex-related differences known to occur in the clini-
cal expression and outcome of schizophrenia extend to those sub-
jects who are judged at high risk of developing psychosis.
Methods: Detailed assessment of 140 patients with ﬁrst-episode psy-
chosis (FEP) and 120 subjects at ultra-high risk of psychosis (UHR) as
enrolled at an early intervention program in northern Italy. All consec-
utive admissions were enrolled in the study. Standard criteria were
used for diagnosis. Patients were assessed on validated scales aimed
at measuring level of psychopathology and functioning.
Results: In both the FEP and the UHR samples, males outnumbered
females. In FEP patients, women had been referred at an older age
than men and had a shorter duration of untreated illness (DUI) and of
untreated psychosis. In UHR patients, no sex differences were found
in age of onset or DUI, nor statistically signiﬁcant differences by sex
were found in exposure to traumatic event, suicide attempt before
enrolment, substance abuse. There was no diagnosis by sex interac-
tion on symptoms severity or level of functioning at presentation.
Conclusion: The factors that are related to sex differences in age of
onset of schizophrenia are speciﬁc to the full-blown psychosis and
are less evident in the prodromal phases. Precipitating factors, such
as stress and substance use and abuse might contribute to explaining
sex differences in onset of schizophrenia, and may affect course and
outcome as well.
Talk 2
Sex Differences in the At Risk Mental State and
First Episode Psychosis
Anita Riecher-Rössler
University of Basel Psychiatric Clinics, Basel, Switzerland
Aims: To analyze sex differences in emerging psychosis, i.e. the prod-
romal phase of psychosis and its ﬁrst episode.
Methods: We examined all patients referred to the specialized Early
Detection Clinic of the University Psychiatric Hospital Basel and fol-
lowed them up over at least 5 years regarding later transition to psy-
chosis within the Basel FePsy (Früherkennung von Psychosen) study.
Results: We could so far analyze data of 173 at-risk mental state
(ARMS) and 130 ﬁrst episode psychosis (FEP) patients. As regards
psychopathology, we did not ﬁnd any signiﬁcant gender differences.
Regarding neurocognition, women performed better in verbal learn-
ing and memory independent of the diagnostic group. Men showed a
shorter reaction time during the working memory task. In the sub-
group of antipsychotic-naïve patients we found hyperprolactinaemia
in a substantial proportion of FEP and ARMS, mainly in women. Pitui-
tary volumes were increased in emerging psychosis (FEP and ARMS
patients with later transition to psychosis > ARMS patients without
later transition and healthy controls) and considerably larger in
women than in men.
Conclusions: There do not seem to exist profound sex differences in
symptomatology in the very early stages of psychosis. Sex differences
in neurocognition seem to be similar to those in the healthy general
population. Prolactin levels and pituitary volumes were increased in
both genders, but much more in women than in men. These latter
ﬁndings might indicate that emerging psychosis is associated with
more stress for women than for men.
Talk 3
Sex Differences in Emotional Reactivity to Daily
Life Stress in Emerging Psychosis
Inez Myin-Germeys
KU Leuven, Leuven, Belgium
Although it has long been suggested that men and women differ in
their vulnerability to and expression of psychosis, recent studies did
not ﬁnd clear-cut sex differences. The current study examined self-
reported psychotic experiences in context in order to more fully
understand the extent and nature of sex differences along the psy-
chosis continuity. 283 healthy controls, 268 subjects at genetic or
psychometric risk for psychosis, and 232 patients diagnosed with a
psychotic disorder were examined with ESM to investigate in the
realm of daily life a) symptoms, b) behaviour in context, and c) under-
lying mechanism of stress and reward sensitivity. Multilevel regres-
sion analyses revealed very little differences in symptom expression
and real life behaviour between men and women in daily life. Men
and women did not differ in their level of social interaction and over-
all activity. However, men at increased risk of psychosis were more
often alone and were less involved in goal-directed activities com-
pared to women. Women reported more emotional reactivity to daily
life stress then men but women also reported a higher increase in
positive affect related to pleasant events. The data suggest only
minor differences between men and women in psychotic symptoms
and behaviour. Furthermore, they seem to reﬂect general rather than
patient speciﬁc differences between men and women. The higher
levels of stress-reactivity and reward-sensitivity in women compared
to men point towards a protective factor, suggesting that increased
environmental reactivity in women in addition to more social contacts
may prevent the development of more severe psychopathology.
Talk 4
Sexual Dimorphism and Heterochronicity of Brain
Maturation Trajectory From Adolescence to
Adulthood
Paolo Brambilla
Ospedale Maggiore, Milan, Italy
Human brain maturation trajectory involves highly coordinated and
sequenced events, but the impact of sexual dimorphism during the
post-adolescence period has not been fully explored. The focus of
the present study is to investigate sexual dimorphism in the post-
adolescent phase of middle-age. A large European multi-site
(EnPACT) sample of males and females between the ages of 18 and
60 was scanned to obtain 3D T1-weighted images, including healthy
individuals and patients with major psychoses. Sampling density
across the age-range was high. Step-wise changes during the devel-
opmental period were analyzed across subjects (separately by gender)
using voxel-wise approaches. Changes in white matter and gray mat-
ter will be shown in both healthy and psychotic subjects. Our ﬁndings
will help to clarify how the sexual dimorphism impacts on brain matu-
ration trajectory from adolescence to adulthood and, consequently,
the cognitive differences that have been documented between males
and females, such as spatial abilities or verbal skills. Future studies
should also consider the hormonal effects on brain maturation and
possibly on behaviour in respect to sexual dimorphism.
Question and Answer Period
Discussant: Alison Yung, Institute of Brain, Behavior and Mental Health,




4:30–6:00 p.m. Washington A
Pathways to Psychosis: New Evidence on
Childhood Adversity and Social Stress Sensitivity in
Early Psychosis
Chair: Mark van der Gaag1, Co-Chair: Ulrich Reininghaus2
Speakers: Wim Veling, Jacqueline Counotte, Lucia Valmaggia, Ulrich
Reininghaus
1VU University, Department of Clinical Psychology, Amsterdam, The
Netherlands, 2Maastricht University, Department of Psychiatry and
Neuropsychology, Maastricht, The Netherlands
Evidence has accumulated that implicates various types of childhood
adversity in the aetiology of psychosis. Although we know there is an
association between childhood adversity and psychosis, we know
very little about the putative mechanisms involved. Contemporary
models of psychosis suggest that exposure to childhood trauma
makes individuals more sensitive to subsequent social stress and,
thereby, contributes to risk. This symposium brings together interna-
tional researchers at the forefront of research into the role of social
stress sensitivity as an important mechanism underlying the associa-
tion between childhood adversity and psychosis using novel ecologi-
cal momentary assessment (EMA) and virtual reality (VR) technology.
Wim Veling will report new ﬁndings from an experimental VR study
that heightened social stress sensitivity in virtual social risk environ-
ments mediates associations between childhood trauma, affective
symptoms, and psychosis liability. Jacqueline Counotte will present
novel data on the autonomic stress response to social stress using
the same experimental VR design; decreased parasympathetic activity
in virtual social risk environments was found in individuals with high
psychosis liability. Lucia Valmaggia will report recent ﬁndings on the
association between bullying-victimisation in childhood, heightened
interpersonal sensitivity and paranoid ideation in individuals at ultra-
high risk (UHR) for psychosis. Ulrich Reininghaus will present novel
ﬁndings from an EMA study in ﬁrst-episode psychosis patients, UHR
individuals, and healthy controls that suggest social stress sensitivity
is a risk and resilience mechanism underlying the association between
childhood sexual abuse and psychosis. Peter Jones will discuss these
ﬁndings in the context of new challenges and directions for future
research.
Talk 1
Childhood Trauma and Social Stress Reactivity in
Psychosis: A Virtual Reality Study
Wim Veling1,2,3, Jacqueline Counotte2, Roos Pot-Kolder2,4,
Jim van Os3,5, Mark van der Gaag2,4
1University of Groningen, University Medical Center Groningen,
Department of Psychiatry, Groningen, The Netherlands, 2Parnassia
Psychiatric Institute, The Hague, The Netherlands, 3Maastricht
University, Department of Psychiatry and Neuropsychology, Maastricht,
The Netherlands, 4VU University, Department of Clinical Psychology,
Amsterdam, The Netherlands, 5King’s College London, King’s Health
Partners, Department of Psychosis Studies, Institute of Psychiatry,
London, UK
Introduction: Childhood trauma may be related to risk for psychosis
by the mechanism of sensitization to social stress. Virtual Reality
(VR) provides the opportunity to test this mechanism by controlled
experimental exposure to different social environments.
Methods: Fifty-ﬁve patients with recent onset psychotic disorder
(FEP), 20 patients at ultra-high risk for psychosis (UHR), 42 siblings of
patients with psychosis and 53 controls walked ﬁve times in a virtual
bar with different levels of environmental social stress. Virtual social
stressors were population density, ethnic density and hostility. Social
stress sensitivity was measured with paranoia and subjective distress
in response to virtual social stress exposures, childhood trauma and
self-esteem were assessed at baseline. Multilevel random intercept
regression analyses were used to test childhood trauma as predictor
and moderator of paranoia and subjective distress in VR. Social stress
sensitivity was tested as mediator between childhood trauma and
symptoms of psychosis.
Results: Childhood trauma was signiﬁcantly associated with higher
paranoia and subjective distress in the virtual social stress experi-
ments. There was a positive and linear interaction between childhood
trauma and degree of environmental social stress on paranoia and
subjective distress. Social stress sensitivity measures mediated asso-
ciations between childhood trauma, (minor) psychotic and affective
symptoms, and psychosis liability.
Conclusions: Childhood trauma is associated with heightened social
stress sensitivity and contributes to psychotic and affective dysregu-
lation later in life by sensitized paranoid and stress response to social
stressors.
Talk 2
High Psychosis Liability is Associated with Altered
Autonomic Balance during Exposure to Virtual
Reality Social Stressors
Jacqueline Counotte1, Roos Pot-Kolder1,2, Arie M. van Roon3,
Olivier Hoskam4, Mark van der Gaag1,2, Wim Veling1,3,5
1Parnassia Psychiatric Institute, The Hague, The Netherlands, 2VU
University, Department of Clinical Psychology, Amsterdam, The
Netherlands, 3University of Groningen, University Medical Center
Groningen, Department of Psychiatry, Groningen, The Netherlands, 4GGZ
Delﬂand,the Netherlands, 5Maastricht University, Department of
Psychiatry and Neuropsychology, Maastricht, The Netherlands
Social stressors are associated with an increased risk of psychosis.
Stress sensitisation is thought to be an underlying mechanism and
may be reﬂected in an altered autonomic stress response. Using an
experimental Virtual Reality (VR) design, the autonomic stress
response to social stressors was examined in participants with differ-
ent psychosis liability. Fifty-ﬁve recent onset psychosis patients,
20 patients at ultra-high risk for psychosis, 42 siblings of patients
with psychosis and 53 controls were exposed to social stressors
(crowdedness, ethnic minority status and hostility) in a VR environ-
ment. Heart rate variability parameters and skin conductance levels
were measured at baseline and during VR experiments. High psycho-
sis liability groups had signiﬁcantly increased heart rate and
decreased heart rate variability compared to low liability groups both
at baseline and during VR experiments. Spectral analysis of heart rate
variability showed that both low frequency (LF) and high frequency
(HF) power were reduced and LF/HF ratio was unaltered compared
to low liability groups, indicating decreased parasympathetic activity
in patients with high psychosis liability. The number of virtual social
stressors signiﬁcantly affected heart rate, HF, LF/HF and skin con-
ductance level in all liability groups. There was no interaction
between psychosis liability and amount of virtual social stress. Thus,
high liability to psychosis was associated with decreased parasympa-
thetic activity in virtual social environments, which reﬂects generally
high levels of arousal, rather than increased autonomic reactivity to
social stressors. Our ﬁndings contribute to increased understanding
of stress sensitisation and highlight the importance of cardiovascular
risk management in psychosis.
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Talk 3
Interpersonal Sensitivity and Bullying Victimisation
in those at Ultra High Risk of Psychosis
Lucia Valmaggia1, J. McDonnell1,2, Daniel Stahl1, Paul Chadwick1,2,
Philip McGuire1,2
1King’s College London, Institute of Psychiatry, Psychology and
Neuroscience, London, UK, 2South London and Maudsley NHS
Foundation Trust, London, UK
In this study we examined the potentially causal link between bully-
victimisation in childhood, heightened interpersonal sensitivity and
paranoid ideation in the ultra-high risk group. Data were collected for
64 individuals in the ultra-high risk group for psychosis, and
43 healthy controls, using measures of interpersonal sensitivity, his-
tory of bullying, and state paranoid ideation in a virtual environment.
Path analysis was conducted to explicate the relationship between
these three variables of interest in the ultra-high risk group. The
ultra-high risk group reported comparatively higher rates of historical
bullying, interpersonal sensitivity and paranoid ideation. Path analysis
indicated that interpersonal sensitivity fully explained the signiﬁcant
association between severe bullying in childhood and paranoid idea-
tion in the ultra-high risk group. The signiﬁcant role played by inter-
personal sensitivity in the association between being bullied in school
and paranoid ideation in the ultra-high risk group suggests that this
should become a target for intervention.
Talk 4
Childhood Trauma, Social Stress Sensitivity and
Psychosis: An Experience Sampling Study
Ulrich Reininghaus1,2, Charlotte Gayer-Anderson2, Lucia Valmaggia3,
Matthew J. Kempton4, Helen L. Fisher5, Philip McGuire4,6,
Philippa Garety3,6, Jim van Os1,4, Robin M. Murray4,6, Til Wykes3,6,
Inez Myin-Germeys7, Craig Morgan2,6
1Department of Psychiatry and Psychology, School for Mental Health
and Neuroscience, Maastricht University, The Netherlands, 2Centre for
Epidemiology and Public Health, Health Service and Population Research
Department, Institute of Psychiatry, Psychology & Neuroscience, King’s
College London, London, UK, 3Psychology Department, Institute of
Psychiatry, Psychology & Neuroscience, King’s College, London, UK,
4Psychosis Studies Department, Institute of Psychiatry, Psychology &
Neuroscience, King’s College, London, UK, 5MRC Social, Genetic &
Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &
Neuroscience, King’s College London, London, UK, 6National Institute for
Health Research (NIHR) Mental Health Biomedical Research Centre
(BRC) at South London and Maudsley NHS Foundation Trust and King’s
College London, 7Department of Medicine, Psychiatry Research Group,
Catholic University of Leuven, Belgium
Evidence has accumulated that implicates childhood trauma in the
aetiology of psychosis, but our understanding of the putative psycho-
logical processes and mechanisms through which childhood trauma
impacts on individuals and contributes to the development of psy-
chosis remains limited. We aimed to investigate whether stress sensi-
tivity underlie the association between childhood abuse and
psychosis. We used the Experience Sampling Method to measure
stress, threat anticipation, negative affect, and psychotic experiences
in 50 ﬁrst-episode psychosis (FEP) patients, 44 At-Risk Mental State
(ARMS) participants, and 52 controls. Childhood abuse was assessed
using the Childhood Trauma Questionnaire. Associations of minor
socio-environmental stress in daily life with negative affect and psy-
chotic experiences were modiﬁed by sexual abuse and group (all p
< 0.05). While there was strong evidence that these associations
were greater in FEP exposed to high levels of sexual abuse, and some
evidence in ARMS exposed, controls exposed were more resilient
and reported less intense negative emotional reactions to socio-
environmental stress. Elevated sensitivity and lack of resilience to
socio-environmental stress in daily life may be an important
psychological mechanism underlying the association between child-
hood sexual abuse and psychosis.
Question and Answer Period




4:30–6:00 p.m. Washington B
Striking Variation in First Episode Psychosis Across
15 Europe Sites
Chair: Robin Murray1, Co-Chair: Jim Van Os2
Speakers: Craig Morgan, Marta Di Forti, Jim Van Os, Robin Murray
1Institute of Psychiatry, Psychology & Neuroscience, Department of
Psychosis Studies, King’s College London, London, UK, 2University of
Maastricht, Amsterdam, The Netherlands
Craig Morgan will show that incidence of psychosis across 15 sites in
Europe, ranged from 10.0 per 100,000 in Cuenca, Spain to 63.9 per
100,000 in London, a six-fold difference. Incidence was highest in
London (63.9 per 100,000) and Amsterdam (50.0 per 100,00) and
lowest in northern European rural sites, and all southern European
sites (e.g., Palermo, 12.8 per 100,000; Madrid, 21.6 per 100,000).
Marta Di Forti will demonstrate that the lifetime prevalence of canna-
bis use across the 16 sites varied between 35% and 75% in cases,
and between 24% and 60% in controls. London and Amsterdam had
the highest proportion of daily users. The proportion of ﬁrst episode
psychosis cases attributable to cannabis (PAF) ranged from 6% to
25%, with London and Amsterdam having the highest PAF attributa-
ble to the use of high potency cannabis. Jim Van Os will show data
concerning ’Jumping to Conclusions’. Working Memory, and psy-
chotic symptoms from a general population sample (n = 4597).
Alterations in JtC and working memory were associated with both
psychotic and non-psychotic psychopathology. Cannabis use was
associated with a more favourable cognitive proﬁle, independent of
psychopathology and demographic confounders. Robin Murray will
consider predictors of treatment resistant schizophrenia (TRS) in two
ﬁrst episode psychosis studies; about one quarter of patients in each
developed TRS. The majority were TRS from the onset, but a minority
(20-30%) had originally responded to antipsychotics; the former may




Similarities and Differences in Rates of Psychoses
and Effects of Environmental Factors Across
Europe
Craig Morgan
Health Services and Population Studies, King’s College, London, UK
As part of the EU-GEI programme, we completed a large multi-centre
incidence and case-control study of psychotic disorders. In deﬁned
catchment areas in 15 sites in 6 countries, we identiﬁed a) all incident
cases of psychotic disorder aged 18 - 64 years over 36 months and
b) population-based samples of controls. We identiﬁed 2,553 cases
from a total of 12,880,210 person years at risk. Crude incidence rates
varied markedly from 10.0 per 100,000 person years in Cuenca, Spain
to 63.9 per 100,000 in London, UK, a six-fold difference. Incidence
rates were highest in northern European urban sites (e.g., London,
UK 63.9 per 100,000; Amsterdam, Netherlands 50.0 per 100,00) and
lowest in both northern European rural sites (e.g., Cambridge, UK
18.9 per 100,000) and all southern European sites (e.g., Palermo, Italy
12.8 per 100,000; Madrid, Spain 21.6 per 100,000). Our analyses to
date have focused on childhood adversities (i.e., household poverty,
household discord, neglect, bullying, and psychological, physical, and
sexual abuse). The effects of these exposures were strikingly similar
across sites. For example, the odds of physical abuse were between
1.5 and 3.5 times higher in cases compared with controls in all but
one of the 15 sites. However, the prevalences of reported adversities
in the control samples varied markedly among sites (e.g., physical
abuse: 25.6% in London, UK; 6.3% in Oviedo, Spain).It may be that
variations in incidence are, at least in part, a function of variations in
the distribution of environmental risk factors across populations.
Talk 2
Geographical Differences in Cannabis Use Explain
Variations in the Proportion of Cases of Psychosis
Attributable to Cannabis Use Across Europe
Marta Di Forti
Social Genetic and Developmental Psychiatry, Institute of Psychiatry,
King’s College, London, UK
Detailed data on pattern of cannabis use were collected from 1200
ﬁrst episode psychosis patients and 1200 population controls across
15 sites from 6 European countries. DNA samples were also collected
from all participants for GWAS analyses and to build a Schizophrenia-
Polygenic Risk score (S-PRS). The measure of cannabis use that best
predicted risk for psychosis consistently across sites was used in the
interaction analyses with the S-PRS, expressed in quartiles, to investi-
gate whether summary scores for Schizophrenia genetic load can
explain variations in the risk of cannabis users to suffer from a psy-
chotic disorder. Lifetime prevalence of cannabis use across the EU
sites varied between 35% and 75% in cases and between 24% and
60% in controls. Age at ﬁrst use was on average 16 years across the
sites (SD 9.5). Frequency of use varied signiﬁcantly across EU:
London and Amsterdam had the highest proportion of daily users
among cases and the highest availability of high potency type of can-
nabis. The proportion of cases attributable to cannabis use (PAF) var-
ied between 6% and 25% with London and Amsterdam having the
highest proportion of cases attributable to the use of high potency
cannabis. Preliminary analyses of the S-PRS and data on frequency of
cannabis use, using the entire sample (n = 2400), suggest a signiﬁcant
interaction between intermediate S-PRS quartiles and daily cannabis
use on risk to suffer from psychosis. Thus, individual genetic load for
schizophrenia, measured as PRS, signiﬁcantly inﬂuences the probabil-
ity of cannabis users to suffer a psychotic disorder.
Talk 3
Cognition, as a Transdiagnostic Factor Underlying
Expression of Psychopathology, is an Important
Phenotype for GxE Research
Jim Van Os
Department of Psychiatry, University of Maastricht, Amsterdam, The
Netherlands
We examined probabilistic reasoning bias, or ’Jumping to Conclu-
sions’ measured with the Beads Task (JtC) and a Working Memory
task in a large general population sample (n = 4597), in order to ana-
lyse associations with psychotic and non-psychotic psychopathology,
the impact of environmental factors on this phenotype, and possible
gene-environment interactions, using polygenic risk scores. Psychotic
symptoms were associated, adjusted for minority status and educa-
tion, with both JtC and reduced working memory, particularly the
combination of delusions and hallucinations and the combination of
psychotic and non-psychotic symptoms. Cannabis use, independent
of psychosis, was associated with BETTER working memory and LESS
tendency to JtC, whereas childhood trauma was not associated with
either. Results of GxE analyses will be presented. Associations
between psychotic symptoms on the one hand, and JtC and working
memory on the other were not speciﬁc, as similar associations existed
with any mood disorder, even in those without psychotic symptoms.
The results suggest that alterations in JtC and working memory are
associated with both psychotic and non-psychotic psychopathology
in the general population, independent of environmental risks. Canna-
bis use was associated with a more favourable cognitive proﬁle, inde-
pendent of psychopathology and demographic confounders.
Talk 4
Early and Late Types of Treatment Resistant
Schizophrenia Develop in Patients with First
Episode Psychosis Followed Up For 5-10 Years
Robin Murray, Arsime Demjaha, Olesya Ajnakina
Psychosis Department, Institute of Psychiatry, King’s College,
London, UK
Surprisingly little is known about treatment resistant schizophrenia
(TRS), its predictors, and the mechanisms which underlie it. We stud-
ied the development of TRS in two large ﬁrst episode psychosis stud-
ies from the UK; the ﬁrst, the AESOP study was followed-up for
10 years and the second, the GAP study for 5 years. The outlook for
ﬁrst episode psychosis as a whole was good with 62% of those in the
AESOP study having no signiﬁcant psychotic symptoms at ten years.
However, about one quarter of patients in each sample (AESOP and
GAP) developed TRS. Between 70 and 83% of TRS patients were
non-responders from the onset of psychosis in the two studies, GAP
and AESOP respectively, but a minority (17-30%) had originally
responded to antipsychotics but then became TRS. Neurochemical
imaging data suggest that the former group do not show any abnor-
mality of stratal dopamine but rather show increased glutamate in
the anterior cingulate; some tentative evidence (e.g. earlier onset,
male gender, predominant negative symptoms) suggest that this
group may have a neurodevelopmental origin. In contrast, the late
onset TRS group may result from antipsychotic-induced dopamine
supersensitivity; i.e. the compounding of the original presynaptic





PEPPNET: A National Network to Support
Coordinated Early Psychosis Service Development
Chair: Kate Hardy1
Speakers: Steven Adelsheim, Vinod H. Srihari, Kate Hardy, Laurie
Flynn
1Stanford University, Palo Alto, California, USA
Early psychosis service implementation in the United States has
lagged behind other countries. Centres of excellence for early psy-
chosis research and treatment exist, typically afﬁliated with academic
settings, but there is generally a dearth of treatment options within
the community. However, recent federal initiatives allocated a 10%
funding set aside from the Mental Health Block Grant (increased this
year from 5%) speciﬁcally to target early psychosis service develop-
ment. Additionally, the publication of outcomes from the RAISE initia-
tive has heightened public interest in this issue and demonstrated the
impact of providing these services within a community setting. This
has resulted in increased demand from the public, and community
agencies, for access to these types of services. The Prodromal and
Early Psychosis Program Network (PEPPNET) was developed in 2014
bringing together national experts in early psychosis from across the
United States. PEPPNET aims to address implementation challenges
and requests from agencies and providers for guidance and technical
assistance to support service development. The network consists of a
steering committee and three workgroups with participants from aca-
demia, community agencies, federal agencies, and those with lived
experience. This symposium will describe the unique structure of this
network and the roles of each of the workgroups including outcomes
from surveys and discussions generated in these workgroups. The
symposium will be of interest to those interested in advocacy, imple-
mentation efforts at a national level, and broad dissemination of
information to providers to support practice change.
Talk 1
Implementation of a National Early Psychosis
Clinical Support Program in the United States: The
Prodrome and Early Psychosis Program Network
(PEPPNET)
Steven Adelsheim1, Vicki Harrison1, Robert Heinssen2,
Jane Isaacs Lowe3, Gary M. Blau4
1Stanford University, Palo Alto, CA, USA, 2Division of Services and
Intervention Research, National Institute of Mental Health, Bethesda,
Maryland, USA, 3Robert Wood Johnson Foundation, Princeton, New
Jersey, USA, 4Center for Mental Health Services, Substance Abuse and
Mental Health Services Administration, Rockville, Maryland, USA
Purpose: The Prodrome and Early Psychosis Program Network
(PEPPNET) provides technical assistance and clinical support for the
growing number of clinical programs focused on supporting those
with clinical high risk or early psychosis across the United States (US).
Materials and Methods: Four core working groups have been devel-
oped to support PEPPNET member program site implementation,
including the overarching steering group, which consists of convening
members from research, clinical care, advocacy, lived experience, and
federal/local agencies. In addition, the three subcommittees of train-
ing, treatment, and lived experience provide coordination and techni-
cal expertise in site implementation. Other core components of
PEPPNET include registration of over 200 PEPPNET members from
sites across the country, launch of a national list-serve, a newsletter
and website.
Results: PEPPNET’s infrastructure and workgroups provide critical
coordination and support for the rapidly expanding number of clinical
early psychosis sites across the US. With additional federal funding
coming to each US state, the need to ensure evidence-based training
and implementation continues to grow in both scope and urgency. In
partnership with other founding agencies, PEPPNET is quickly moving
to ﬁll that gap.
Conclusion: While sustainable funding for PEPPNET remains a ques-
tion for the future, the Network continues to provide valuable coor-
dination of local program development and technical assistance.
Talk 2
PEPPNET Treatment Workgroup for Early
Intervention Services (EIS)
Vinod H. Srihari1,2, Lisa Dixon3,4
1Department of Psychiatry, Yale University School of Medicine, New
Haven, CT, USA, 2Program for Specialized Treatment Early in Psychosis
(STEP), New Haven, CT, USA, 3Columbia University Medical Center,
New York, NY, USA, 4New York State Psychiatric Institute, New York,
NY, USA
Purpose: Studies have tested a variety of multi-element packages for
EIS, but substantial uncertainty remains regarding what speciﬁc treat-
ment components are critical for different subgroups in different set-
tings. In the US, “coordinated specialty care” has been offered as a
starting point. However, new services can draw from a wealth of
empirically based treatments and implementation experiences when
designing packages of care.
Methods: This workgroup facilitates dialogue on candidate treatment
components for individuals at clinical high risk for, or experiencing
ﬁrst episode psychosis. This is a rapidly evolving ﬁeld, and one in
which service context and population may impact choice of treat-
ments and their effectiveness. Thus, rather than identify core compo-
nents, emphasis is placed on sharing expertise in various empirically
based approaches with adequate discussion of implementation
context.
Results: A monthly tele-forum has elicited broad representation from
programs across the country, and interest in a variety of treatments
(e.g. CBTp, supported education). Brief presentations by content
experts are followed by active discussions focused on adaptations
and implementation challenges. Slide presentations, written summa-
ries and recordings of all workgroup meetings have been made availa-
ble online. The workgroup will include problems without deﬁned
treatments (e.g. disengagement) or for which program level responses
are necessary (e.g. reducing duration of untreated psychosis). Bench-
marks for relevant effectiveness outcomes will be considered, to sup-
port high standards of practice across these services.
Discussion: This model for sharing expertise can support implementa-
tion of new programs, and reﬁnement of established services, all
toward optimizing the public health impact of early intervention.
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Talk 3
PEPPNET: Addressing Training and Technical
Assistance Needs in the Community
Kate Hardy1, Tamara Sale2
1Stanford University, Palo Alto, CA, USA, 2Portland State University,
Portland, OR, USA
Purpose: Increased understanding of the need for widespread early
psychosis implementation in the United States has resulted in com-
munity agencies seeking appropriate consultation and training to sup-
port service development efforts. Unfortunately, despite dedicated
federal funding, there is no national guidance to support these
efforts. This has resulted in agencies reporting confusion as they
research the different early psychosis models currently available in
the United States in particular recognizing a need to adapt these
models to ﬁt their community but unsure as to how to do so.
Methods: The Training and Technical Assistance (TA) workgroup
meets monthly as part of the Prodromal and Early Psychosis Program
Network (PEPPNET) and was formed to address the training and TA
needs of communities implementing early psychosis services, to share
information about training and TA, and to build a national infrastruc-
ture to support effective implementation. It comprises of members
from across the United States currently engaged in both the develop-
ment and delivery of training and TA related to early psychosis
implementation.
Results: A survey of PEPPNET members was conducted to assess
training and TA needs and initiatives. Results indicated a three-tiered
approach to training and TA and an overwhelming recognition that
demand has surpassed supply. The group has also created consensus
document to support new service development initiatives in the
community.
Conclusions: The surge in early psychosis service development is
welcomed however it has associated challenges with the provision of
evidence-based training. The national Training and TA workgroup
addresses these challenges to support widespread implementation.
Talk 4
PEPPNET: Integrating Peers and Individuals with
Lived Experience into National Service
Development and Reform
Laurie Flynn
NAMI NYC Board of Directors, New York, USA
Purpose: First episode psychosis is a profoundly distressing experi-
ence. The young person and their family are often frightened and
bewildered. Effective early psychosis programs must begin where the
person is, listening to their experience and needs. It’s vital that pro-
grams engage, inform and support an ongoing partnership for recov-
ery. The voice of individuals with lived experience (both consumers
and families) is crucial to this process. PEPPNET leaders respect the
voices of peers and family members and formed a workgroup of a
diverse group of peers and caregivers involved in outreach, education
and advocacy.
Method: Monthly teleconferences were formed to exchange informa-
tion, discuss projects and work towards achieving the workgroup
goals of: 1) Raising awareness and incorporate best practices in work-
ing with families and people with lived experience. 2) Helping engage
and educate consumers/families on clinical aspects of care, 3) Helping
engage, recruit and promote these programs.
Results: Active for nine months, we’ve already had an impact. Mem-
bers of our workgroup joined the other PEPPNET workgroups
(Training & Technical Assistance and Treatment) providing updates
on our activities and concerns. We focused on two strategic projects:
1) adapting resources aimed at incorporating cultural awareness
across early psychosis recruitment and treatment, 2) developing an
online survey to collect experiences of peers and families in their ini-
tial contact with the mental health system.
Conclusion: The lived experience workgroup is using our collective
knowledge to inform education and recruitment efforts, increase





The Long Journey from Biological Markers,
Environment Adversities and Treatment
Effectiveness of Early Interventions on Psychosis -
Data from the GET UP Project in Community
Services Serving a 10 million Inhabitant
Catchment Area
Chair: Mirella Ruggeri1, Co-Chair: Maximilian Birchwood2
Speakers: Luisella Bocchio Chiavetto, Letizia Squarcina, Maximilian
Birchwood, Juliana Onwumere
1Section of Psychiatry, Department of Neuroscience, Biomedicine and
Movement, University of Verona, Italy, 2Mental Health and Wellbeing,
Warwick Medical School, Coventry, UK
In this Symposium, a set of data on biological and environmental mar-
kers and moderators of response in patients and their relatives to
standard and innovative interventions in psychosis will be discussed.
More speciﬁcally, we will present a body of evidence on Immune and
Metabolic Alterations, cognitive and neuro-functional and neurologi-
cal endophenotypes; cerebral morpho-functional and neuropsycho-
logical markers of prognostic value and on adverse events that can
contribute to enhancing treatment response, patients’ clinical
improvement and relatives coping skills. Data from the research pro-
gramme “Genetics Endophenotypes and Treatment: Understanding
early Psychosis” (GET-UP) funded by the Italian Ministry of Health,
which aims to apply innovative and targeted forms of intervention
for ﬁrst episode psychosis and to test its effectiveness and feasibility
in the community care will be presented. The randomised controlled
trial launched in the frame of the GET UP research Programme is
based on sophisticated epidemiological, clinical, environmental biolog-
ical, and neurocognitive investigations and involves 117 Mental
Health Centres located throughout a 10 million-inhabitant catchment
area, including two Regions (Veneto and Emilia Romagna) and the
Bolzano, Florence, and Milan provinces. This is the largest Trial ever
conducted so far in this ﬁeld and aims to enhance knowledge of clini-
cal, social, and environmental predictors for illness course, outcomes,
and treatment response and providing key information to orient prog-
nostic judgement, plan targeted and individualized intervention.
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Talk 1
Molecular Markers of Psychosis Onset: Immune
and Metabolic Alterations in First Episode
Psychosis (FEP) Patients
Luisella Bocchio Chiavetto1, Roberta Zanardini2, Clarissa Ferrari2,
Sarah Tosato3, Antonio Lasalvia3, Paolo Santonastaso4,
Giovanni de Girolamo2, Francesca Pileggi5, Fausto Mazzi6,
Emanuela Leuci7, Mirella Ruggeri2, Massimo Gennarelli3
1IRCCS Fatebenefratelli Brescia, Italy, 2University of Verona, Italy,
3University of Brescia, Italy, 4University of Padova, Italy, 5AUSL Bologna,
Italy, 6AUSL Modena, Italy, 7AUSL Parma, Italy
Purpose: The molecular underpinnings associated to ﬁrst episode
psychosis (FEP) remains to be elucidated, but this issue is of great
interest considering the usefulness of possible biomarkers for the
improvement of diagnosis and treatment personalization. Compelling
evidence supported an association of FEP with blood alterations in
immune system, neurotrophins, growth factors and metabolism
regulators.
Materials and Methods: In order to identify possible biomarkers for
differential diagnosis in FEP patients, the serum levels of the neuro-
trophins BDNF and VEGF, the cytokines IL-1RA, IL-6, IL-10 and IL-
17, RANTES, MIP-1 beta, IL-8 and the metabolic regulators C-pep-
tide, Ghrelin, GIP, GLP-1, Glucagon, Insulin, Leptin, PAI-1, Resistin
and Visfatin were analysed in 260 subjects collected in the GET-UP
project (49 were controls).
Results: The results indicated alterations of serum VEGF, MIP-1, IL-6,
Ghrelin, GLP-1, Glucagon and PAI-1 in FEP patients (p < 0.01). The
principal component analysis (PCA) revealed that the most important
variables to discriminate patients versus controls are Ghrelin, Gluca-
gon, VEGF and MIP-1. Moreover, a signiﬁcant increase of IL-8 serum
levels in patients with an affective psychosis diagnosis vs other FEP
patients was observed (p = 0.008). The ROC analysis evidenced a
high discrimination performance of MIP-1 concentrations in classify-
ing patients (AUC = 0.864), whereas only a weak effect was found
for IL-8 measures in the identiﬁcation of affective psychosis vs other
FEP diagnoses (AUC = 0.629).
Conclusion: The data evidenced a dysregulation in the inﬂammatory
system and glucose metabolism in FEP patients, in line with previous
ﬁndings, nevertheless none of the studied markers showed a poten-
tial usefulness for the differential diagnosis.
Talk 2
Classiﬁcation of First-Episode Psychosis Using
Machine Learning Techniques on Multimodal
Multisource MRI Data
Letizia Squarcina1, Umberto Castellani1, Marcella Bellani1,
Cinzia Perlini2, Nicola Dusi1, Mirella Ruggeri2, Paolo Brambilla3
1Aoui Verona, Italy, 2University of Verona, Italy, 3University of Milano,
Italy
First episode psychosis (FEP) patients are of particular interest for
neuroimaging investigations because of the absence of confounding
effects due to medications and chronicity. Nonetheless, imaging data
are prone to heterogeneity because for example of age, gender or
parameter setting differences. In our recent works, we tried to auto-
matically discriminate FEP patients and normal controls on the basis
of multi-modal magnetic resonance imaging (MRI) data. In particular
we have employed support vector machine (SVM) classiﬁers on gray
matter structures, white matter ﬁbre bundles, and perfusion indexes.
Brain hemodynamic and structural changes have been reported in
major psychosis in respect to healthy controls, and could be therefore
of relevance for the onset of psychosis. In general, our studies show
that multivariate machine learning approaches integrating multi-
modal and multisource imaging data can classify FEP patients with
high accuracy. Interestingly, speciﬁc grey matter structures and white
matter bundles reach high classiﬁcation reliability when using
different MRI modalities and indices, with particular regards to frontal
and temporo-parietal areas. Therefore, we found evidence that brain
perfusion, cortical thickness, and white matter integrity can be used
as potential markers to classify patients with FEP.
Talk 3
From Childhood Adversity to First-Episode
Psychosis: Associations Between Social
Environment and Speciﬁc Symptom Proﬁles.
Data from the GET UP PIANO Trial
Maximilian Birchwood1, Rosa Ritunnano2, Andrew Thompson1,
Rachel Upthegrove3, Katia De Santi4, Chiara Bonetto2,
Doriana Cristofalo2, Angelo Fioritti5, Antonio Lasalvia4, Sarah Tosato2,
Mirella Ruggeri2, The GET UP Group2
1Mental Health and Wellbeing, Warwick Medical School, Coventry, UK,
2University of Verona, Italy, 3Universityof Birmingham, Edgbaston, West
Midlands, UK, 4AOUI Verona, Italy, 5AUSL Bologna, Italy
Purpose: Childhood adversity increases risk of developing psychiatric
symptoms including those belonging to the psychosis continuum, and
predisposes to more negative outcomes. However, the pathways
leading from early adverse experiences to outcome trajectories in
ﬁrst-episode psychosis (FEP) are yet to be revealed.We explored the
associations between speciﬁc forms of childhood adversity and indi-
vidual psychotic symptoms in a large, representative and well-
characterized sample of FEP patients.
Methods: The study was conducted within the framework of the Psy-
chosis early Intervention and Assessment of Needs and Outcome
(PIANO) Trial - part of the larger research program “Genetics Endo-
phenotypes and Treatment: Understanding early Psychosis” (GET
UP).Symptom severity was evaluated using the Positive and Negative
Syndrome Scale (PANSS). Information on childhood adversity was
obtained from 356 patients (80.2%) using the Childhood Experience
of Care and Abuse Questionnaire (CECA-Q).
Results: Maltreated FEP patients showed higher positive and affec-
tive symptoms, poorer premorbid adjustment and impaired global
functioning. Physical abuse showed a signiﬁcant association with
grandiosity (OR 2.28), unusual thought content (OR 2.05), motor
retardation (OR 2.12) and emotional withdrawal (OR 1.85). Sexual
abuse was associated with guilt feelings (OR 2.10). Parental neglect
was associated with passive-apathetic social withdrawal (OR 1.75)
and active social avoidance (OR 1.82). Estimated ORs remained sig-
niﬁcant after adjusting for age, sex and lifetime cannabis use.
Conclusions: Different forms of childhood adversity may foster a spe-
ciﬁc and more severe
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Talk 4
Identifying Moderators and Predictors of
Treatment Outcome in Caregivers. Results from
the GET UP PIANO Pragmatic Cluster Randomized
Controlled Trial
Juliana Onwumere1, Elisabeth Kuipers1, Paul Bebbington2,
Chiara Bonetto3, Doriana Cristofalo2, Carla Cremonese4,
Maurizio Miceli5, Silvio Scarone6, Anna Meneghelli7,
Giovanni de Girolamo8, Mirella Ruggeri3, The GET UP Group3
1King’s College London, Institute of Psychiatry, Psychology and
Neuroscience (IoPPN), Department of Psychology, London, UK,
2University College London, Department of Mental Health Sciences,
3Unversity of Verona, Italy, 4ULSS15 Padova, 5AUSL of Florence,
Florence, Italy, 6University of Milano, Milan, Italy, 7Azienda Ospedaliera
Niguarda ca Grande Milano, Italy, 8IRCCS Fatebenefratelli – Brescia,
Italy
Background: Over the last decade, family interventions (FI) and cog-
nitive behavioural therapy(CBT) have featured in psychosis treatment
guidelines in different countries and alongside case management,
form part of optimal packages of care in ﬁrst episode psychosis (FEP)
services. Robust evidence in support of their efﬁcacy and acceptabil-
ity to clinical groups is well established. However, data remains scarce
and our understanding limited, on moderators of treatment outcome
for carers in FEP services. This study investigated what carer and
patient demographics and clinical proﬁles were associated with gains
from psychosocial treatment interventions within FEP services.
Methods: Data was collected as part of the GET UP (Genetics, Endo-
phenotypes, Treatment: Understanding early Psychosis) PIANO
(Psychosis: early intervention and Assessment of Needs and Out-
come) pragmatic cluster RCT that compared additional psychosocial
intervention (CBT, FI case management) with treatment as usual for
FEP cases in 126 mental health centres in Italy. Patients were
assessed with a range of clinical assessments before treatment initia-
tion and 9 month follow up.
Results: Signiﬁcant interactions were identiﬁed between psychosocial
interventions, patient and carer factors and carer outcomes. The
results suggested that psychosocial interventions, when compared to
routine care alone, delivered greater reductions in carer distress par-
ticularly in patients reporting higher levels of carer EE and more neg-
ative accounts of early caregiving experiences and carers reporting
greater caregiving hours. Further analyses are in progress.
Conclusions: Current ﬁndings are encouraging and offer indications
for future investigations. Further studies are required to replicate the
ﬁndings and assess the contribution of local contexts.
Symposium Session 13
Friday, October 21,
1:00–2:30 p.m., Washington A
Immunotherapies for Psychosis and Depression:
Promising New Lead or a Blind Alley?
Chair: Peter B. Jones1, Co-Chair: Merete Nordentoft2
Speakers: Valeria Mondelli, Golam Khandaker, Belinda Lennox,
Michael Benros
1University of Cambridge, Cambridge, UK, 2University of Copenhagen,
Copenhagen, Denmark
Contrary to the traditional view that the brain is an immunologically
privileged site shielded behind the blood-brain barrier, emerging evi-
dence indicate complex interactions between the immune system
and the brain that can lead to changes in mood, cognition and
behaviour. Convincing evidence from epidemiological, genetic, and
experimental studies now implicate the immune system in the patho-
genesis of major mental disorders such as schizophrenia and depres-
sion. Focusing on new clinical studies and meta-analysis of treatment
trials, this symposium will provide an update on the relevance of
inﬂammation and auto-immunity for treatment of psychosis and
depression, and argue whether it is now time for evidence-based
immunotherapeutic strategies to enter psychiatric clinics. Dr Mondelli
(Institute of Psychiatry, Psychology and Neuroscience) will present
evidence showing that activation of proinﬂammatory immune
response, as reﬂected by elevated circulating inﬂammatory cytokine
levels (e.g. IL-6, INF-γ), is associated with poor antipsychotic response
in ﬁrst episode psychosis. Dr Khandaker (University of Cambridge)
will present data showing that inﬂammatory cytokines (e.g. IL-6) play
a role in the development of psychotic and depressive symptoms,
symptom persistence, followed by a meta-analysis of RCTs demon-
strating effectiveness of anti-cytokine treatment for depression in
people with chronic inﬂammatory illness. Dr Lennox (University of
Oxford) will discuss the evidence for effectiveness of immunothera-
pies for psychotic disorders particularly patients with NMDAR auto-
antibodies. Dr Benros (University of Copenhagen) will present novel
ﬁndings regarding immunological risk factors for schizophrenia and
depression from Danish population-based studies, followed by a
meta-analysis of anti-inﬂammatory treatment for depression.
Talk 1
Inﬂammation and Response to Antipsychotic
Treatment
Valeria Mondelli
Institute of Psychiatry, Psychology and Neuroscience, King’s College
London, Department of Psychological Medicine, London, UK
Background: Activation of the immune system has recently been
reported in several studies in patients with ﬁrst episode psychosis.
However, the consequences of this increased inﬂammation remain
still unclear. In this presentation I aim to show some of our recent
studies investigating the effects of increased inﬂammation on clinical
outcome and physical health in patients with ﬁrst episode psychosis.
Methods: We collected blood samples in patients with ﬁrst episode
psychosis and healthy controls. To evaluate inﬂammation we
assessed serum levels and blood mRNA levels of interleukin-6 (IL-6)
and Tumour Necrosis Factor-alpha (TNF-alpha), interferon-gamma
(INF-gamma) and serum levels of high sensitive C reactive protein
(CRP). In order to test the effects of inﬂammation on clinical out-
come, patients were divided in Non-Responders and Responders
according to the Remission criteria of the Schizophrenia Working
Group Consensus, measuring a reduction in symptoms severity using
the Positive and Negative Syndrome Scale over the ﬁrst three
months of treatment. We also evaluated the association between
variation in CRP levels and variation in metabolic variables in a longi-
tudinal study in patients with ﬁrst episode psychosis.
Results: Patients non-Responders showed signiﬁcantly higher base-
line levels of IL-6 and INF-gamma when compared with Responders.
Increases in CRP levels of 3 months follow-up is associated with
increase in triglycerides independently by weight gain.
Conclusions: Increased inﬂammation appears to predict patients with
worse clinical and metabolic outcome at the onset of psychosis.
Inﬂammatory markers should be considered for stratiﬁcation of
future therapeutic strategies in ﬁrst episode psychosis.
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Talk 2
Role of Cytokines in Depression and Psychosis and
Evidence for Effectiveness of Anti-cytokine
Treatment in Depression
Golam Khandaker, Peter B. Jones, Golam Khandaker
Department of Psychiatry, University of Cambridge, Cambridge, UK
Background: I will present evidence from a population-based longitu-
dinal study and a meta-analysis of clinical trials to address whether
inﬂammatory cytokines play a causal role in depression and psycho-
sis, and so could be a therapeutic target.
Methods: The longitudinal relationships between serum IL-6 and CRP
levels at age 9 years and subsequent depressive and psychotic symp-
toms between 10 and 18 years were examined in the Avon Longitu-
dinal Study of Parents and Children (ALSPAC) birth cohort
(N = 4415). Secondly, we carried out a systematic review and meta-
analysis of antidepressant activity of anti-cytokine treatment (mono-
clonal antibodies and cytokine inhibitors) using clinical trials of
chronic inﬂammatory conditions where depression was measured as
a secondary outcome.
Results: Higher serum IL-6 levels at age 9 years were associated with
increased risks of developing depression (OR = 1.55; 95% CI, 1.13-
2.14), psychotic experiences (OR = 1.81; 95% CI, 1.01-3.28) and psy-
chotic disorder (OR = 2.40; 95% CI, 0.87-6.62) at age 18 years, and
persistent depressive symptoms between 10 and 18 years
(OR = 1.19; 95% CI, 1.02-1.39). Random effect meta-analysis of
seven RCTs involving 2370 participants showed signiﬁcant antide-
pressant effect of anti-cytokine treatment compared with placebo
(SMD = 0.39; 95% CI, 0.19-0.60). Meta-regression exploring predic-
tors of response found that the antidepressant effect was associated
with baseline depression severity (P = 0.033) but not with improve-
ment in primary physical illness, sex or age.
Conclusions: The ﬁndings suggest a potentially causal role for inﬂam-
matory cytokines in the pathogenesis of depression and psychosis,
and that cytokine modulators may be novel drugs for depression in
chronically inﬂamed subjects.
Talk 3
Evidence for Effectiveness of Immunotherapy in
Psychosis
Belinda Lennox
University of Oxford, UK
Advances in pharmacotherapy for psychosis are desperately needed.
One potential area for advance is in the repurposing of immune mod-
ifying treatments for use in psychosis. For this talk I will review the
current evidence base for immunotherapy in treating psychosis. This
includes historical studies on the use of steroids to treat schizophre-
nia, and more recent studies on the use of anti-inﬂammatory drugs
such as Celecoxib (a selective COX-2 inhibitor), which has been
reported to improve cognitive function in early stages of schizophre-
nia, and Minocycline, a centrally acting tetracyclic anti-inﬂammatory
agent which has been reported to improve negative symptoms and
cognitive function in schizophrenia. A constant challenge to psychosis
research is the heterogeneity of the patient group. Ant-inﬂammatory
drugs will only be effective in those with an inﬂammatory component
to their illness and to date it has been difﬁcult to identify this sub-
group of patients. One potential advance has been the description of
antineuronal cell surface antibodies in a proportion of people with
ﬁrst episode psychosis. In other presentations with these antibodies,
for instance with encephalitis or seizures, patients respond to treat-
ment with immunotherapy, rather than symptomatic treatments. I will
report our clinical experience to date of using steroids, intravenous
immunoglobulins, plasma exchange and rituximab in the treatment of
those with psychosis and antibodies against the NMDA receptor. Of
18 patients treated so far all have improved, and most have achieved
remission. However the relevance of antibodies in psychosis,
particularly at low levels, remains controversial, and I will discuss the
protocol for a double blind placebo controlled RCT of immunotherapy
in patients with psychosis and antibodies that is needed to move the
ﬁeld forwards and conﬁrm whether this should be a new approach
for treatment in psychosis.
Talk 4
Immune-related Risk Factors for Schizophrenia and
Depression in Danish Epidemiological Studies and
Meta-analysis of Anti-inﬂammatory Treatment for
Depression
Michael Benros
Mental Health Centre Copenhagen, University of Copenhagen, Faculty of
Health Sciences, Copenhagen, Denmark
Utilizing the extensive Danish Registers we have shown that particu-
larly severe infections requiring hospitalization but also milder infec-
tions not requiring hospitalization, and autoimmune diseases where
associated with an increased risk of schizophrenia and mood disor-
ders in a dose-response relationship, which seem compatible with an
immunological hypothesis for subgroups of the patients. Several stud-
ies have indicated antidepressant effects of anti-inﬂammatory treat-
ment; however, the results have been conﬂicting and detrimental
side effects may contraindicate anti-inﬂammatory treatment. Hence,
we systematically reviewed the antidepressant and possible side
effects of anti-inﬂammatory interventions on individuals with depres-
sion. The pooled effect estimate suggested that anti-inﬂammatory
treatment reduced depressive symptoms compared to placebo. This
effect was observed both in studies including patients with depres-
sion and depressive symptoms. The heterogeneity of the studies was
not explained by differences in inclusion of clinical depression versus
depressive symptoms or NSAIDs versus cytokine inhibitors. Sub-
analyses particularly emphasized antidepressant properties for the
selective COX-2 inhibitor celecoxib in general, on remission and
response. Among the studies reporting on side effects, we found no
evidence of an increased number of gastrointestinal or cardiovascular
events after 6 weeks or infections after 12 weeks of anti-
inﬂammatory treatment compared to placebo. Hence, our analysis
suggests that anti-inﬂammatory treatment, in particular celecoxib,
decreased depressive symptoms without increased risks of side
effects. However, a high risk of bias and high heterogeneity made the
mean estimate uncertain. Our studies supports a proof-of-concept
concerning use of anti-inﬂammatory treatment in depression and
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Early Phases of Bipolar Disorder
Chair: Andreas Bechdolf1, Co-Chair: Ingrid Melle2
Speakers: Ingrid Melle, Andrea Pfennig, Andreas Bechdolf, Jan Scott
1Charité Medical University Berlin, Germany, University of Cologne, Köln,
Germany, University of Melbourne, Melbourne, Australia, 2University of
Oslo, Oslo University Hospital, Norway
The early phases of Bipolar Disorder (BD) demonstrate a range of
complex clinical presentations. For example, it is presumed that long
duration of untreated BD has a negative impact on illness course and
outcome, but evidence is inconsistent and there is limited knowledge
about how to deﬁne and assess key milestones in untreated BD as
compared to psychosis. Likewise, whilst it is possible to differentiate
between youth at high risk of developing BD from others with heter-
ogeneous problems, it is unclear is proposed Bipolar-At-Risk (BAR)
criteria can differentiate between persons at risk for BD from those
at risk for psychosis, or for recurrent unipolar depression. This sym-
posium examines the current state of the art and addresses these
issues through presentations of empirical studies of cases of ﬁrst epi-
sode mania and systematic research on different at-risk populations.
Talk 1
Untreated Bipolar Illness and its Association to
Outcome in First Episode Mania
Ingrid Melle, Levi Kvitland, Christine Demmo, Soﬁe Aminoff,
Tone Hellvin, Ole Andreassen, Trine Vik Lagerberg,
Petter Andreas Ringen
NORMENT, K.G. Jebsen Centre for Psychosis Research, Division of
Mental Health and Addiction, Institute of Clinical Medicine, University of
Oslo and Oslo University Hospital, Oslo, Norway
Purpose: We have limited knowledge about how aspects of
untreated bipolar illness inﬂuences clinical outcome in ﬁrst episode
bipolar disorder I (BD I). Half of patients experience one or more
depressive episodes before the ﬁrst deﬁning manic episode. Mood
episodes can also be self-limiting with long periods of euthymia in-
between. Untreated illness can thus be deﬁned either as the duration
of time from the onset of the ﬁrst mood/manic episode to start of
adequate treatment (Duration of Untreated Bipolar Disorder, DUB)
or as the number of untreated mood/manic episodes. The present
study examines the associations between aspects of untreated illness
in BD-I and key clinical outcomes.
Method: Patients (N = 62) were recruited at ﬁrst adequate treatment
for mania, and followed-up after one year with comprehensive
assessments at both time-points.
Results: There were no signiﬁcant associations between DUB and
key clinical outcomes neither at baseline nor at one-year follow-up.
The same was the case for associations to the number of untreated
mood/manic episodes. Longer time from ﬁrst mania to adequate
treatment was associated with higher risk of post-onset excessive
cannabis use.
Conclusion: The initial phases of early bipolar disorder have a com-
plex clinical presentation with uncertain links to clinical outcome. We
need better assessments to capture important aspects of this period
Talk 2
Symptom Constellations and Health Care
Experiences in Bipolar-At-Risk
Andrea Pfennig1, Stefﬁ Pfeifer1, Michael Bauer1, Karolina Leopold1,2
1Department of Psychiatry and Psychotherapy, Carl Gustav Carus
University Hospital, Technische Universität Dresden, Germany,
2Department of Psychiatry, Psychotherapy and Psychosomatics,
Vivantes Klinikum am Urban, Academic Hospital of Charite Medicine
Berlin, Berlin, Germany
Purpose: Most young subjects considered at heightened risk to
develop bipolar disorder already suffer from severe symptomatology
and functional impairment even without the manifestation of full-
blown bipolar disorder. For a number of reasons, the identiﬁcation of
high-risk subjects is difﬁcult but it is crucial to provide them with the
appropriate counselling and, if needed, treatment. We here aim at
describing the symptom constellations of patients and their health
care experiences prior and after visiting the Early Recognition Centre
of our Mental Health Centre.
Method: A structured diagnostic process was applied to clients visit-
ing the Early Recognition Centre including two instruments devel-
oped to detect a heightened risk for bipolar disorder (BPSS and
EPIbipolar). Retrospective and prospective data on diagnoses, con-
tacts to the health care system and treatment approaches were col-
lected prospectively for six years. Conversion to manifest disorders
was assessed using standardized diagnostic instruments.
Results: Data from 660 clients (12 to 40 years old) visiting the Early
Recognition Centre were analysed. About 15% of those seen in com-
prehensive diagnosis visits (about 400) were i meeting the research
criteria for heightened bipolar risk. Symptom constellations including
disturbances in sleep and circadian rhythm and mood swings includ-
ing euphoric states leading up to mania prodrome will be described.
Most patients had prior contacts with the health care system that
were frustrate. Follow-up including conversion data will be
presented.
Conclusions: In light of the results, the importance of specialized
early recognition and intervention centres will be discussed.
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Talk 3
Predictive Validity of Bipolar At Risk (BAR) Criteria
Andreas Bechdolf1,2,3, Aswin Rateesh2,4, Sue M Cotton2,4,
Jennifer Betts2,4, Andrew Chanen2,4, Barnaby Nelson2,4,
Michael Berk4,5,6, Patrick D McGorry2,4
1Department of Psychiatry, Psychotherapy and Psychosomatics,
Vivantes Klinikum am Urban, Early Intervention and Treatment Center –
FRITZ am Urban, Charité Medical University, Berlin, Germany, 2Centre
for Youth Mental Health, University of Melbourne, Parkville, Australia,
3Department of Psychiatry and Psychotherapy, University of Cologne,
Cologne, Germany, 4Orygen, The National Centre of Excellence in Youth
Mental Health, Parkville, Australia, 5Deakin University, Geelong,
Australia, 6Florey Institute of Neurosciences and Mental Health,
Parkville, Australia
Purpose: We developed the Bipolar-At Risk criteria (BAR) which
include being at peak age range of the onset of the disorder, as well
as a) sub- threshold manic features, b) presence of subthreshold
depression with cyclothymic features and c) presence of subthreshold
depression in combination with genetic risk. The primary aim of the
present study was to determine the predictive validity of the BAR cri-
teria. Moreover, we aimed to examine the relationship between BAR
criteria and other clinical syndromes associated with bipolar risk.
Method: Twelve-month prospective trial. Baseline measures included
substance- and antidepressant use, Attention Deﬁcit Hyperkinetic
Disorder (ADHD), Borderline personality disorder (BPD) and tempera-
mental traits, criteria for Ultra-High Risk for psychosis (UHR) and the
Bipolarity Index to determine relationships between concepts.
Results: Thirty-ﬁve participants were included in the BAR group and
35 matched participants in the control group. Five BAR patients
(14.3%) converted to ﬁrst-episode hypomania/mania and none in the
non-BAR group [χ(2) (1) = 5.38, p = 0.020]. Baseline BAR criteria
were associated with higher scores on Bipolarity Index, Young Mania
Rating Scale, Brief Psychiatric Rating Scale, TEMPS-A and its cyclo-
thymic subscale. It was also associated with more baseline cannabis
use disorder diagnoses. BAR criteria were not associated with UHR
criteria, Brown ADD scores and BPQ scores.
Conclusions: BAR criteria present with clinical relevant conversion
rates into bipolar disorder and with expected overlap with mania
symptoms and cyclothymic traits, without overlap with risk for psy-
chosis, ADHD and BPD. Cannabis use may represent a distal addi-
tional risk factor.
Talk 4
Strategies to Identify Individuals at High Risk of
Developing First Episode Mania
Jan Scott
Institute of Neuroscience, Newcastle University, Newcastle upon
Tyne, UK
Purpose: Bechdolf and colleagues developed a bipolar disorder
(BD) ‘at-risk’ assessment tool for use with help-seeking individuals.
The BAR assessment incorporates general and speciﬁc criteria that
can be used to identify those at high risk of developing BD: cyclo-
thymia, sub-threshold mania, depression and genetic risk. Utilisation
of these criteria in early intervention services have been promising.
A speciﬁc challenge is not just their ability to identify BD at risk
cases from young people with heterogeneous problems, but also to
determine which individuals are at risk of imminent ‘transition’ to
BD from populations comprised of early onset depression cases. This
is of great importance clinically and a signiﬁcant challenge to the
utility of the BAR criteria. The present study addresses this issue
and reports on the validity of the BAR criteria in differentiating early
onset BD from UP.
Method: A sample of 100 cases matched for gender and year of birth
were followed prospectively after participating in systematic screen-
ing assessments for a different research studies in the UK.
Results: We examine additional criteria that may be particularly
important in identifying those at risk of mania from large populations
of young adults with recurrent depression (e.g. symptoms of activa-
tion or fatigue). Finally, taking all this information together, the pres-
entation provides an estimate of the ‘Number needed to screen’
(NNS), a parameter for case ﬁnding that can be used by clinicians to
determine how likely they are to identify cases of ﬁrst episode mania




Vulnerability to the Effects of Cannabis on
Transition to Psychosis
Chair: Katherine Aitchison1, Co-Chair: Robin Murray2
Speakers: Robin M Murray, Philip Tibbo, Jean Addington, Tamar
Kraan
1Departments of Psychiatry and Medical Genetics, University of Alberta,
Alberta, Canada; King’s College London, Institute of Psychiatry,
Psychology & Neuroscience, London, UK, 2Institute of Psychiatry,
Psychology & Neuroscience, Department of Psychosis Studies, King’s
College London, London, UK
While several vulnerability factors for transitioning to a psychotic ill-
ness after consumption of cannabis have been described, there are
inconsistencies in the data. For example, there has been some difﬁ-
culty in replicating the ﬁndings of Caspi et al (2005). This symposium
focuses on delineating genetic, environmental, and demographic fac-
tors that contribute to the transition to a psychotic illness. The ﬁrst
speaker, Robin Murray (Institute of Psychiatry, London), will discuss
cannabis, and its ingredient THC, as a risk factor for psychosis and
cognitive dysfunction, and compare and contrast patients with an “At
Risk Mental State” to ﬁrst episode psychosis patients. The second
speaker, Phil Tibbo (Dalhousie University, Halifax, Canada), will report
on a Canadian sample in which, consistent with Caspi et al (2005),
COMT genotype was seen to have a signiﬁcant effect on age of
onset of psychosis, in those who had ﬁrst used cannabis at less than
or equal to 19 years of age. The third speaker, Jean Addington
(University of Calgary, Canada), will present data on cannabis use in
those in a clinical high risk state and association with symptoms and
subsequent conversion to psychotic illness. The fourth speaker,
Tamar Kraan (Amsterdam, NL) will review the data on cannabis use
and transition to psychosis in individuals at ultra-high risk for psycho-
sis. Unpublished data will be included. In summary, this symposium
will shed light on the complexity regarding the association between
cannabis and subsequent development of a treatable psychotic ill-




The Role of Cannabis Use and Individual
Susceptibility in Inﬂuencing Outcome Among
Patients with A) The ARMS and B) Frank Psychosis
Robin M Murray1, Tabea Schoeler1, Daniel Friedman2,
Elizabeth Tunbridge2, Olesya Ajnakina1, Marta Di Forti2
1King’s College London, London, UK, 2University of Oxford, Oxford, UK
Strikingly, all nine longitudinal prospective studies of young people in
the general population have shown that those who use cannabis have
a greater risk of developing psychosis than non-users. Of course, only
a minority of cannabis users will develop psychosis. Some people
appear genetically susceptible; at least three genes are implicated:
DRD2, AKT1, and COMT. Our experimental studies have demon-
strated that IV administration of tetrahydrocannibinol (THC) can
readily induce a transient psychosis in normal volunteers. In a recent
study of 78 schizotypal individuals, we examined whether the COMT
Val/Met genotype moderated THC-induced paranoia. This did not
occur, rather, a greater impairment of working memory resulted in
those of COMT Val/Val genotype. In a meta-analysis, we found that
those psychotic individuals who continue to use cannabis have a
worse outcome with higher relapse rates, more hospitalisations, and
more continued positive symptoms than both those former users
who stop their use and also psychotic patients who never used can-
nabis. In considering whether cannabis use inﬂuences risk of transi-
tion in individuals with an ARMS, it is important to address the
question of how representative such individuals are of FEPs. Our evi-
dence is that only about 5% of FEP in South London have attended
prodromal services with an ARMS and that those who have differ in
that they were more likely to have been referred by general practi-
tioners, live with their family and be born in the UK than the majority
of FEP; they did not, however, differ signiﬁcantly in their use of
cannabis.
Talk 2
COMT Genotype is Associated with Age of Onset
of Psychosis After Adolescent Cannabis Use: A
Replication in Canadian Caucasians
Philip Tibbo1,2, Katherine J Aitchison3,4,5, Rohit J. Lodhi3,
Yabing Wang3, Alexandra Loverock5, Aleksandra Dimitrijevic3,
Candice Crocker1, Hongyan Ren3, Darren Bugbee3,
Georgina Macintyre3, Scot E Purdon3,4,6
1Dalhousie University, Halifax, Nova Scotia, Canada, 2Nova Scotia Early
Psychosis Program, Canada, 3University of Alberta, Edmonton, Alberta,
Canada, 4Edmonton Early Psychosis Intervention Clinic, Alverta, Canada,
5Northern Ontario School of Medicine, Sudbury, Ontario, Canada,
6Alberta Hospital Edmonton, Canada
Background: While several vulnerability factors for transitioning to a
psychotic illness after consumption of cannabis have been described,
there are inconsistencies in the data. For example, there has been
some difﬁculty in replicating the ﬁndings of Caspi et al (2005).
Methods: Patients of self-reported Caucasian ethnicity with psycho-
sis were recruited from two ﬁrst episode psychosis teams, in Edmon-
ton, and Halifax (Canada), and a collaborating hospital. Age of onset
of psychosis (AoP), deﬁned as age of DSM-IV diagnosis (schizophre-
nia, schizoaffective disorder, schizophreniform disorder, delusional
disorder, brief psychotic episode, psychosis not otherwise speciﬁed,
and substance-induced psychosis) was established using the Struc-
tured Clinical Interview for DSM-IV. Data on cannabis use were col-
lected using a self-report computerized questionnaire. DNA was
extracted from saliva collected using Oragene kits. The COMT
Val158Met variant (rs4680) was genotyped by SNaPshot and Taq-
Man assays.
Results: COMT genotype was associated with lifetime cannabis use
and with age of ﬁrst cannabis use. In those who had used cannabis
≤19 years of age, COMT genotype had a signiﬁcant effect on AoP.
Conclusion: Our data are consistent with those of Caspi et al (2005),
which may reﬂect factors such as Caucasian ethnicity (conﬁrmed
using ancestry informative markers), and other sociodemographic fac-
tors. Funding: Bebensee Schizophrenia Research Unit, Canadian Insti-
tutes of Health Research (grant 200810), Nova Scotia Health
Research Foundation, Canadian Foundation for Innovation, Alberta
Innovation and Advanced Education, Government of Alberta (Alberta
Centennial Addiction and Mental Health Research Chair to KJA).
Talk 3
Cannabis Use in Individuals at Clinical High Risk of
Psychosis
Jean Addington1, Kristin S Cadenhead2, Tyrone D Cannon3,
Barbara A Cornblatt4, Thomas H McGlashan3, Diana O Perkins5,
Larry J Seidman6,7, Elaine F Walker8, Scott Woods3,
Carrie E Bearden10, Daniel Mathalon11, Lisa Buchy1
1University of Calgary, Alberta, Canada, 2University of California, San
Diego, CA, USA, 3Yale University, New Haven, CT, USA, 4Zucker Hillside
Hospital, New York, USA, 5University of North Carolina,USA, 6Harvard
Medical School at Beth Israel Deaconess Medical Center, Boston, MA,
USA, 7Massachusetts General Hospital, USA, 8Emory University, Atlanta,
GA, USA, 9National Institutes of Mental Health, Bethesda, MD,
10University of California, Los Angeles, CA, USA, 11University of
California, San Francisco, CA, USA
It has been suggested in the literature that cannabis use may have an
impact on the later development of psychotic symptoms. This presen-
tation will focus on cannabis use in youth at clinical high risk (CHR)
of developing psychosis.
Method: The sample consisted of 735 CHR youth and 278 healthy
controls. All participants were recruited as part of the 8-site North
American Prodrome Longitudinal Study (NAPLS-2) and met criteria
for a clinical high risk syndrome based on the Structured Interview
for Prodromal Syndromes. Sample were assessed at baseline, 6, 12,
18 and 24 months. Measures included the SCID, the Scale of Prodro-
mal Symptoms, the Alcohol and Drug Use Scale plus some additional
questions about cannabis use.
Results: Cannabis was the most widely used drug in both CHR and
control groups. Cannabis use was signiﬁcantly higher in the CHR
group than in the controls and use did not change over time.
Increased use was signiﬁcantly associated with higher ratings on
attenuated psychotic symptoms. The CHR group was signiﬁcantly
younger than controls when they ﬁrst used and had used more often
across their lifetime. CHR youth were more likely to currently use
alone and during the day compared to controls. Those who later con-
verted to psychosis demonstrated using slightly more cannabis than
those who did not.
Conclusion: Although there are limitations to the data those at CHR
had increased use of cannabis compared to controls and for those at
CHR there was an impact of cannabis on their symptoms.
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Talk 4
Current Cannabis Abuse is Associated with
Transition to Psychosis in Individuals at Ultra-high
Risk for Psychosis
Tamar Kraan1, Eva Velthorst1,2, Laura Koenders1, Kimberley Zwaart3,4
, Helga K Ising4, David van den Berg4, Lieuwe de Haan1,
Mark van der Gaag3,4
1University of Amsterdam, The Netherlands, 2Mount Sinai, New York,
USA, 3VU University, Amsterdam, The Netherlands, 4Parnassia
Psychiatric Institute, The Hague, Netherlands
Background. Cannabis is the most used drug worldwide. The use of
this drug has been widely associated with psychotic disorders. The
present study aimed to review the existing literature on the associa-
tion between cannabis use and transition to psychosis in UHR
samples.
Method: We reviewed the literature on all available prospective stud-
ies on cannabis use in UHR cohorts. Out of 5559 potentially relevant
articles, 36 articles were screened on full text for eligibility. Two
random-effects meta-analyses were performed. First, we compared
transition rates to psychosis of UHR individuals with lifetime cannabis
use with non-cannabis-using UHR individuals. Second, we compared
transition rates of UHR individuals with a current DSM-IV cannabis
abuse or dependence diagnosis with lifetime users and non-using
UHR individuals.
Results: We selected seven studies that reported on lifetime cannabis
use in prospective UHR cohorts (n = 1171). Of these seven studies,
ﬁve studies looked into cannabis abuse or dependence. Using meta-
analytical techniques, we found that lifetime cannabis use was not
signiﬁcantly associated with transition to psychosis [odds ratio
(OR) 1.14, 95% conﬁdence interval (CI) 0.856–1.524,p = 0.37]. Exam-
ining cannabis abuse or dependence, an OR of 1.75 (95% CI
1.135–2.710,p = 0.01) was found, indicating a signiﬁcant association
between current cannabis abuse or dependence and transition to
psychosis.
Conclusions: Our results show that cannabis use was only predictive
of transition to psychosis in those who met criteria for cannabis
abuse or dependence, tentatively suggesting a dose–response rela-




Similarities and Differences of Early Intervention
Programs in Italian Regions
Chair: Walter Di Munzio1, Co-Chair: Andrea Alpi2
Speakers: Anna Meneghelli, Angela Caroﬁglio, Marco Vaggi, Giuliano
Limonta
1Dipartimento di Salute Mentale, Salerno 1, ASL Salerno, Salerno, Italy,
2Programma 2000, Milan, Italy
The symposium, organized by the AIPP (Italian Association for Pre-
vention and Early Intervention in Mental Health) and dedicated to
the memory of Angelo Cocchi, is aimed at describing some relevant
and paradigmatic EI experiences within the Italian context. Four ser-
vices, implemented at different moments and within different geo-
graphic and organizational contexts, that share however orientation
and objectives, are described. “Programma 2000”, a speciﬁc service in
MHD of Niguarda, Milan, has been since late 90s’ the ﬁrst national
leading service for the development of this area, regarding treatment
as well as research. The GIPPSI Project in Bari, a city located in
Southern Italy, with more than 300,000 inhabitants, has followed the
same model, using an original collaboration among MHD and private-
social subjects. CSM in Genova Voltri, is a generalist service
addressed to an area with 100,000 inhabitants (in a city with
600,000 inhabitants) located in Northern Italy, where a dedicated
group, with specialized workers, has been operating since 2003. DSM
in Piacenza, a city in Northern Italy with 100,000 inhabitants, has
adopted the model of a dedicated service in a generalist context.
However, it operates within the whole Mental Health Department
territory, contrarily to the one in Genova. Contributions show that
sharing references and the strong motivation, in a country like Italy,
where the National Health Care Service (SSN) is run by Regions
through local models, are trying to allows the activation of focused
interventions of prevention and treatment of young individuals
adapting the organization to speciﬁc situations.
Talk 1
Programma 2000: A Leading Model for the Early
Intervention Paradigm in Italy
Anna Meneghelli1, Emiliano Monzani1, Antonio Preti1,2,
Mariano Bassi1
1Programma 2000 Milan, Italy, 2University of Cagliari, Cagliari, Italy
Purpose: To illustrate the organization, functioning and main out-
comes of the Programma2000, the ﬁrst multi-modal, comprehensive
program targeted at the early detection and intervention for persons
at the onset and for those with a high risk of psychosis established in
Italy in 1999.
Materials and Methods: All patients who are referred to Pro-
gramma2000 receive a prompt admission in treatment (within 24 h),
and undergo a comprehensive, multidimensional evaluation with a
package of standardized assessments. Those who comply with the
criteria for diagnosis are proposed an individualized, multicomponent
protocol of treatment including evidence-based drug and psychoso-
cial treatments and a wide range of therapeutic support group
activities.
Results: Over 16 years of activity, the Programma2000 assessed over
500 subjects, 302 of whom were entered in treatment. Treatment
appears effective in reducing morbidity and improving social func-
tioning. About 2/3 patients with ﬁrst episode of psychosis achieved
remission after 1 year, with 67% being in remission at 3 years. Transi-
tion to psychosis was limited to 5% of patients at ultra high risk of
psychosis. The Programma2000 actively promoted the knowledge of
the early intervention paradigm, with conferences, congresses, scien-
tiﬁc publications and national surveys.
Conclusion: Programma2000 gained a respected leadership role as a
referent model for the creation of early intervention services. The
effort of establishing a ﬁdelity model for the early intervention proto-
col of care resulted in 2014 in a proposal of a general reform of the
Italian Department of Mental Health, aimed at spreading a preventa-
tive approach to mental distress.
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Talk 2
Model-conformity and Field Testing: GIPPSi, an
Original Experience of “Center Speciﬁcally
Dedicated to FEP and HR”
Angela Caroﬁglio1, Cristina Filograno2, Elvira Damato2,
Francesca Gatti2, Rosa Marinelli2, Annamaria Piperis2,
Gerolamo Stea2, Daria Portnova2, Giuseppe Verrastro1,
Domenico Semisa1
1Mental Health Department - ASL Bari, Italy, 2Foundation EPASSS (ACLI
Institution Provincial Social Services-Health), Italy
In 2010 a small group of professionals, basing on the model of Pro-
gramma 2000, decided to launch a centre dedicated to onset of psy-
chosis, ﬁrst centre of this kind in Apulia and Southern Italy. The
centre immediately adopted problem solving as procedure to face
obstacles, which allowed to use the resources of the context as effec-
tively as possible. Starting with an uncommon close cooperation
between “public” and “private”, the centre chose to beneﬁt from the
resource of a pre-existing daily-care centre, employing its physical
spaces and specialized experts in psychiatric rehabilitation, in order to
launch a care-service focused on the process of individuation and
promotion of autonomy in young individuals. Components recom-
mended by guidelines (Nice-ISS 2007), in particular individual CBT,
intervention on families and recovery of social functioning, have been
preserved, within a work based on extreme ﬂexibility and inclusive-
ness.The transition to taking care of HR was natural and prompted us
to set up an intervention protocol speciﬁcally addressed to young
subjects facing this condition. At the end of 2015, GIPPSI has scored
180 diagnostic assessments, taken on responsibility of 37 FEP and
33 HR, discharged 13 young subjects who had successfully com-
pleted their individual therapeutic project.
Talk 3
Implementation of a Prevention and Early
Intervention Clinical Service in a Mental Health
Community Center of Genoa, Italy
Marco Vaggi1, Eugenia Perelli1, Valeria Puppo1, Monica Zambonini1,
Panﬁlo Ciancaglini2
1Department of Mental Health and Substance Abuse, ASL3 Genoa, Italy,
2Italian Association for Prevention and Early Intervention in Mental
Health (AIPP)
Aim: The work describes the organizational changes of a not special-
ized Mental Health Centre (CSM) in Genoa (Italy), inspired by the
principles of Early Psychosis and by the "Memo for the Mental Health
Services development oriented to prevention and focused on young
people" by AIPP.
Method: The fundamental principles of the change have been:1. the
cooperation with the general practitioners (MMG) and the services
for teenagers 2. evaluation visits differentiated by age groups (<25,
25-65, >65) 3. the identiﬁcation of speciﬁc treatments for different
pathologies and the related "specialization" of health workers 4. the
creation of a group dedicated to early intervention 5. the gradual shift
of resources to young patients. The reallocation of resources has
been made possible thanks to the creation of a psychogeriatric serv-
ice, to the rationalization of the assistance to patients suffering from
persistent pathologies and to the limitation of in-house treatments.
The second section shows the treatment plans and the monitoring of
under 25 aged patients, who started using the services for the ﬁrst
time between Jan. 1st, 2012 and Dec. 31st, 2015.
Results: The course of treatment following the ﬁrst visit of two hun-
dred and ﬁfty patients (126 males and 124 females) was analysed and
ﬁve groups were identiﬁed: 53 cases (21%) followed by multi-
professional teams, 43 cases (17%) treated by one unit (or centre),37
cases (15%) watched with an active clinical follow up4. 85 cases
(34%) monitored, 32 cases (13%) sent to different public health care
agencies.
Talk 4
Stand UP Project Addressed to Onset of Psychosis
in the Network of the Standardized Instrument
PTDA (Diagnostic Therapeutic And Assistance
Pathway) of Piacenza Mental Health Department
Giuliano Limonta
Mental Health and Pathological Addictions Department - AUSL
Piacenza, Italy
Premise: An organizational model focused on institutional setting and
treatment centres rather than on the patient, exposes to the risk of
fragmented interventions, poor adherence to treatment and difﬁcult
outcome evaluation.
Method: The model of combined therapeutic functions, structured
within a path, promotes interventions enhancing and reinforcing good
practice, sharing speciﬁc and global treatment objectives within the
team. The Mental Health and Pathological Addictions Department of
AUSL Piacenza has undertaken a gradual and radical transformation
of traditional organizational models (Simple or Complex Operating
Unit), using the PDTA model on different speciﬁc pathologies, includ-
ing onset of psychosis. According to this model, PDTA become a sort
of "underground network" that enhances, replaces and inspects tradi-
tional institutions in the territory (Services and Operating Units of
DSMDP), facilitating a radical reorganization of Health Care Services.
More speciﬁcally on 288.980 inhabitants, among them about 5.775
(3,2% of target aged 18-65 referring to MHC, whereas 2.818 (7,1%
of target aged 0-17 referring to CAMHS.
Results: In each MHC teams dedicated to treatment of onset of psy-
chosis have been planned; they are made of professionals trained in
CBT and family psychoeducation, including: psychiatrists, child psy-
chiatrists, psychologists, social workers, educators, nurses. PDTA
were realized after the implementation of an educational path started
in 2011, still in progress: a high - quality, effective path, efﬁcient in
increasing knowledge, operational skills and self-efﬁcacy as essential
requisites in order to get to "know-how" and to an appropriate empir-
ical consequence of the learnt contents.
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Research and Management Approaches to
Psychosis Onset and Substance Abuse: From
Behavioural Neurosciences to Real Clinical Life
Chair: Carlo Altamura1, Co-Chair: Anita Riecher-Rössler2
Speakers: Stefan Borgwardt, Fabrizio Schifano, Paolo Brambilla,
Marta Di Forti
1University of Milan, Italy, 2Universitäre Psychiatrische Kliniken (UPK),
Basel, Switzerland
It is important to evaluate the impact of substance abuse on onset
and course of psychosis, as regular use of drugs can move up the age
of onset of prodromal symptoms, or ﬁrst episode psychosis, and
worsen the manifestation of psychotic symptoms in those adoles-
cents who use them regularly, with particular regards to cannabis. In
this symposium we will illustrate the major research and management
approaches to psychosis and substance abuse, including both the
ﬁelds of behavioural neurosciences and real clinical life. First, major
UK and European studies will be presented to discover if and how
variations in cannabis use, in different countries, can explain their var-
iations in the Incidence of Schizophrenia and other Psychosis. Then,
imaging studies on affective and schizophrenia psychosis and comor-
bid substance abuse will be presented; in fact, structural and func-
tional magnetic resonance imaging (MRI) studies have identiﬁed
robust changes in brain structure and activity during the early devel-
opment of psychosis, but the contribution of substance use around
the onset of schizophrenic psychosis is unclear. Finally, convenors will
be provided with a range of information relating to most recent pre-
vention and treatment approaches in terms of both ’classical’ and
more recent drugs of misuse. In conclusion in this symposium we will
try to enlighten whether adolescent initiation of substance abuse use
is associated with emergence and severity of psychotic symptoms,
functional impairment and brain alterations, particularly for adoles-
cents at high risk for developing a psychotic disorder. Also, we will
deepen actual treatment and prevention approaches.
Talk 1
Imaging of Early Schizophrenic Psychosis and
Substance Abuse
Stefan Borgwardt
University of Basel, Basel, Switzerland
Structural and functional magnetic resonance imaging (MRI) studies
have identiﬁed robust changes in brain structure and activity during
the early development of psychosis, but the contribution of sub-
stance use around the onset of schizophrenic psychosis is unclear.
We report single study and meta-analytical results of studies compris-
ing healthy users and non-users with respect to drug related altera-
tions on the white and grey matter structures as well as brain activity
changes. We then systematically reviewed structural and functional
brain imaging and post mortem studies addressing the effects of
drugs use on brain structure and function in schizophrenic psychoses.
The aim of this presentation is to discuss whether the healthy brain,
chronic and long-term drug exposure may exert signiﬁcant effects in
speciﬁc brain areas and whether while early psychosis patients might
be particularly vulnerable to brain volume and function alterations
due to drug use exposure.
Talk 2
Prevention and Treatment of Substance Abuse
Fabrizio Schifano
University of Hertfordshire, Hatﬁeld, UK
During the presentation, convenors will be provided with a range of
information relating to most recent prevention and treatment
approaches in terms of both ’classical’ and more recent drugs of mis-
use. Over the last 10 years or so, many NPS have become available.
These are advertised via the Internet as being safer and legal alterna-
tives to illicit drugs. However, information on their effects is minimal
or inaccurate. They can be just as harmful and addictive as illegal
drugs such as cocaine, ecstasy or ketamine. The regular development
of further NPS, combined with the web ability to spread information
quickly, presents with a number of challenges for public health across
the globe. The products are just a ’click away’ from our homes and
thus potentially available to everyone, especially young people who
are amongst the most at risk. Convenient labelling of NPS maintains
that they are "not for human consumption", this loophole sometimes
allowing them to be distributed cheaply, remain legal and easy to
obtain. Popularity of the NPS is on the increase because of the
advantage to users of the incapacity of the standard drug tests to
identify them. Without the knowledge of the NPS pharmacological/
toxicological proﬁle, however, their use is to be considered danger-
ously experimental, good effects serendipitous. Many of the NPS are
research chemicals, sometimes even discarded products from drug
research. They are produced mainly in Asian countries and usually on
a large scale.
Talk 3
Imaging of Bipolar Disorder and Substance Abuse
Paolo Brambilla
University of Milan, Milan, Italy
Bipolar Disorder (BD) is commonly characterized by the presence of
psychotic symptoms and by the co-occurrence of substance use, fea-
tures which may act to exacerbate its clinical manifestation. However,
the speciﬁc role and the neurophysiological correlates of co-morbid
substance abuse remain unclear. Therefore, this study aims at identi-
fying diagnosis-speciﬁc structural and metabolic alterations within
fronto-temporal and striatal regions differentiating psychotic BD
patients with or without substance abuse and substance-induced psy-
chotic patients, coupling MRI and Positron Emission Tomography
(PET) approaches. BD type I psychotic patients with and without sub-
stance abuse, and healthy controls were enrolled in this study. MR
images were acquired using a 3-Tesla MRI scanner and patients fur-
ther underwent 18-FDG-PET scanning. The group analyses reported
a common pattern of GM volumes and metabolic abnormalities in
several fronto-temporal and striatal regions in affected patients com-
pared to healthy controls. Also, diagnosis-speciﬁc abnormalities
emerged from our results. Our ﬁndings suggest that the exposure to
substance of abuse may alter, both structurally and metabolically,
selective brain structures which, in turn, may lead to the identiﬁcation




Cannabis Use Across the EU: A Ticket to
Psychosis?
Marta Di Forti
IOPPN, King’s College, London, UK
Between May 1, 2005, and May 31, 2011, we obtained data from
410 patients with ﬁrst-episode psychosis and 370 population con-
trols. The risk of individuals having a psychotic disorder showed a
roughly three-times increase in users of skunk-like/high potency can-
nabis and over 5 times in daily users of high potency cannabis com-
pared with those who never used cannabis. The population
attributable fraction of ﬁrst- episode psychosis for skunk-like/high
potency cannabis use for our geographical area was 24% (95% CI
17–31), possibly because of the high prevalence of use of high-
potency cannabis (218 [53%] of 410 patients) in our study (Lancet
Psychiatry, 2015). We concluded that the ready availability of high
potency cannabis in south London might have resulted in a greater
proportion of ﬁrst onset psychosis cases being attributed to cannabis
use than in previous studies. Moreover, we know that the distribution
of environmental risk factors can signiﬁcantly vary across different
countries resulting in geographical differences in the incidence of
complex diseases. Therefore, we measured differences in prevalence
and pattern of cannabis use across 5 European countries and to
investigate whether this resulted in differences in the proportion of
new cases of psychosis attributable to cannabis use across Europe. I
shall start presenting our South London GAP study ﬁndings. Then I
shall take you on the EU GEI-study train for a “preview” trip across
the EU to discover if and how variations in cannabis use, in different
countries, can explain their variations in the Incidence of Schizophre-
nia and other Psychosis.
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New Targets for Prevention of Schizophrenia: Is it
Time for Interventions in the Premorbid Phase?
Chair: Larry J. Seidman1, Co-Chair: Merete Nordentoft2
Speakers: Larry Seidman, Rudolf Uher, Nicoline Hemager, Matcheri
Keshavan
1Harvard Medical School, Massachusetts General Hospital, Boston, MA,
USA, 2Institute for Clinical Medicine, University of Copenhagen,
Copenhagen, Denmark
A number of inﬂuences have converged suggesting that the time is right
for primary prevention strategies with interventions in the premorbid
phase of schizophrenia. These factors include: 1. There is substantial
knowledge about premorbid developmental vulnerabilities to psychosis,
especially regarding schizophrenia. Data from family high-risk (FHR)
studies indicate that in addition to a 10% risk for psychotic disorders,
these children run a 50%–60% risk for signiﬁcant difﬁculties including
nonpsychotic psychopathology, socio-emotional, cognitive, neuromo-
tor, and speech-language problems. Thus, while these children are pre-
prodromal, they are not unaffected. 2. The promising results emerging
from interventions during the clinical high-risk (CHR) phase of psychosis
give hope that earlier interventions are possible. 3. There is recognition
that the CHR period is a relatively late phase of developmental derail-
ment. These factors have together led to a perspective that even earlier
intervention is warranted. While the FHR approach was originated in
the 1950’s, it was not until recently, that interventions have begun to
be initiated. A new round of FHR studies has focused on preteen
offspring or siblings of people with schizophrenia or bipolar disorder,
starting as early as ages 7-9 years. We bring together 4 active studies
that address these issues in Pittsburgh (Keshavan) and Boston
(Seidman) in the United States, Halifax, Canada (Uher) and Copenhagen,
Denmark (Hemager). These authors will document the clinically mean-
ingful dimensions that will be targeted in interventions, and the nature
of planned interventions. We will discuss ethics, safety, potential
stigma, feasibility, tolerability, and the meaning to the people involved.
Talk 1
Family Structure, Behavior and Symptoms in Young
Children at Familial Risk for Schizophrenia
Larry Seidman1, Elena Molokotos1, Benjamin Brent1, Ashley Ronzio1,
Eugene D’Angelo1, Joanne Wojcik1, Raquelle Mesholam-Gately1,
Cindy Liu1, Matcheri Keshavan1, John Gabrieli1
1Harvard Medical School, Boston, MA, USA, 2Massachusetts Institute of
Technology, Boston, MA, USA
Objective: To evaluate function in parents with schizophrenia, and
behaviour in their offspring.
Methods: Using a family high-risk (FHR) design, we evaluated
20 non-psychotic, offspring of parents with psychotic disorders
(HRP), contrasting them with 30 non-psychotic controls (CON) with-
out any ﬁrst-degree relatives with psychosis. The mean age of the
child sample was 9 years (range 7-12).
Results: Preliminary analyses on the ﬁrst half of the sample were
revealing. Of the ﬁrst 10 families, 70% of the ill parents were
mothers, 20% were fathers, and 10% were siblings. In virtually all of
these families, the mother was the primary caretaker, and in only two
families was there a partner. Mothers were primarily from lower
socio-economic status and often conveyed a sense of being over-
whelmed economically and emotionally. More than half of the chil-
dren met criteria for ADHD and/or oppositional deﬁant disorder. The
children were signiﬁcantly impaired on all dimensions of the BRIEF
including the Executive Composite (P = .003). They were also signiﬁ-
cantly impaired on many dimensions of the CBCL including both
Internalizing and Externalizing Problems. The HRP children did not
show signiﬁcant differences on scales of Magical Thinking or
Psychotic-Like Experiences.
Conclusion: These results demonstrate that signiﬁcant behavioural
difﬁculties are present in pre-teen HRP children, especially in aspects
of executive control of behaviour, and not in pre-psychotic experi-
ences. Also striking was the sense of being overwhelmed in the par-
ents. These preliminary results suggest interventions building social




Skills for Wellness: An Early Intervention to Pre-
empt Mood and Psychotic Disorders in Non-
treatment Seeking High-risk Youth
Rudolf Uher, Barbara Pavlova, Alim Awadia, Alexa Bagnell,
Sabina Abidi, Alisa Pencer, Jason Morrison
Dalhousie University, Halifax, Canada
Family history and psychopathological antecedents may help target
early interventions to those at risk for severe mental illness, but most
youth with early psychopathology do not seek treatment. We have
developed Skills for Wellness (SWELL) as a cognitive-behavioural
pre-emptive intervention for non-treatment seeking youth. We are
testing the acceptability and effectiveness of SWELL in a randomized
controlled trial embedded within a high-risk cohort of youth aged
9 to 21 years. The Families Overcoming Risks and Building Opportu-
nities for Well-being (FORBOW) cohort including 234 sons and
daughters of parents with major depressive disorder, bipolar disorder
or schizophrenia (family high risk, FHR) and 66 offspring of parents
with no major mood or psychotic disorders (comparison offspring,
CO). We annually assess four putative antecedents that may precede
and predict severe major illness: affective lability (present in 34%
FHR and 17% CO), anxiety (32% FHR, 15% CO), psychotic symptoms
(20% FHR and 9% CO) and basic symptoms (20% FHR and 9% CO).
Youth presenting with one or more of the antecedents are eligible for
SWELL. SWELL is delivered by a psychologist in 8-16 individual ses-
sions. In addition to core elements including emotion knowledge,
realistic thinking, problem solving and present moment focus, mod-
ules addressing affective lability, anxiety and psychotic/basic symp-
toms are selected to ﬁt each participant’s risk proﬁle. At the time of
writing, 34 youth have been randomized. Of the 17 youth allocated
to SWELL, 14 (82%) completed the intervention, suggesting high
acceptability. Testing of effectiveness is in progress
Talk 3
Cognitive Proﬁles in 7-Year-Old Offspring of
Parents with Schizophrenia or Bipolar Disorder
Nicoline Hemager1, Jens Jespen1, Camilla Christiani1, Anne Thorup1,
Ditte Ellersgaard1, Katrine Spang1, Birgitte Burton1, Maja Gregersen1,
Anne Ranning1, Aja Greve1, Ditte Gantriis1, Kate Kold1
1University of Aarhus, Denmark, 2University of Copenhagen, Denmark
Schizophrenia (SZ) and bipolar disorder (BD) are severe, complex neu-
rodevelopmental disorders with multifactorial etiology of interacting
genetic and environmental factors. One of the aims of the Danish
High Risk and Resilience Study – VIA 7 is to characterize neurocogni-
tion, social cognition and social functioning of 7-year-old offspring
with familial high risk for SZ (FHR-SZ) or BD (FHR-BD) and compare
them with control offspring without FHR for these disorders (FHR-C).
We hypothesize that the FHR-SZ and FHR-BD groups will show
impairments in neurocognition and social cognition and display lower
social functioning compared to the FHR-C group. The FHR-SZ group
is expected to show more pronounced impairments than the FHR-BD
group. The aim is to describe proﬁles of impairments across the fol-
lowing domains: general intelligence, processing speed, language,
memory, attention, executive function, Theory of Mind and emotion
recognition. We established a stratiﬁed cohort of 522 7-year-old off-
spring recruited on the basis of parental diagnosis in the register:
Subgroup 1: 202 children with 1 or 2 parents with SZ. Subgroup 2:
120 children with 1 or 2 parents with BD. Subgroup 3: 200 children
of parents with no history of SZ or BD matched with subgroups
1 and 2 on age, gender, and municipality. The domains are measured
with a comprehensive test battery of standardized individual assess-
ment methods and questionnaires. Analyses are ongoing and will be
presented. Identifying cognitive proﬁles enables an integrative per-
spective on impaired and intact cognitive abilities and has potential
implications for early intervention and prevention strategies in the
FHR groups.
Talk 4
Poly-enviromic Scores Predict Psychosis in
Adolescents at Familial High Risk For Schizophrenia
Matcheri Keshavan1, Jaya Padmanabhan1, Neeraj Tandon1, Jai Shah1,
Diana Mermon1, Debra Montrose1
1Harvard Medical School, Boston, MA, USA, 2University of Pittsburgh,
Pittsburgh, PA, USA
A substantial proportion of young relatives at high familial risk for
Schizophrenia (FHRS) show premorbid cognitive, psychopathological
and neurobiological alterations; Genetic and environmental factors
interactively contribute to such risk. However we still do not have
reliable predictors of later psychopathology in FHRS. We have previ-
ously reported that baseline measures of schizotypy and positive
prodromal symptoms are highly predictive of later psychosis, and that
the combined effect of multiple phenotypic variables including
impaired cognition is better than individual predictors alone. In a lon-
gitudinal study of FHRS subjects followed up to 3 years we examined
the predictors of conversion. We combined several environmental
risk factors (including obstetric complications, childhood trauma, can-
nabis abuse, and season of birth), weighted by odds ratios of these
measures in the literature to create a “poly-envirome” score (PES).
We examined the value of PES in FHRS subjects (n = 92) with
follow-up data up to 3 years. PES signiﬁcantly predicted psychosis
converters (n = 14) at follow up (p = 0.004). A model using PES had
a higher model ﬁt (Nagelkerke R2 = 0.17) than models using individ-
ual risk factors (range: 0.031-0.148). Combining familial risk, multiple
environmental risk factors and premorbid phenotypic signatures
might help prediction of psychosis risk in FHRS and thereby facilitate
early intervention efforts.
Question and Answer Period
Discussant: Patrick McGorry, M.D., Ph.D., Orygen, the National Centre
of Excellence in Youth Mental Health, Centre for Youth Mental Health,
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Thinking Through a “Fog of Cannabis”: Cannabis
Use and Cognition
Chair: Marta Di Forti1, Co-Chair: Robin Murray2
Speakers: Tom Freeman, Giorgio Di Lorenzo, Laura Ferraro, Tiziana
Rubino
1Social Genetic and Developmental Psychiatry, Institute of Psychiatry,
King’s College, London, UK, 2Institute of Psychiatry, Psychology &
Neuroscience, Department of Psychosis Studies, King’s College London,
London, UK
The association between cannabis use and increased psychosis has
been consistently reported. Nevertheless, it remains a topic of discus-
sion, which is the relationship between adolescence cannabis use
affects cognitive function. We propose to present data from general
population and clinical samples to provide clear evidence of the direc-
tion of the association between cannabis use and cognitive function
and ﬁnally to explore animal model data to point at the underlying
biology. Firstly, Tom Freeman, in a sample of healthy volunteers will
show that cannabis containing high THC (Delta-9-Tetrahydrocannabi-
nol), its main active ingredient, is associated with a greater severity of
addiction. It was also rated as most strongly associated with memory
impairment. Furthermore, Giorgio Di Lorenzo, will presents data from
a sample of healthy adolescents, suggesting that deﬁcits in working
memory performance are strongly associated with current cannabis
use particularly in individuals with schizotypal traits. Laura Ferraro,
from a large case-control pan- European sample, will report that
patients who present with their First Episode of Psychosis (FEP) and
a history of cannabis use have higher IQ and better pre-morbid socia-
bility (age 12 and 16 years) compared FEP who never used cannabis.
Finally Tiziana Rubino in her animal model of adolescence exposure
to THC shows that chronic THC treatment induces a different epige-
netic picture in the adolescent brain in comparison to the adult one.
These different responses indicate how exposure to cannabis use,
during brain development, might induce long-lasting adverse effects
on cognition.
Talk 1
Comparing Different Types of Cannabis on
Cognition, Reward and Addiction
Tom Freeman1,2
1IOPPN, KCL, 2Clinical Psychopharmacology Unit University College
London, London, UK
Cannabis is used by ~182 million people each year. This number may
increase as legalisation of recreational and/or medical use prolifer-
ates. Some people are more vulnerable to its harmful effects than
others: genetics, age of onset and frequency of use are all important
factors. Another key issue is the type of cannabis used. The cannabis
plant produces over 100 ‘cannabinoids’ and the two most abundant
of these (delta-9-tetrahydrocannabinol, ‘THC’ and cannabidiol, ‘CBD’)
can cause opposite effects on brain and behaviour. I will present data
from three studies: a naturalistic design measuring THC and CBD in
134 peoples’ own cannabis, a controlled study comparing the acute
effects of cannabis with THC, THC + CBD and placebo in 16 volun-
teers, and a cross-sectional study of 2514 people using different
types of cannabis. Study 1 found that cannabis containing THC only
robustly impaired verbal memory. By contrast, cannabis with the
same level of THC (but also containing CBD) caused no impairment.
In study 2, THC enhanced anticipation of reward (‘wanting’) but
attenuated the neural correlates of reward delivery (‘liking’), an effect
that was blocked by CBD co-administration. Study 3 found that can-
nabis containing high THC and negligible CBD was associated with a
greater severity of addiction. It was also rated as most strongly asso-
ciated with memory impairment and paranoia. In conclusion, these
ﬁndings add to accumulating evidence linking high-potency cannabis
to users’ risk of psychosis. They further demonstrate that the type of
cannabis used has critical implications for cognition and mental
health.
Talk 2
Cannabis Use and Working Memory Deﬁcits in a
General Population Sample of Young Adults
Giorgio Di Lorenzo
Laboratory of Psychophysiology, Chair of Psychiatry, Department of
Systems Medicine, University of Rome Tor Vergata, Rome, Italy,
Psychiatry and Clinical Psychology Unit, Department of Neurosciences,
Fondazione Policlinico “Tor Vergata”, Rome, Italy
Working memory (WM) is commonly impaired in people affected by
schizophrenia and in those individuals at high-risk for psychosis.
Information about WM in the general population exposed to risk fac-
tors for psychosis is sparse. The aim of the current study was to
investigate, in a general population of young adults, the relation
between the WM performance and the presence of risk factors for
psychosis. In a large sample of young adults WM was measured with
the Change Localization Task (CLT), along with the collection of infor-
mation on past and current exposition to risk factors for psychosis
(early traumatic life events, smoking, cannabis use). The schizotypal
trait, another risk factor for psychosis, was also measured through
the Schizotypal Personality Questionnaire (SPQ). Relations between
WM and single risk factors for psychosis were not signiﬁcant. When
the population was divided based on the presence or the absence of
a current use of cannabis relations between WM and other risk fac-
tors for psychosis emerged. In particular, in the current cannabis
users, and not in the past cannabis users, higher scores of SPQ were
associated with a worse WM performance. These ﬁndings revealed
that deﬁcits of WM in young adults are associated with schizotypal
traits and current cannabis use. These results, moreover, suggest a
speculative model about the role of cannabis use in determining WM




Better IQ but Worse Premorbid Academic
Adjustment in Cannabis-Users Psychotic Patients
Across Europe: Another Brick in the Intuition
Laura Ferraro1, Veronica Cappuccio1, Erika La Cascia1, Lucia Sideli1,
Alice Mule’1, Fabio Seminero1, Giada Tripoli1, Robin Murray2,
Daniele La Barbera1, Marta Di Forti2
1Section of Psychiatry and Department of Statistics, Medical School,
University of Palermo, Italy, 2IoPPN, King’s College London, UK
Purpose: Several studies report that patients with psychosis who
used cannabis in their lifetime have a better cognitive performance
than those who did not and this association is most likely due to a
better premorbid functioning. We aimed to test the hypothesis of a
better premorbid functioning in First Episode Psychosis (FEP)
cannabis-using and non-using patients coming from different
European countries.
Materials and Methods: 1.745 people (746 cases; 999 healthy con-
trols) completed the assessment for Intellectual Quotient (IQ) (WAIS-
brief version) premorbid adjustment (Premorbid Adjustment Scale –
PAS) and cannabis use (CEQ-Revised). We ﬁrst obtained two main
factors from PAS: “Premorbid Social Adjustment” (PSA) and “Premor-
bid Academic Adjustment” (PAA). We therefore performed linear
mixed models with IQ, PSA, and PAA as dependent variables and can-
nabis lifetime (Yes/No) and subject status (Cases/Controls) as inde-
pendent variables.
Results: across all countries, IQ was higher in cannabis users patients
compared to non users (p = 0.027). Conversely, PAA resulted worst
in cannabis-users patients than non users (p < 0.001). Nevertheless,
cannabis-users patients showed better PSA scores than non users
(p = 0.009) and this difference was signiﬁcantly greater in
patients than controls (p = 0.038). Moreover, a better IQ resulted
related to a better PAA (<0.001) but not to PSA (p = 0.260).
Conclusions: a better IQ is not directly predictable by a better adjust-
ment at school between 12 and 16 years (PAA), even if these two
scores are positively correlated. Additionally, we can speculate an
independent relationship of IQ and a better sociability between
12 and 16 years (PSA) with cannabis use.
Talk 4
Effects of Adolescent THC Exposure in the
Prefrontal Cortex of Female Rats: From Histone
Modiﬁcations to Cognitive Deﬁcits
Tiziana Rubino, Pamela Prini, Federica Penna, Daniela Parolaro
DiSTA and Neuroscience Center, University of Insubria, Varese, Italy
The emerging role of epigenetics in the development of psychiatric
diseases led us to hypothesize that epigenetic modiﬁcations could
play a part. We investigated whether epigenetic mechanisms may
contribute to the long-lasting adverse effects triggered by THC expo-
sure in an experimental model represented by adolescent animals.
We ﬁrst performed a time-course study of different histone H3 modi-
ﬁcations occurring in the prefrontal cortex (PFC) of female rats
exposed to THC during adolescence. Next, to verify the vulnerability
of the adolescent brain, we performed the same analysis after adult
THC exposure. Finally, through the administration of a speciﬁc epige-
netic drug, we investigated the role played by histone modiﬁcations
in the complex phenotype present in adult animals after adolescent
THC exposure Adolescent THC exposure induced alterations in selec-
tive histone modiﬁcations in different cerebral areas relevant for cog-
nition and emotionality. On the contrary, adult THC exposure
induced histone modiﬁcations ending in transcription activation.
Changes in histone modiﬁcations were more widespread and intense
after adolescent treatment in comparison with that of adults, sup-
porting the existence of higher adolescent sensitivity. Finally, pharma-
cological blockade of the enzyme responsible for the main histone
modiﬁcation induced by adolescent THC exposure during the THC
treatment was able to prevent THC-induced cognitive deﬁcits at
adulthood. As a whole these data suggest that chronic THC treat-
ment induces a different epigenetic picture in the adolescent brain in
comparison to the adult one. This different response might play a





New Models of Psychosocial Rehabilitation in Early
Phases of Psychosis
Chair: Masafumi Mizuno1, Co-Chair: Giancarlo Vinci2
Speakers: Takahiro Nemoto, Sung-Wan Kim, Raffaele Popolo, Andrea
Fiorillo
1Department of Neuropsychiatry, Toho University School of Medicine,
Tokyo, Japan, 2Department of Mental Health Rome, Italy
Social functioning represents a crucial component of patients’ quality
of life. Therefore, interventions on patients affected by severe condi-
tions should not only aim to the remission of symptoms but also to
the improvement of such functions. Moreover, it is necessary to eval-
uate social functioning in the context of interpersonal relations,
within the family and in the vocational sphere. This has the objective
of designing psychosocial rehabilitation models, including both social
functioning impairment and psychopathological picture treatment. In
this symposium, we are going to discuss models that can inspire such
designs. The focus will be on interventions that can improve the
patients’ social functioning and quality of life. We will present inter-
ventions on different functions. Firstly, cognitive functioning on acute
phases of schizophrenia, secondly, metacognitive treatments based
on group therapy with the use of smartphones as well as sport prac-




Cognitive Rehabilitation in Acute Phase of
Schizophrenia and Its Feasibility
Takahiro Nemoto1, Kiyoaki Takeshi1, Miki Tobe1, Hidehito Niimura2,
Ryosuke Ito3, Akiko Kojima1, Megumi Iba1, Tomoyuki Funatogawa1,
Taiju Yamaguchi1, Naoyuki Katagiri1, Naohisa Tsujino1,
Masafumi Mizuno1
1Toho University School of Medicine, Tokyo, Japan, 2Keio University
School of Medicine, Tokyo, Japan, 3Funabashi Special Support Education
School, Chiba
Although rehabilitation in psychiatry is usually implemented in
chronic phase, the importance of rehabilitation in acute phase is
emphasized in the ﬁeld of physical medicine. Psychiatric rehabilitation
in acute phase includes a number of problems to be resolved like psy-
chiatric symptoms and lack of spontaneity. The aims of the present
study were to examine the feasibility and the effectiveness of cogni-
tive rehabilitation in acute phase of schizophrenia. In-patients with
schizophrenia aged 15 to 50 years who were admitted to the Toho
University Omori Medical Center in Tokyo were recruited for this
study. Patients who could start cognitive rehabilitation within 2 weeks
from the admission were considered to be candidates for this study.
We developed a cognitive rehabilitation program that consisted of an
8-week workbook that was suitable to patients in acute phase.
Eighty-three in-patients with schizophrenia were newly admitted to
the hospital in 15 months. After screening by exclusion criteria,
49 patients were considered introducing into the study. Of them,
22 patients (45%) agreed to their participation and started the cogni-
tive rehabilitation program. Their mean GAF score was 32 and the
mean period between the admission and the start of the program
was 9 days. Sixteen patients (73%) completed the program. Their
GAF score was signiﬁcantly improved and their satisfaction with the
program was good. Conclusion: About half of patients with schizo-
phrenia could start cognitive rehabilitation and their continuation was
good even in acute phase in which various psychotic symptoms and
disabilities were obvious.
Talk 2
Group Cognitive-Behavioural Therapy and
Smartphone Application for Young Individuals with
Early Psychosis
Sung-Wan Kim
Chonnam National University Hospital, Gwangju, South Korea; Gwangju
Bukgu Community Mental Health Center, South Korea
This study aimed to develop group cognitive-behavioural therapy
(CBT) and the Smartphone application for case management of young
individuals with early psychosis. Methods: We developed a Korean
version of group CBT consisting of metacognitive training, cognitive
restructuring, life style modiﬁcation, and stress management. The
Subjective Wellbeing under Neuroleptics (SWN-K) scale, Ambiguous
Intentions Hostility Questionnaire (AIHQ), Drug Attitude Inventory
(DAI), Beck Depression Inventory (BDI), and Perceived Stress Scale
(PSS) were administered before and after 14 sessions. In addition, we
developed and launched a Smartphone app for cognitive–behavioural
case management and symptom monitoring. A total of 34 patients
completed scales both before and after group CBT. Scores on the
SWN and DAI increased signiﬁcantly (p-value = 0.044 and < 0.001,
respectively) and those on the AIHQ and PSS decreased signiﬁcantly
(p-value = 0.005 and 0.045) after group CBT. More than 80% of par-
ticipants using the app reported that it was easy to learn to use it,
and no one described this app as very complicated. About 80% of
participants were satisﬁed with this app, and 70% reported that they
received help as a result of using this app. Group CBT had a positive
effect on the quality of life, attitude toward treatment, perceived
stress, and suspiciousness of patients with early psychosis. Further-
more, a Smartphone app for case management may be useful for
young individuals with early psychosis. This study may contribute to
the development of a youth- and customer-friendly case manage-
ment system for individuals with early psychosis.
Talk 3
The Metacognitive-Interpersonal Model in
Psychosocial Rehabilitation
Raffaele Popolo1, Giancarlo Vinci2, Maurizio Parisi3, Bruno Ruscello3,
Francesca R. Vinci4, Andrea Balbi2
1Centro Terapia Metacognitiva Interpersonale Rome, Italy, 2Department
of Mental Health Rome, Italy, 3Univeristy of Rome Tor Vergata, Italy,
4University of Nottingham, UK
Numerous studies have shown the presence in schizophrenic patients
of impaired metacognitive functions, i.e. those skills that enable
awareness of mental status. We designed a model of psychological
rehabilitation with the aim to improve metacognitive functioning,
testing the hypothesis that an early intervention can favour a more
rapid recovery of the compromised abilities. We evaluated the varia-
tion of such functions in patients who took part in a psychosocial
rehabilitation programme, using an integrated model of intervention.
This consisted in a group sport activity of 120 minutes twice a week,
followed by a metacognitive psychotherapeutic group session of
90 minutes once a week. Two groups of patients with diagnoses
within the schizophrenia spectrum were compared. All subjects were
selected among the patients of the Department of Mental Health
Rome 3. The ﬁrst group was made up of 21 subjects, aged between
18 and 25, whilst the second involved 16 patients, between 26 and
35 years of age. We performed formal assessments at the baseline
and after one year of intervention, running a battery of metacognitive
tests speciﬁcally constructed by our research team. These included
the Hinting Task, the Brune sequencing pictures task, BCSI and the
Eyes tests. As for psychopathological scales, we performed the
PANSS and Cgi test, while we chose Gaf as a function test and SF36
as a quality of life assessment tool. Preliminary results conﬁrmed the
impairment of metacognitive functions in both samples. We expect




A New Psychoeducational Approach to Improve
Lifestyle Behaviours in Patients with Severe Mental
Disorders
Andrea Fiorillo, Mario Luciano, Gaia Sampogna, Valeria Del Vecchio
University of Naples, SUN, Italy
People with severe mental illness (SMI) have an increased rate of
chronic physical illnesses and an unacceptable reduced life expect-
ancy of up to 30 years compared to the general population. In partic-
ular, a higher prevalence of cardiovascular diseases, diabetes, obesity,
metabolic syndrome, cancer and infectious diseases has been found
in these patients. The higher mortality rates can be explained by sev-
eral factors including unhealthy lifestyle, disparities in access and
quality of health care, and side effects of antipsychotics. As regards
lifestyle behaviours, patients with SMI are more frequently heavy
smokers with a low level of physical activity, unhealthy eating habits
and abuse of alcohol or drug. Most clinical guidelines for the treat-
ment of SMI suggest the use of these interventions and emphasize
the need of regular health monitoring and check-ups. Lifestyle beha-
viours can be improved through speciﬁc psychosocial interventions.
Recently several psychosocial interventions, such as the STRIDE and
the CHANGE trials, have been developed with a speciﬁc focus on
lifestyle modiﬁcations. These approaches have been proved to be
effective in improving patients’ physical health indices, such as BMI,
waist circumferences, weight, blood pressure and cardiovascular risk
index. We developed a new psychoeducational group intervention
for improving lifestyle behaviours in patients with SMI. Our approach,
which includes elements of classical psychoeducation, motivational
interview, problem solving and health coaching techniques,
addresses: healthy eating, smoking cessation, physical activity, sleep-
wake cycle, sexual habits, alcohol abuse. Sessions take place on a
weekly basis for a period of six months (24 sessions in total). Each
session lasts about 90 minutes and includes: a) information on the
topic of the session; b) motivation to change; c) group discussion; d)
physical activity.
Question and Answer Period




Results of New Intervention Trials in People at
Clinical High Risk of Psychosis
Chair: Patrick D. McGorry M.D., Ph.D.,1,2, Co-Chair: Andreas Bechdolf3
Speakers: Helen J. Stain, Mark van der Gaag, Andreas Bechdolf,
Patrick D. McGorry
1Orygen, the National Centre of Excellence in Youth Mental Health,
Parkville, Australia 2Centre for Youth Mental Health, University of
Melbourne, Parkville, Australia, 3Department of Psychiatry,
Psychotherapy and Psychosomatics, Vivantes Hospital am Urban and
Friedrichshain, Charite Medicine Berlin, Germany
Recent research has indicated that preventative intervention is likely
to beneﬁt patients at clinical high risk (CHR) for psychosis, both in
terms of symptom reduction and delay or prevention of onset of
threshold psychotic disorder. However a number of questions regard-
ing the long term effects and the differential effects of preventive
interventions are still open. In this symposium on actual randomized
controlled trials (RCT) some of these issues will be addressed. Stain
et al., present results of a RCT comparing CBT with Non Directive
Reﬂective Listening (NDRL) in addition to standard care in 57 young
adults with CHR, indicating that in this group there were no differ-
ences between the treatment groups in terms of transitions to psy-
chosis and functioning. Van der Gaag et al present results of a RCT
comparing CBT and Tau with TAU alone, which indicated an effect
on CBT on transitions still at 4 year follow-up in n = 113. Bechdolf
et al., compared CBT, with Clinical management and placebo and clin-
ical management and aripripazole in more than 200 participants with
CHR. The results indicated that CBT presents with lowest progres-
sion rates towards psychosis on a descriptive level, although only on
a trend level when compared with clinical management and placebo.
McGorry et al., will present data from a large 6-months, double-blind,
placebo controlled RCT of 1.4 g day- omega-3 polyunsaturated fatty
acids in CHR patients, in order to a replication the large effects of an
earlier small scale trial.
Talk 1
A Randomised Controlled Trial of Cognitive
Behaviour Therapy Versus Non-Directive Reﬂective
Listening for Young People at Risk of Developing
Psychosis
Helen J. Stain1, Sandra Bucci2, Amanda L. Baker3, Vaughan Carr4,
Richard Emsley7, Sean Halpin8, Terry Lewin3, Ulrich Schall5,9,10,
Vanessa Clarke3, Kylie Crittenden11, Mike Startup8
1School of Medicine, Pharmacy and Health, Durham University, UK,
2School of Psychological Sciences, University of Manchester, Manchester,
UK, 3School of Medicine and Public Health, University of Newcastle,
NSW, Australia, 4School of Psychiatry, University of New South Wales,
NSW, Australia, 5Schizophrenia Research Institute, NSW, Australia,
6Department of Psychiatry, Monash University, Vic, Australia, 7Institute
of Population Health, University of Manchester, Manchester, UK, 8School
of Psychology, University of Newcastle, NSW, Australia, 9Priority Centre
for Translational Neuroscience & Mental Health Research, University of
Newcastle, NSW, Australia, 10Hunter Medical Research Institute, NSW,
Australia, 11Western New South Wales Local Health District, NSW,
Australia
Background Intervention trials for young people clinically at risk
(AR) for psychosis have shown cognitive behaviour therapy (CBT) to
have promising effects on treating psychotic symptoms but have
not focused on functional outcomes. We hypothesised that com-
pared to an active control, CBT would: (i) reduce the likelihood of,
and/or delay, transition to psychosis; and (ii) reduce symptom sever-
ity while improving social functioning and quality of life, whether or
not transition occurred. Method This was a single-blind randomised
controlled trial for young people AR for psychosis (aged 14-35
years) comparing CBT to Non Directive Reﬂective Listening (NDRL)
in addition to standard care, with a 6 month treatment phase and
12 months of follow-up. Results There were 57 young people (mean
age of 16.5 years) randomised for treatment. The rate of transition
to psychosis was 5%, with all 3 transitions occurring in the CBT
condition (baseline, 2 months and 5 months respectively). The active
control condition, NDRL, resulted in a signiﬁcantly greater reduction
in distress associated with psychotic symptoms compared to CBT.
Both conditions showed reductions in the frequency and intensity
of psychotic symptoms over time. There were no signiﬁcant treat-
ment effects on global, social or role functioning. Conclusion Our
sample was higher functioning, younger and experiencing lower
levels of psychotic like experiences than other trials. The signiﬁ-
cantly better treatment effect of NDRL on distress associated with
psychotic symptoms supports the recommendations for a stepped-
care model of service delivery. This treatment approach would




The Four-Year Follow-Up Data of Cognitive
Behavioural Therapy for Ultra High Risk Subjects
Mark van der Gaag1,2, Helga K. Ising1, Tamar C. Kraan3,
Judith Rietdijk1, Sara Dragt3, Rianne M. C. Klaassen4,
Nynke Boonstra5, Dorien H. Nieman2,
Monique Willebrands-Mendrik3, David P. DG. van den Berg1,
Wim Veling6, Filip Smit2,7,8
1Parnassia Psychiatric Institute, The Hague, The Netherlands, 2VU
University and EMGO Institute for Health and Care Research,
Amsterdam, The Netherlands, 3Academic Medical Center, Amsterdam,
The Netherlands, 4De Bascule, Academic Center for Child and
Adolescent Psychiatry, Amsterdam, The Netherlands, 5Friesland Mental
Health Services, Leeuwarden, The Netherlands, 6University Medical
Center Groningen and University of Groningen, Groningen, The
Netherlands, 7Trimbos Institute (Netherlands Institute of Mental Health
and Addiction), Utrecht, The Netherlands, 8VU University Medical
Center, Amsterdam, The Netherlands
Previously, we demonstrated that cognitive behaviour therapy for ultra-
high risk (called CBTuhr) halved the incidence of psychosis over an 18-
month period. The four-year follow-up was conducted. Of the
196 patients included in the study, 113 consented to a 4-year follow-up
(57.7%; CBTuhr = 56 vs TAU = 57). Over the follow-up period, the
number of participants in the CBTuhr group making the transition to
psychosis increased from 10 at 18-month follow-up to 12 at 4-year
follow-up, whereas it did not change in the TAU group (n = 22); this still
represents a clinically important (incidence rate ratio [IRR] = 12/
22 = 0.55) and signiﬁcant effect (F(1,5) = 8.09, P = .03), favouring
CBTuhr. The odds ratio of CBTuhr compared to TAU was 0.44 (95% CI:
0.24-0.82) and the number needed to treat was 8. Moreover, signiﬁ-
cantly more patients remitted from their UHR status in the CBTuhr
group (76.3%) compared with the TAU group (58.7%) [t(120) = 2.08, P
= .04]. Transition to psychosis was associated with more severe psycho-
pathology and social functioning at 4-year follow-up. CBTuhr to prevent
a ﬁrst episode of psychosis in persons at UHR of developing psychosis is
still effective at 4-year follow-up. Our data also show that individuals
meeting the formal criteria of a psychotic disorder have worse functional
and social outcomes compared with non-transitioned cases.
Talk 3
PREVENT: A Randomized Controlled Trial
Comparing Cognitive Behavioural Therapy, Clinical
Management and Aripirazole and Clinical
Management and Placebo for the Prevention of
First Episode Psychosis
Andreas Bechdolf1,2, Hendrik Mueller1, Wolfgang Gaebel4,
Alkomiet Hasan5, Wolfgang Maier8, Georg Juckel6, Martin Lambert7,
Marion Lautenschlager3, Franziska Rausch10, Michael Riedel11,
Frank Schneider9, Joachim Klosterkötter1
1Department of Psychiatry and Psychotherapy, University of Cologne,
Germany, 2Vivantes Hospital am Urban/Charite University Medicine,
Berlin, Germany, 3Charité University Medicine Berlin, 4Heinrich-Heine-
University Duesseldorf, Germany, 5Georg-August-University Goettingen,
Germany, 6Ruhr University Bochum, Germany, 7University Medical
Centre Hamburg-Eppendorf, Germany, 8Friedrich Wilhelms University of
Bonn, Germany, 9RWTH Aachen, 10Central Institute of Mental Health
Mannheim, Germany, 11Ludwig-Maximilians-University Munich, Germany
Purpose: Antipsychotics, omega-3-fatty acids and psychotherapy
have been found to be effective to prevent transition to ﬁrst episode
psychosis in individuals at clinical high risk for psychosis (CHR). How-
ever, little data is available regarding the differential effects of the
preventive interventions. PREVENT was a multicenter, prospective,
randomized, blinded trial with three parallel groups designed to com-
pare 1. Aripiprazole (ARI) + clinical management (CM) and 2. cognitive
behavioural therapy (CBT) to 3. placebo (PL) + clinical management.
Materials and Methods: Individuals aged 18-49 identiﬁed as CHR by
UHR and/or basic symptoms COGDIS criteria were assessed at base-
line, 28 and 52 weeks including clinical symptoms, social functioning,
quality of life and safety. The primary outcome was progression and
the secondary was transition to psychosis.
Results: Overall 280 individuals [mean age 24.4 (5.1) years; about 66 %
male] were randomized. In terms of the primary outcome, there was no
statistical difference between the three treatment arms (p > 0.05).
Exploratory pairwise comparisons showed a statistical trend in favour
of CBT compared with CM + PL. With respect to the secondary out-
come, there was a reduction in favour of CBT compared to CM + ARI
also approaching statistical signiﬁcance. Drop-out rates between the
arms differed over time (p < .05), with indications for more premature
terminations in ARI + CM and PL + CM compared to CBT.
Conclusions: Pairwise comparisons showed a clinically relevant
reduction regarding the primary (about 35 %) and secondary outcome
(about 40 %) in favour of CBT. Lower drop-out rates in CBT could be
interpreted as higher adherence and acceptance of psychotherapy
within this trial.
Talk 4
NEURAPRO-E: A Multicentre Randomized
Controlled Trial of Omega-3 Fatty Acids and
Cognitive-Behavioural Case Management for
Patients at Ultra High Risk of Schizophrenia and
Other Psychotic Disorders
Patrick D. McGorry1, B Nelson1, C Markulev1, A R Yung2, G Berger3,
L de Haan4, A Riecher-Rössler5, M Nordentoft6, E Y Chen7, S Verma8,
Ian Hickie9, G P Amminger1
1Orygen, the National Centre of Excellence in Youth Mental Health,
Centre for Youth Mental Health, University of Melbourne, Parkville,
Australia, 2Institute of Brain, Behaviour and Mental Health, University of
Manchester, Manchester, UK, 3Department of Child and Adolescent
Psychiatry, University of Zurich, Zurich, Switzerland, 4Academic
Psychiatric Centre, AMC, Amsterdam, The Netherlands, 5Psychiatric
University Clinics, University Psychiatric Outpatient Department, Basel,
Switzerland, 6Department of Psychiatry E, Bispebjerg Hospital,
Copenhagen, Denmark, 7Department of Psychiatry, University of Hong
Kong, Hong Kong, 8Early Psychosis Intervention, Institute of Mental
Health, Singapore, 9Brain & Mind Research Institute, University of
Sydney, NSW, Australia
Aim: Recent research has indicated that preventative intervention is
likely to beneﬁt patients ’at-risk’ for psychosis, both in terms of symp-
tom reduction and delay or prevention of onset of threshold psy-
chotic disorder. The strong preliminary results for the effectiveness
of omega-3 polyunsaturated fatty acids (PUFAs), coupled with the
falling transition rate in ultra high-risk (UHR) samples, mean that fur-
ther study of such benign, potentially neuroprotective interventions
is clinically and ethically required. Employing a multicentre approach,
enabling a large sample size, this study will provide important infor-
mation with regard to the use of omega-3 PUFAs in the UHR group.
Methods: This trial is a 6-month, double-blind, randomized placebo-
controlled trial of 1.4 g day-1 omega-3 PUFAs in UHR patients aged
between 13 and 40 years. The primary hypothesis is that UHR
patients receiving omega-3 PUFAs plus cognitive-behavioural case
management (CBCM) will be less likely to transition to psychosis over
a 6-month period compared to treatment with placebo plus CBCM.
Secondary outcomes will examine symptomatic and functional
changes, as well as examine if candidate risk factors predict response
to omega-3 PUFA treatment in the UHR group.
Conclusion: This is the protocol of the NeuraproE study. Utilizing a large
sample, results from this study will be important in informing indicated
prevention strategies for schizophrenia and other psychotic disorders,
which may be the strongest avenue for reducing the burden, stigmatiza-
tion, disability and economic consequences of these disorders.
Question and Answer Period
Discussant: Alison Yung, Institute of Brain, Behavior and Mental Health,
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Pharmacological and Non-Pharmacological
Interventions to Reduce Cardiometabolic Risk
During Treatment of Mental illness: Managing the
Risks of Early Intervention
Chair: Ane Storch Jakobsen1
Speakers: John W Newcomer, Jackie Curtis, Ane Storch Jakobsen,
Faith Dickerson
1University of Copenhagen, Mental Health Center Copenhagen, Denmark
Early intervention for mental health disorders offers the potential for
important advantages in managing long term mental health outcomes.
Importantly, major mental health conditions are also associated with an
increased risk for diabetes and cardiovascular disease compared with
the general population, largely explained by increased rates of key risk
factors like overweight and obesity, dyslipidaemia, hyperglycaemia,
hypertension, and smoking. While genetic inﬂuences and disease-
related lifestyle factors have been implicated as contributors to overall
risk, unmedicated ﬁrst episode patients have been observed to have
cardiometabolic risk similar to the general population, with treatments
such as antipsychotic medication associated with substantial increases
in risk factors for both diabetes and cardiovascular disease. Recent
research and international guidelines have focused on opportunities to
increase screening and monitoring of risk during treatment, but the
effect of pharmacological and non-pharmacological treatments to miti-
gate cardiometabolic risk –especially early in treatment- have received
limited study. This symposium will review evidence that early pharma-
cological treatment of mental health conditions can be associated with
rapid onset adverse effects on long-term risk for cardiovascular disease
and diabetes, and then report on the results of a series of important
studies of pharmacological and non-pharmacological interventions to
reduce cardiometabolic risk in patients with mental health disorders.
The mixed results of these studies indicate the importance of avoiding
high-risk pharmacotherapies in the treatment of mental illness and the
high-value of early screening and intervention to manage the medical
health outcomes of patients with mental health disorders.
Talk 1
Rapid Onset Adverse Cardiometabolic Effects of
Pharmacotherapy for Mental Health Disorders:
Review of the Evidence Including Results from the
NIMH-funded Metabolic Effects of Antipsychotics
in Children (MEAC) Study
John W Newcomer1, Ginger E Nicol2
1Charles E. Schmidt College of Medicine, Florida Atlantic University,
USA, 2Washington University School of Medicine, St. Louis, MI USA
Antipsychotic and other psychotropic treatments are associated with
adverse effects on body weight and other risk factors for diabetes
and cardiovascular disease. Evidence from observational databases
suggest rapid onset risk for diabetes and dyslipidaemia. Randomized
clinical trials have rarely been designed and powered to measure met-
abolic risk as primary endpoints. The randomized, NIMH-funded Met-
abolic Effects of Antipsychotics in Children study (MEAC)
characterized the metabolic effects of 12 weeks of antipsychotic
treatment using gold-standard measures in children with disruptive
behaviours. Antipsychotic-naive youth with clinically signiﬁcant
aggression/irritability were randomized to treatment with aripipra-
zole, olanzapine or risperidone. Over just 12 weeks, the pooled
patient sample increased the rate of overweight and obesity from a
US paediatric general population norm of 30% to a remarkable 47%.
Signiﬁcant effects of treatment were observed on measures of adi-
posity (body fat) and insulin sensitivity. Differential effects of individ-
ual treatments were observed on measures of adiposity, insulin
sensitivity and other endpoints. Importantly, treatment resulted in
marked improvement in irritability/aggression, with no signiﬁcant dif-
ferences across individual treatments. The results indicate that anti-
psychotic treatment of previously antipsychotic-naïve children results
in rapid onset adverse effects on metabolic risk. While risk differs sig-
niﬁcantly across individual treatments, the efﬁcacy of the treatments
was similar, suggesting the importance of careful selection of pharma-
cotherapies to minimize risk and improve overall effectiveness. The
results suggest that antipsychotics should be used judiciously and
with careful metabolic monitoring, and underscore the importance of
adjunctive pharmacological and non-pharmacological treatments to
manage cardiometabolic risk in patients who require psychotropic
therapy.
Talk 2
Keeping the Body in Mind for Youth Experiencing
Psychosis: Translating Research into Routine
Practice
Jackie Curtis1,2, Andrew Watkins2, Scott Teasdale2, Oscar Lederman2,
Megan Kalucy1,2, Julia Lappin1,2, Katherine Samaras1,
Simon Rosenbaum1, Philip Ward1
1University of New South Wales, Sydney, Australia, 2South Eastern
Sydney Local Health District, Sydney, Australia
The Bondi “Keeping the Body in Mind” (KBIM) program is a multidis-
ciplinary, 12-week intervention aimed at attenuating weight gain in
young people (15-25 years) recently commenced on antipsychotic
medication (within 4 weeks). KBIM includes weekly, individualized,
and group-based dietetic, exercise, health-coaching and motivational
interviewing components delivered by specialist clinicians. In addition,
peer-wellness coaches encourage participation and adherence. Parti-
cipants who completed KBIM (n = 16) experienced signiﬁcantly less
weight gain than a comparison group (n = 12) who received best-
practice FEP care without additional lifestyle intervention elements.
There was no change in waist circumference in the intervention
group, whilst waist circumference increased signiﬁcantly for controls.
Seventy-ﬁve percent (75%) of the intervention group did not experi-
ence clinically signiﬁcant weight gain. Two-year follow up data for
the intervention group (n = 13) indicated that preventing weight and
waist circumference gains can be sustained when participants con-
tinue to have access to key lifestyle intervention elements (gym,
cooking group, sports group). Primary outcomes from the 12-week
program have been replicated in a second sample of youth with FEP
(n = 17). KBIM is now being extended to other adults with SMI. Mul-
tidisciplinary early lifestyle interventions can attenuate antipsychotic
induced weight gain in young people with FEP and may be an impor-
tant means of achieving the key Healthy Active Lives (HeAL) targets
(www.iphys.org.au). Additional components of the program now
include oral health and sexual health screening. People with psychosis
deserve support to secure the same life expectancy and expectations
of life as their peers who do not have psychosis.
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A Randomized Clinical Trial Investigating the Effect
of a Lifestyle Coaching Intervention on
Cardiovascular Risk in People with Schizophrenia
and Overweight
Ane Storch Jakobsen1,2, Helene Speyer1,2, Hans Christian N Brix3,
Merete Nordentoft1,2
1Mental Health Center Copenhagen, Denmark, 2University of
Copenhagen, Denmark, 3Aarhus University Hospital, Mental Health
Center Aarhus, Denmark
CHANGE is a randomized, parallel-group, superiority, multi-centre trial
with blinded outcome assessment, testing the efﬁcacy of an interven-
tion aimed to improve cardiovascular risk proﬁle and hereby poten-
tially reduce mortality. A total of 428 patients with schizophrenia
spectrum disorders and abdominal obesity were recruited and cen-
trally randomized 1:1:1 to 12 months of lifestyle coaching plus care
coordination plus treatment as usual (N = 138), or care coordination
plus treatment as usual (N = 142), or treatment as usual alone
(N = 148). The primary outcome was 10-year risk of cardiovascular
disease assessed post-treatment and standardized to age 60 using the
Copenhagen risk score, which is a composite measure including both
non-modiﬁable (gender, family history of cardiovascular disease, prior
heart disease) and modiﬁable factors (smoking, diabetes mellitus, total
cholesterol, high density lipoprotein (HDL) cholesterol, systolic blood
pressure, and body mass index). At 12 months follow-up, the mean
10-year risk of cardiovascular disease was 8.4 ± 6.7% in the group
receiving lifestyle coaching, 8.5 ± 7.5% in the care coordination group,
and 8.0 ± 6.5% in the treatment as usual group (p = 0.41). We found
no intervention effects for any secondary or exploratory outcomes,
including cardiorespiratory ﬁtness, physical activity, weight, diet and
smoking. In conclusion, the CHANGE trial did not support superiority
of individual lifestyle coaching or care coordination compared to treat-
ment as usual in reducing cardiovascular risk in patients with schizo-
phrenia spectrum disorders and abdominal obesity. At the symposium
we will be able to present and discuss the 2 years follow-up results
Talk 4
Comprehensive Cardiovascular Risk Reduction Trial
(IDEAL Trial) in Persons with Serious Mental Illness:
Description and Baseline Results
Faith Dickerson1, Arlene Dalcin2, Gerald Jerome3, Nae-Yuh Wang2,
Deborah Young4, Lawrence Appel2, Joseph Gennusa2,
Stacy Goldsholl2, Ann Heller2, Courtney Cook2, Gail L Daumit2
1Sheppard Pratt Health System, Maryland, USA, 2Johns Hopkins
University School of Medicine, Maryland, USA, 3Towson University,
Maryland, USA, 4Kaiser Permanente Research, CA, USA
Purpose: Persons with serious mental illness (SMI) have an extraordi-
nary burden of cardiovascular disease risk factors. We describe base-
line data and intervention strategies for an ongoing NIH-funded trial
of an 18-month comprehensive cardiovascular risk reduction
program.
Materials and Methods: The IDEAL Trial will enrol 250 adults with
SMI with at least one cardiovascular risk factor from 4 psychiatric
rehabilitation program and clinic sites of a large community mental
health organization in Maryland. As the control condition, we provide
group exercise classes and healthy menu changes for all sites. Indivi-
duals randomized to active intervention in addition receive: individual
cardiovascular risk reduction counselling (e.g., smoking cessation,
weight management) by a health coach, a mental health organization
employee; and 2) a study nurse who communicates/coordinates with
primary care providers to advocate for optimal management of health
risk factors (e.g., lipid, blood pressure and diabetes control).
Results: Of the 193 enrolled to-date, 55% are female, and 36% are
African-American with mean age of 49 (SD 12) years. At baseline,
37% have diabetes, 44% have hypertension and 50% smoke, with
mean Framingham global risk score of 12.1% (SD 11.6). We will
describe detailed intervention elements including prioritization and
management of multiple risk factors in a population with high base-
line risk for cardiovascular disease.
Conclusion: Evidence-based approaches to reduce cardiovascular dis-
ease risk in those with SMI are urgently needed. This randomized
clinical trial will provide a rigorous evaluation of a practical interven-
tion designed to improve cardiovascular health in this population.
Question and Answer Period
Discussant: John W Newcomer, Charles E. Schmidt College of Medicine
Florida Atlantic University, Boca Raton, FL, USA
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Symptomatic and Neurobiological Characteristics of
Clinical High Risk States of Psychosis
Chair: Chantal Michel1, Co-Chair: Anastasia Theodoridou2
Speakers: Chantal Michel, Anastasia Theodoridou, Jochen Kindler,
Diana Wotruba
1University Hospital of Child and Adolescent Psychiatry and
Psychotherapy, Bern, Switzerland, 2The Zurich Program for Sustainable
Development of Mental Health Services (ZInEP); Department of
Psychiatry, Psychotherapy and Psychosomatics, University Hospital of
Psychiatry, Zurich, Switzerland
In clinical samples of specialized early detection and intervention ser-
vices, both ultra-high risk (UHR) and basic symptom criteria are not
only associated with a 1-year conversion rate of roughly 20% but also
with various other impairments. Thus, in addition to symptoms
included in clinical high risk (CHR) criteria, neurobiological predictors
have been suggested to enhance predictive accuracy of CHR criteria.
In the symposium different psychopathological and neurobiological
aspects in CHR samples are presented: (1) neurocognitive characteris-
tics of a sample of children and adolescents with and without a CHR
state, (2) ﬁndings on differential subtle, self-experienced cognitive
disturbances of a CHR-sample for psychosis, (3) results of an arterial
spin labelling MRI study in 8-40-year old patients of the Bern Early
Recognition and Intervention Centre, and (4) aberrations in dynamic-
functional networks in a 16-35-year-old CHR of psychosis sample.
Consistently, UHR criteria were assessed with the Structured Inter-
view for Psychosis-Risk Syndromes (SIPS) and basic symptom criteria
with the Schizophrenia Proneness Instrument, Adult (SPI-A) and Child
and Youth version (SPI-CY), respectively. Study results and their com-
parison will shed light on clinical and neurobiological characteristics




Neurocognitive Deﬁcits According to Norms in
Adolescents With and Without Clinical High Risk
States of Psychosis
Chantal Michel1, Liz Rietschel1, Nina Schnyder1, Petra Walger2,
Maurizia Franscini3, Benno G. Schimmelmann1,
Frauke Schultze-Lutter1
1University Hospital of Child and Adolescent Psychiatry and
Psychotherapy, Bern, Switzerland, 2University Hospital of Child and
Adolescent Psychiatry and Psychotherapy, Cologne, Germany,
3University Hospital of Child and Adolescent Psychiatry, Zurich,
Switzerland
In the early detection of psychosis, neurocognitive predictors have
been suggested to enhance predictive accuracy of clinical high risk
(CHR) criteria. While mainly sample-dependent means of adult sam-
ples were used so far, a recent study of an adult sample used neuro-
cognitive deﬁcits deﬁned according to test norms in order to
facilitate individual prediction. Yet, data on child and adolescent sam-
ples are missing. We investigated the discriminative power of neuro-
cognitive deﬁcits deﬁned according to norms in 8-17-year-olds.
84 CHR outpatients (AtRisk; mean age = 15.02 ± 2.20, 39% male),
134 non-psychotic inpatients (ClinS; mean age = 14.46 ± 2.43, 38%
male) and 124 subjects of a general population sample (GPS; mean
age = 13.91 ± 2.78, 48% male) had been assessed with a neurocog-
nitive battery, including a verbal ﬂuency (VF) test, the Digit-Symbol
Test, TMT A and B, the Auditory Verbal Learning Test (AVLT) and the
Subject Ordered Pointing Task. GPS were slightly younger than
AtRisk and ClinS (Chi2(2) = 7.656, p = 0.022); no differences were
found with regard to gender and premorbid IQ. Compared to ClinS
and GPS, AtRisk more frequently exhibited deﬁcits according to
norms in verbal memory (AVLT learning capacity; 22.4% vs. 10.7%;
OR = 2.4, 95% CI: 1.3-4.6) and VF (48.8% vs. 34.1%; OR = 1.8, 95%
CI: 1.1-3.0), while ClinS and GPS did not differ. Partly in line with
ﬁndings from adult samples, deﬁcits in verbal memory and VF might
be speciﬁcally associated with a CHR state in children and adoles-
cents – even when compared to a more severely ill inpatient group.
Yet, these ﬁndings need further examination in larger samples and
longitudinal studies.
Talk 2
Perspectives on Subjective and Objective Cognitive
Disturbances in the Clinical High Risk State for
Psychosis
Anastasia Theodoridou1,2, Mario Müller1,2, Diane Dvorsky1,2,
Karsten Heekeren1,2, Wulf Rössler1,3
1University Hospital of Psychiatry Zurich, The Zurich Program for
Sustainable Development of Mental Health Services (ZInEP), Switzerland,
2Department of Psychiatry, Psychotherapy and Psychosomatics,
University Hospital of Psychiatry, Zurich, Switzerland, 3Laboratory of
Neuroscience (LIM-27), Institute of Psychiatry, University of Sao Paulo,
Sao Paulo, Brazil
The clinical high risk (CHR) states for developing psychosis are well
established and there is some evidence for neurocognitive deﬁcits
already in the prepsychotic period. The purpose of this study was to
compare the subjective perception of cognitive disturbances in CHR
individuals and objective variables according to neurocognitive mea-
sures. For the current study, we targeted individuals meeting criteria
for a CHR state (either basic symptom criteria according to the Schiz-
ophrenia Proneness Instruments: SPI-A/SPI-CY, or ultra high-risk cri-
teria according to the Structured Interview for Psychosis-Risk
Syndromes). We examined the relationship of the “cognitive-
attentional impediments” (CAI) and “cognitive disturbances”
(CD) items from the SPI-A/SPI-CY with performance on neurocogni-
tive tests. N = 221 participants have fully completed the baseline
examinations. Using a latent class approach we empirically derived
homogeneous subgroups that showed unique patterns of CAI and
CD. Based on a three-class solution, a “low thought initiative level”
(LTI) subgroup and a “low functioning in receptive speech” (LRS) sub-
group was found. In subsequent regression models LTI was linked to
performance in verbal working memory and with perseveration-errors
of the Wisconsin Card Test. The four-class solution derived another
subgroup, “slowed down thinking” (SDT). SDT was associated with
verbal ﬂuency, Trail Making Test and FAIR. Our ﬁndings suggest dif-
ferential subjective perceptions of neurocognitive functioning that
can be subdivided into impaired thought initiative and disturbances
of receptive speech. Speciﬁc associations with neurocognitive vari-
ables support this view. This raises the question of whether there are
distinctive impaired subtypes as indicated by speciﬁc psychopatho-
logical and functional outcomes.
Talk 3
Cerebral Blood Flow in Psychosis Risk, First
Episode Psychosis and Schizophrenia
Jochen Kindler1, Frauke Schultze-Lutter1, Daniela Hubl2
1University Hospital of Child and Adolescent Psychiatry and
Psychotherapy, Bern, Switzerland, 2University Hospital of Psychiatry and
Psychotherapy, University of Bern, Switzerland
Research on clinical high risk (CHR) states for psychosis indicates
increased presynaptic striatal dopamine synthesis in CHR individuals
as compared to controls. An increase in metabolic rate might also
affect cerebral blood ﬂow (CBF). Here, we examined if CBF in striatum
differs between patients with CHR, ﬁrst episode psychosis (FEP) and
schizophrenia (SZ) when compared with controls. A total of 59 patients
of the Bern Early Recognition and Intervention Centre were included.
A CHR state was met by 29 patients, 12 patients met criteria for FEP.
The clinical controls (CC, n = 18) did not fulﬁl CHR criteria or suffered
from psychosis. Ultra-High Risk criteria were assessed by the Struc-
tured Interview for Psychosis-Risk Syndromes, Basic Symptom criteria
by the Schizophrenia Proneness Instrument. Additionally, patients with
an ICD-10 diagnosis of schizophrenia (n = 32) and healthy controls
(HC, n = 31), were included. A pseudo-continuous arterial spin label-
ling MR technique was used to measure CBF. Signiﬁcantly increased
CBF in the right striatum (p < 0.05, FWE corrected) was revealed in
CHR and FEP as compared to CC. In comparison to HC, SZ demon-
strated a signiﬁcantly increased striatal CBF, in the caudate head and
body (p < 0.05, FWE corrected). CBF in striatum correlated with posi-
tive symptom scores (p < 0.001) and executive dysfunctions (p
< 0.05) in CHR. This is the ﬁrst study to demonstrate increased neu-
ronal activity within the striatum in CHR, FEP and SZ as compared to
the respective controls. Our results indicate that increased CBF in stri-




Resting-State fMRI Dynamics Reveal Increased
State Switching in the At-Risk Stage for Psychosis
Diana Wotruba1,2, Thomas Bolton3,4, Roman Buechler1,
Anastasia Theodoridou1,5, Wulf Rössler1,6, Dimitri Van de Ville3,4,
Karsten Heekren1
1University Hospital of Psychiatry Zurich, the Zurich Program for
Sustainable Development of Mental Health Services (ZInEP), Switzerland,
2Collegium Helveticum, a joint Research Institute between the University
of Zurich and the Swiss Federal Institute of Technology Zurich,
Switzerland, 3Institute of Bioengineering, Ecole Polytechnique Fédérale
de Lausanne, Switzerland, 4Faculty of Medicine, University of Geneva,
Switzerland, 5Department of Psychiatry, Psychotherapy and
Psychosomatics, University Hospital of Psychiatry, Switzerland,
6Laboratory of Neuroscience (LIM-27), Institute of Psychiatry, University
of Sao Paulo, Sao Paulo, Brazil
A fundamental feature of the human brain is its intrinsic organization
into anticorrelated functional networks. The right anterior insula (rAI)
has been proposed to play a causal role in regulating the competing
activity of the Default-Mode (DMN)- and Task-Positive Network
(TPN). A disturbed network-coordination has been associated with
the confusion of internally and externally focused attention. Thus,
the aim of this study was to examine the dynamic ﬂuctuations of
spontaneous brain activity in order to test to what extent rAI co-
activation patterns (CAP) would be disturbed in the at-risk state for
psychosis. Using resting-state fMRI data we characterized the
dynamic ﬂuctuations of spontaneous brain activity by probing rAI
interactions through CAP-analysis in 28 subjects with basic symp-
toms, 19 suffering from attenuated and/or brief limited intermittent
psychotic symptoms, and 29 controls. In controls, the most frequent
state displayed was rAI-TPN co-activation while the DMN was deac-
tive, the second a rAI/DMN coactivation. Both at-risk groups
engaged in shorter excursions in any state of rAI-coactivation and
had a signiﬁcantly smaller occurrence rate of the ﬁrst state. The ﬁnd-
ings substantiate the pivotal role of rAI in governing TPN-to-DMN
transitions, which seems to be dysfunctional in the psychosis at-risk
state. Here, it is less likely to be active in concert with TPN-activation
and DMN-deactivation and less able to remain active as part of a
brain network, denoting increased state switching. This is, interest-
ingly, regardless of symptom constellation.
Question and Answer Period
Discussant: Stephan Ruhrmann, Department of Psychiatry and Psy-




Major Italian Programs on Early Identiﬁcation and
Characterisation of Children and Adolescents at
Risk for Psychopathology
Chair: Ernesto Caffo1, Co-Chair: Frauke Schultze-Lutter2
Speakers: Paolo Brambilla, Alberto Parabiaghi, Paolo Fiori Nastro,
Benedicto Crespo-Facorro
1Università di Modena e Reggio Emilia, Modena, Italy, 2University of
Bern, Germany
Major psychoses, such as schizophrenia (SCZ) and bipolar disorder
(BD) are very common and severe diseases. The onset is usually dur-
ing adolescence, with devastating effects on school and functioning,
representing a high cost for the community. The prevalence of
affective and schizophrenic psychoses has been increasing, even dur-
ing childhood. Potential risk factors have been indicated, such as
familiality, childhood adverse events, prenatal infection, cannabis
abuse, with increasing risk of conversion when multiple risk factors
are associated. Still, programs dedicated to identify pre-psychoses
lack in Italy and the pathophysiology is not completely elucidated.
Moreover, despite signiﬁcant advances of biological psychiatry, there
has been little progress in resolving the complex clinical phenotype of
psychosis. In this context, the search for common and unique endo-
phenotypes for major psychoses is an innovative and very compelling
issue based on the increased degree of overlap in the pathophysiol-
ogy of schizophrenia (SCZ) and bipolar disorder (BD). This has
renewed interest in the validity of the Kraepelinian dichotomy. In
addition, there is evidence that the exposure to speciﬁc environmen-
tal factors such as psychosocial and prenatal stress could result in dif-
ferent patterns of behavioural problems in adolescence. In this
symposium we will present three major Italian research programs on
adolescents and psychopatholgoy trying particularly to deepen the
potential additive factors in the ultimate expression of psychosis and
emotional-behavioural problems. Also, as per an international per-
spective, a consistent early intervention program will be presented at
the end of the symposium.
Talk 1
Research Programs on Juvenile Populations with
Developmental Psychopathology Funded by the
Italian Ministry of Health
Paolo Brambilla
University of Milan, Milan, Italy
In our research programs (SPES, WM?P) funded by the Italian Minis-
try of Health have mainly focused on children and adolescents with
emotional and behavioural problems and have investigated personal-
ity and psychotic traits in twin populations. An integrated and multi-
disciplinary approach has been implemented including
psychopathological, neuropsychological, neuroimaging, neuroimmu-
nological, and genetic evaluations. Our programs are in line with the
initiative of the NIH Research Domain Criteria (RDoC), trying to over-
come diagnoses as only supported by symptom description. Several
centres across North of Italy has participated in our research pro-
grams, including centres of the IRCCS “E. Medea” (Dr. Nobile, Prof.
Fabbro, Dr. Molteni), the IRCCS San Raffaele of Milan (Dr. Furlan),
the Programma2000 of Niguarda Hospital in Milan (Dr. Meneghelli,
Dr. Monzani), and national twin surveys have been conducted in col-
laboration with the National Twin Registry of the Italian Institute of
Health in Rome (Dr. Stazi, Dr. Fagnani). We will show the preliminary
ﬁndings of such multimodal multi source dataset.
44 SYMPOSIUM
Talk 2
Integrated Actions to Improve the Early
Identiﬁcation and Treatment of Vulnerable Youth
Groups at Risk For Serious Mental Disorders
Alberto Parabiaghi1, Barbara D’Avanzo1, Mauro Percudani2
1IRCCS Istituto di Ricerche Farmacologiche ’Mario Negri’, Milan, Italy,
2Director Department of Mental Health at AOG Salvini, Garbagnate
Milanese, Milan, Italy
Background: In the 2000s, a number of early psychosis teams were
created In Italy to promptly ensure patients’ engagement with best-
possible psychosocial treatments. The present study explores the fea-
sibility of the translation of the ultra-high risk (UHR) model into Ital-
ian community mental health services in order to move their action
towards a more prevention-oriented approach.
Methods: This study, funded by the National Centre for Disease Pre-
vention and Control, aimed at assessing the feasibility of the pro-
posed prevention model, by uncovering the barriers within Italian
mental health system and by evaluating the prospects for success in
terms of clinical activity, recruitment ﬂow, and patients’
characteristics.
Results: During the past two years a model of service organization
was developed and applied to six Italian mental health departments.
Coordinated actions to improve the integration between child and
adult mental health services, the accessibility to services for young
and adolescents, the competence on the assessment and treatment
of UHR individuals, and the capacity to deal with vulnerable groups
like ﬁrst- and second-generation immigrants were performed. Local
community coalitions for improving awareness on the need for men-
tal health prevention, and for ameliorating community’s ability to deal
with this problem were established. As by December 2015, a total of
215 subjects, aged 15-24 years, were assessed by the study teams
with a prevalence of UHR individuals ranging 2-21%.
Conclusions: The UHR model with integrated community coalition
proved transferability to Italian services. Some pitfalls and barriers
were identiﬁed and discussed. There is concern about its long-term
sustainability.
Talk 3
PhD Course on “Early Detection And Prevention Of
Severe Mental Illnesses.” An Italian Perspective
Paolo Fiori Nastro, Massimo Biondi, Paolo Girardi
Sapienza University of Rome, Rome, Italy
Worldwide mental disorders represent a striking and growing chal-
lenge for health systems in developed and developing regions. The
peak of onset of mental disease is from the early teens to the mid-
twenties. The early intervention paradigm advocates detecting and
treating mental illness at their earliest stages, with the goal of inﬂuen-
cing the trajectory of illness evolution. This is not a simple task. In
most countries, included Italy, child and adolescents mental health
services are separated from adult services; this lack in continuity of
care has been described as the “weakest link in a system where it
should be most robust”. To promote a cultural change allowing a valid
and different clinical approach to mental health, from 2008 Sapienza
University of Rome has established a PhD course on “Early detection
of mental illness”. Since then, in collaboration with other foreign insti-
tutions, researches mainly focused on diagnostic aspects of UHR
states, combining more diagnostic criteria centred on psychopatho-
logical aspects (i.e. basic symptoms and self disorders), as well as on
psychotherapeutic interventions. Promotion of these research issues
needs to be strongly supported in the future.
Talk 4
What We Talk About When We Talk About
Specialized Early Intervention Programs: 15 Years
of PAFIP (Cantabria, Spain)
Benedicto Crespo-Facorro
University of Cantabria, Santander, Spain
Specialized early intervention program in Cantabria (Programa Asis-
tencial Fases Iniciales de Psicosis, PAFIP) was initiated in 2001 with
the aims of shortening time of undetected non-affective psychosis, to
provide acute care during ﬁrst break of the illness, and to set up a
recovery-oriented service offered over at least a 3-year period fol-
lowing ﬁrst contact with PAFIP. During the former 15 years more
than 590 individuals, and their cares, have been initially treated and
followed in PAFIP. PAFIP is a team-based that rely on a multi-
element approach to facing the illness with a personalized evaluation
of needs and with several interventions (case management, group or
individual psychotherapy, supported employment, educational pro-
grams, family intervention and education, suicide risk detection and
intervention, treatment optimization (lower effective doses, mono-
therapy, AEs detection) with a focus on recovering individuals with a
ﬁrst episode of psychosis. Only if special treatment requirements are
need, clients remain in PAFIP beyond 3 years and eventually they
transit to regular services at community mental health services. ,
social workers, nurses and work counsellors—i.e., p and Psychiatrists,
nurses and social worker and psychologists are primarily responsible
for case management, pharmacotherapy, individual and family ther-
apy, and coordination with primary healthcare. Allied health profes-
sionals generally provide supportive employment and rehabilitation
and education services. Weekly team meetings and frequent commu-
nication among passionate team members bolsters commitment to
the early intervention model, focuses treatment on each client’s
recovery goals and needs, and builds interdisciplinary team spirit that
sustains high-quality service provision over time.
Question and Answer Period
Discussant: Maria Nobile, Child Psychopathology Unit, Scientiﬁc Insti-





Mechanisms and Outcomes of Novel Psychological
Interventions Targeting Social Recovery in Young
People with At Risk Mental States and Psychosis
Chair: Kathryn Greenwood1, Co-Chair: David Fowler2
Speakers: Clio Berry, Brioney Gee, Paul French, Kathryn Greenwood
1University of Sussex, Sussex Partnership NHS Foundation Trust, UK,
2University of Sussex, UK
This symposium will present data from 4 novel mixed-methods stud-
ies, that aim to understand how hope, relationships, stigma and nega-
tive symptoms inﬂuence social and functional outcomes in the at risk
mental state and psychosis. Data from both large quantitative data
sets, and focussed qualitative studies are included. The second half of
the symposium will present the outcomes of two novel psychological
interventions to promote enhanced engagement and functional out-
comes in these populations. PRODIGY is a deﬁnitive Randomised Con-
trolled Trial of Social Recovery focussed Cognitive Behaviour Therapy
in young people with Emerging Mental Health problems. This report
on the internal pilot study will describe client characteristics and out-
comes for the ﬁrst 100 participants. Finally, the Early Youth Engage-
ment in ﬁrst episode psychosis (EYE) project will present the
development and piloting of a new service level youth early youth
engagement model on disengagement outcomes, as well as a range of
other outcomes including communication, social involvement, relation-
ships, hope and trust. Collectively these studies are at the forefront of
new approaches to the development of psychological interventions in
psychosis which have moved away from a primary focus on symptom
reduction to recovery oriented outcomes. This focus is in tune with
patient preferences, and provides data which is readily understandable
in terms of policy makers and health economic demands. The studies
offer considerable promise to intervene and address social disability
and negative symptoms which are outcomes long neglected but are at
the core of longer term social impacts of psychotic illness.
Talk 1
Hopefulness as a Mechanism for Promoting
Positive Social Outcomes in Early Psychosis
Clio Berry1, Victoria Bonnett2, Sue Holtum2, Sara Meddings,
Ross Robinson1, David Fowler1, Kathryn Greenwood1,3
1University of Sussex, UK, 2Salomons Clinical Training Course,
Canterbury Christchurch University, UK, 3Sussex Partnership NHS
Foundation Trust, UK
Background: Hope, ‘the will and the way’ to achieve goals, is often
mentioned as a ‘non-speciﬁc’ factor in psychological treatment out-
come and perhaps especially important to recovery in psychosis. Yet
empirical investigations of how and how much hope impacts on out-
come in psychosis are limited. This paper will present hope as a key
mechanism by which community psychiatric care facilitates positive
social outcomes in psychosis.
Methods: A quasi-longitudinal study in early psychosis (N = 51, 18-
36 years) used directed path analysis with measures of self-stigma,
therapeutic relationship and professional expectations of a key com-
munity professional obtained at time 1 and hopefulness and social
inclusion at time 2. Findings will also be presented from narrative
analysis of hope stories in early psychosis (N = 10, 16-26 years) and
larger studies in non-clinical populations.
Results: A large association between hopefulness and social inclusion
was observed in the quasi-longitudinal study in psychosis. Path analy-
sis supported hopefulness as a mediator of the association between
pre-existing self-stigma and outcome. Additionally, data support
hopefulness as a mechanism by which community psychiatric care
facilitates social inclusion; through community professionals inspiring
hope within positive therapeutic relationships and optimistic expecta-
tions. Complimentary ﬁndings from narratives of hope in early psy-
chosis will be shared. Larger studies of hopefulness and social
outcomes in non-clinical populations will indicate a particularly impor-
tant role for hopefulness in youth mental health.
Conclusions: Hopefulness represents a potentially key mechanism to
facilitate positive social outcomes in early psychosis and mitigate the
impact of negative self-beliefs and experiences; especially for
adolescents.
Talk 2
The Relationship Between Social Recovery and
Negative Symptom Course in First-Episode
Psychosis: Insights from a Mixed-Methods Approach
Brioney Gee1, Jo Hodgekins1, David Fowler2, Caitlin Norey1
1University of East Anglia, Norwich, UK, 2University of Sussex, UK
Purpose: Negative symptom severity has been identiﬁed as a signiﬁ-
cant predictor of poor recovery following ﬁrst-episode psychosis. This
study aimed to: (a) investigate the relationship between early nega-
tive symptom course and concurrent social recovery, and (b) explore
the understanding and experience of recovery of individuals with dif-
fering early negative symptom trajectories.
Materials and Methods: The early negative symptom and social
recovery trajectories of 764 Early Intervention in Psychosis service-
users (participants in the EDEN study) were examined. Negative
symptoms trajectories were established using latent class growth
analysis to model PANSS data, social recovery trajectories by using
the same technique to model structured time-use measured using the
Time Use Survey. The association between negative symptom and
social recovery trajectory class membership was examined statisti-
cally. Next, transcripts of in-depth interviews with a purposive sub-
sample of participants were analysed thematically in order to explore
lived-experiences of recovery.
Results: Negative symptom and social recovery trajectories were not
independent of one another (χ2 = 57.06, p = <0.001). Where ele-
vated negative symptoms are present at baseline, whether or not
they remit, they are associated with poor social recovery. Those with
differing early negative symptom trajectories had contrasting under-
standings and experiences of recovery.
Conclusions: Early negative symptom severity is associated with poor
social recovery, even when these symptoms remit. Differences
between the accounts of recovery given by those with differing early
negative symptoms courses may provide clues as to the nature of the
relationship between negative symptom severity and poor social
recovery following ﬁrst-episode psychosis.
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Talk 3
PRODIGY: Prevention of Long Term Social
Disability Amongst Young People with Emerging
Mental Health Problems: A Deﬁnitive RCT of Social
Recovery Focused CBT
Paul French1, Tim Clarke2, David Fowler3
1University of Manchester, UK, 2University of East Anglia, UK,
3University of Sussex, UK
Background: Outcome studies of young people with At Risk Mental
states have consistently identiﬁed that those at greatest risk are
young people who present with social decline, alongside sub-
threshold psychosis. The focus of intervention in this group has been
on prevention of psychosis symptoms. This trial aimed to identify and
target the group of young people who are socially disabled, with
severe At Risk mental health problems and to evaluate the efﬁcacy of
a new psychological intervention speciﬁcally tailored to their needs.
Methods: The study is the ﬁrst large, deﬁnitive, blinded, randomised
controlled treatment trial in this area, comprising a 9-month interven-
tion and 15-month follow up of 135 treatment cases and 135 controls
in three centres. The intervention involves a multisystemic CBT
approach, promoting a sense of agency, hope, motivation and activity
whilst managing psychotic and other symptoms and problems, com-
pared to Enhanced Standard Care (ESC). The primary outcome is
hours per week engaged in constructive activity.
Results: Client characteristics and outcomes are reported from the
ﬁrst 100 participants in the internal pilot, as well as qualitative data
on participants’ experiences of therapy. Participants had extremely
low activity levels, typically fewer than 9 hours per week, extreme
social withdrawal, paranoia, social anxiety, depression and emerging
negative symptoms.
Conclusions: Intervention in this population is of major importance as
this group is at the highest risk of the poorest long-term outcomes.
These are a challenging group to engage and treat but the strategies
adopted indicate the potential and promise for effective intervention.
Talk 4
The Early Youth Engagement (EYE) Project: A
Feasibility and Pilot Study to Promote Better
Engagement and Outcomes in First Episode
Psychosis
Kathryn Greenwood1,2, Kirsty Labuschagne1, Ruth Chandler1,
Emmanuelle Peters3, Katie Alford1, Richard deVisser2, Andy Field2,
Philippa Garety3
1Sussex Partnership NHS Foundation Trust, UK, 2University of Sussex,
UK, 3Institute of Psychology, Psychiatry and Neuroscience, Kings College
London, England
Background: Engagement with Early Intervention in Psychosis (EIP)
services improves symptoms, illness course, social and occupational
function, yet, 25-30% of patients disengage from services within the
ﬁrst 12 months. This study aimed to develop an intervention to pro-
mote better youth engagement and health outcomes for this
population.
Method: First, a cross-sectional qualitative study investigated facilita-
tors and barriers to engagement from the perspective of EIP service
users, their relatives and healthy young people. Forty focus groups/
interviews were conducted with 68 participants, and thematic analy-
sis was applied to the transcribed data. Next, a Delphi consultation
with 27 clinicians, managers and experts, reached consensus on a set
of pragmatic, deliverable service adaptations which formed the new
Early Youth Engagement (EYE) service model. Finally, 298 ﬁrst epi-
sode psychosis services users received either the original model (pre-
adaptation) or the EYE model (post-adaptation), and both engage-
ment at 12 months, and feasibility and satisfaction were explored.
Results: A generalized linear model with engagement status nested
within teams, revealed that the proportion disengaged was
signiﬁcantly lower in the EYE model cohort. Engagement was not
predicted by team, age or gender. Disengagement decreased from
24% prior to 14.5% post the intervention. Qualitative feedback
revealed impacts on communication, social involvement, staff
approaches, collaboration, practical goals, hope and trust.
Conclusion: This study demonstrates how a new early youth engage-
ment model might reduce drop out, and promote satisfaction and
better social and health outcomes for this sub-group of young people
at risk of disengagement.
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1:00–2:30 p.m., Washington A
Early Intervention Services for First-Episode
Psychosis: How long?
Chair: Ashok Malla1, Co-Chair: Merete Nordentoft2
Speakers: Eric Chen, Nikolai Albert, Srividya Iyer, Ashok Malla
1McGill University, Montréal, Canada, 2University of Copenhagen,
Mental Health Centre Copenhagen, Denmark
Specialized Early Intervention (SEI) services for ﬁrst-episode psycho-
sis are shown to have positive effects on positive and negative symp-
toms, medication adherence, relapse, substance abuse, functional
outcome and quality of life after two years of treatment. However,
follow up studies suggest that these beneﬁts are not maintained
when SEI is not sustained beyond 2 years. A Canadian study
(Norman et al 2011) showed that, by maintaining patients in an EI
service with even a lower intensity of service, beneﬁts accrued after
2 years of SEI service were largely maintained at 5 years unlike the
OPUS study where the beneﬁts were lost when patients were trans-
ferred to regular care after 2 years of SEI. The objective of this sym-
posium is to present the results of three different clinical trials
conducted in three different countries with different service systems
to answer the question whether extending SEI services beyond the
ﬁrst 2 years provides greater beneﬁts than are achieved in regular
care. Chen will present results of two studies conducted in a low-
resource environment in Hong Kong. This will be followed by results
of two randomized controlled trials conducted in Copenhagen
(Denmark) and Montréal (Canada), to be presented, respectively, by
Albert and Iyer. The fourth presentation by Malla will synthesize
insights from the ﬁndings of studies that explore the optimal duration
of SEI. It will also highlight methodological learnings and propose
future directions. Finally, Birchwood will discuss the results of these




Critical Period in Early Psychosis Intervention:
Possible Dose Effect From Longitudinal Studies
from Hong Kong
Eric Chen, Wing Chung Chang, Edwin Lee, Kit Wa Sherry Chan,
Christy Hui
University of Hong Kong, Hong Kong
Purpose: The critical period hypothesis – that the outcome of psy-
chosis is largely determined within the ﬁrst few years — constitutes a
rationale for focusing psychosis intervention resources on the early
years. This hypothesis predicts that intervention in the initial years
yields better outcomes that are maintained in the subsequent post-
intervention years. Since 2001, Hong Kong has provided two years
of specialised early service to patients with ﬁrst-episode psychosis
aged 15 to 25. Controlled studies suggest that this yielded improved
outcomes that were sustained for up to 10 years. This suggests an
overall efﬁcacy of intervention consistent with the critical period
hypothesis. We further explored enhancing the intervention with an
additional year of service.
Method: Patients completing two years of intervention were rando-
mised to receive either one more year of intervention (three years
total), or to transition to a year of standard care.
Results: The functioning of patients receiving an additional year of
intervention continued to improve in the third year, while that of the
control group remained unchanged. However, the effects of this
additional year did not persist, largely due to catch-up in the group
which did not receive additional intervention.
Conclusion: We conclude that after two years, further outcome
improvements could be effected. Our observations are suggestive of
a dose effect of intervention. The critical period effect is evident with
lower-level input, but with more input, the additional beneﬁt did not
persist. The validity of the critical period hypothesis is not uniform
and appears contingent upon the intensity of intervention.
Talk 2
How Long Should Early Intervention Last? Results
from a Randomized Clinical Trial of the Effect of
Five-Years versus Two Years Specialized Assertive
Intervention for First Episode Psychosis – The
OPUS-II Trial
Nikolai Albert1,2, Carsten Hjorthøj1,2, Heidi Jensen1, Marianne Melau1,
Ole Mors3, Charlotte Emborg3, Merete Nordentoft1,2
1Mental Health Centre Copenhagen, Denmark, 2University of
Copenhagen, Denmark, 3Center for Psychiatric Research, Aarhus
University Hospital, Denmark
Purpose: The OPUS I trial found that it was possible to improve clini-
cal outcome in ﬁrst episode psychosis through a specialized early
intervention service (SEI). However, the ﬁve-year follow-up showed
that few of the positive clinical effects were sustained when the
intensive treatment was terminated. The question arose whether two
years of SEI were too short. This represents the rationale for the
OPUS II-trial, investigating if ﬁve years of SEI treatment is more
appropriate to ensure long lasting clinical effect.
Materials and Methods: The OPUS II trial recruited 400 patients
from the now established OPUS teams. Patients were randomized to
three further years of OPUS treatment or transfer to standard treat-
ment. The primary outcome is negative symptoms. Secondary out-
comes are, psychotic- and disorganized symptoms, client satisfaction,
hospitalization, labour marked afﬁliation, substance abuse, working
alliance, medication and self-efﬁcacy.
Results: The study did not ﬁnd any effect on the primary outcome or
any of the functional or psychopathological outcomes. We did ﬁnd
that patients in the prolonged OPUS group had a stronger working
alliance with their case manager and were more content with their
treatment.
Conclusion: Based on the results we don’t believe that the OPUS
treatment in its current form should be extended, but we will discuss
the implications of delayed treatment start and developments within
the standard treatment which might shed light on the lack of results.
Also sub-group analyses are needed to establish if some groups bene-
ﬁts more from the prolonged treatment.
Talk 3
A Randomized Controlled Trial of Extended
Specialized Early Intervention Verses Specialized
Early Intervention Followed by Regular Care for
Treatment of Early Psychosis over the Five Year
Critical Period
Srividya Iyer1,2, Ashok Malla1,2, Ridha Joober1,2, Ross Norman3,
Eric Latimer1, Norbert Schmitz1, Eric Jarvis1, Howard Margolese1,
Amal Abdel-Baki4, Sherezad Abadi2, Sally Mustafa2, Danyael Lutgens1
1McGill University, Montréal, Canada, 2Prevention and Early Intervention
Program for Psychosis (PEPP), Douglas Mental Health University
Institute, Montréal, Canada, 3Western University, Ontario, Canada,
4University of Montréal, Montréal, Canada
Purpose: The objective of this trial was to test the effectiveness of a
3-year extension of specialized early Intervention (SEI) beyond the
initial 2 years of SEI compared to 3 years of regular care following
2 years of SEI.
Methods: Patients were randomized following 2 years of SEI to
receive either 3-years of continued EI or regular care. Blinded evalua-
tions on multiple outcome variables were conducted every three
months. Remission (proportion and length) of positive and negative
symptoms was the primary outcome. 220 patients were randomized
to either extended SEI (n = 109) or to regular care (n = 111).
Results: Preliminary survival analysis results show a signiﬁcantly
lower rate of and a longer time to disengagement from treatment for
the SEI group compared to “regular care” (22% vs 58%, respectively,
p < .001; 32 vs 23 months, p < .001). Patients receiving extended
SEI were in positive symptom remission for a longer period than
those in regular care (23 vs 17 months, p < .001); the difference in
length of total remission was not signiﬁcant; and there were no dif-
ferences in relapse rates. Full analyses for all primary and secondary
outcomes, including service utilization and economic consequences,
will be conducted in the summer of 2016.
Conclusion: Our preliminary ﬁndings suggest that providing EI
throughout the critical period of 5 years may facilitate better out-
comes than SEI followed by regular care. Findings from this study
have implications for service provision in ﬁrst-episode psychosis.
Challenges of a service-based study and attrition from research eva-
luations will be discussed.
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Talk 4
The Optimal Duration of Specialized Early
Intervention Services for Psychosis: The State of
the Field and Future Directions
Ashok Malla1, Merete Nordentoft2, Srividya Iyer1
1McGill University, Montréal, Canada, 2University of Copenhagen,
Denmark
Purpose: The development of specialized early intervention (SEI) ser-
vices for psychotic disorders has been one of the major achievements
in mental health in the past 20 years. Although, substantial evidence
for the effectiveness of SEI has been accumulating over the past dec-
ade, several challenges remain. Chief among them is the question of
how long patients with ﬁrst-episode psychosis require such special-
ized, resource-intensive services.
Method: A number of recent studies have addressed this question.
This presentation will provide an overview of these studies, focusing
on insights from their ﬁndings and key considerations about method-
ology, outcome variables and design for future studies.
Results: SEI yields better outcomes than regular care two years after
treatment. However, Denmark’s OPUS study found that most gains
from two years’ SEI were not sustained at ﬁve years. A Canadian
study of regular SEI followed by three years of lower-intensity SEI
reported sustenance of symptomatic beneﬁts and further functional
improvements in the last three years. Our team, the OPUS team and
Chen’s group in Hong Kong are concluding RCTs comparing extended
SEI with SEI followed by regular care. Preliminary ﬁndings support an
extension of SEI, but not unequivocally.
Conclusion: Findings of existing studies will be examined with
respect to the “critical period” hypothesis. Discussion will also high-
light methodological learnings and suggest future directions, such as
targeted interventions for those less likely to functionally improve,
custom durations (longer EI for more vulnerable patients), and differ-
ing delivery modes (complete or stepped-down; complete or regular
care supplemented by tele-SEI, etc.).
Question and Answer Period
Discussant: Max Birchwood, Mental Health and Wellbeing, Warwick
Medical School, Coventry, UK
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Understanding the Trauma-Psychosis Link: Can
Translational Research Bring Us a Step Further?
Chair: Philippe Conus1
Speakers: Helen L Fisher, Luis Alameda, Daniella Dwir, Monica Aas
1DP-CHUV, Lausanne University, Lausanne, Switzerland
Recent literature has repeatedly shown that trauma is more prevalent
in psychosis patients than in control populations and thus trauma has
been identiﬁed as a potential risk factor for the emergence of psy-
chosis. In addition, several papers have shown that clinical outcome,
both symptomatic and functional, is poorer in psychosis patients who
have been exposed to trauma than in patients who haven’t. Many
hypotheses have been proposed to explain these correlations, but
the possible underlying mechanisms remain largely unknown. In this
symposium we will provide an overview of the association between
exposure to childhood trauma and both the onset of psychosis and
outcome of patients regarding symptoms and functional levels. We
will also discuss how the age at the time of exposure to trauma may
inﬂuence the correlation with symptomatic and functional outcome.
On this basis we will then explore some recent data on possible
mechanisms which may underlie this link and investigate how collab-
oration with basic neurosciences in the framework of translational
research may bring us a step further in our understanding of this
issue and closer to potential speciﬁc treatments.
Talk 1
Childhood Trauma and the Onset and Outcome of
Psychosis: What is the Evidence?
Helen L Fisher1, Paola Dazzan1, Julia Lappin1, Margaret Heslin1,
Gillian Doody2, Peter B. Jones3, Robin M Murray1, Craig Morgan1
1King’s College London, UK, 2University of Nottingham, Nottingham, UK,
3University of Cambridge, Cambridge, UK
Purpose: Increasing evidence suggests that exposure to traumatic
events in childhood is linked to the emergence of psychotic disorders
in adulthood. However, the impact of childhood trauma on the
longer-term outcomes of psychosis is largely unknown. Therefore,
this presentation will provide an overview of existing literature
including a recent meta-analysis and provide novel data on the
impact of childhood abuse on the course and outcomes of psychotic
disorders over 10 years.
Methods: Data on 214 patients presenting for the ﬁrst time to men-
tal health services with psychosis was drawn from the UK Aetiology
and Ethnicity of Schizophrenia and Other Psychoses (AESOP) study.
Childhood abuse was assessed retrospectively using the Childhood
Experience of Care and Abuse Questionnaire at baseline and exten-
sive information on psychosis course and functional outcomes over
10 years was obtained via interviews and case-notes.
Results: Psychosis cases who reported exposure to physical, sexual
or emotional abuse prior to age 17 were more likely to achieve remis-
sion within 6 months of ﬁrst presentation than non-exposed cases
(OR = 2.91). However, they were at increased risk of self-harm
(OR = 3.3) and suicide attempts (OR = 2.3), had more severe positive
psychotic symptoms (OR = 3.2) and were less likely to be employed
(OR = 0.4) during 10-year follow-up.
Conclusion: Childhood trauma is associated with the onset of psy-
chosis but its impact on clinical course of psychotic disorder remains
unclear. However, initial ﬁndings suggest that Early Intervention Ser-
vices should screen new patients for childhood abuse and be mindful




Age at the Time of Exposure to Trauma Modulates
the Psychopathological Proﬁle and the Impact on
Functional Outcome in Early Psychosis Patients
Luis Alameda1,2, Philippe Golay2, Philippe S Baumann1,2,
Carina Ferrari1,2, Mhedi Gholam-Rezaee3, Kim Q Do2,
Philippe Conus1
1Center for Psychiatric Neuroscience, Department of Psychiatry,
Lausanne University Hospital (CHUV), Switzerland, 2Service of General
Psychiatry, Treatment and Early Intervention in Psychosis Program
(TIPP-Lausanne), Lausanne University Hospital (CHUV), Switzerland,
3Department of Psychiatry, Center for Psychiatric Epidemiology and
Psychopathology, Lausanne University Hospital (CHUV), Switzerland
Objectives: We aim to examine, in a sample of Early Psychosis
(EP) patients treated in a specialized program during three years, the
potential differential impact of childhood trauma, according to age at
the time of exposure, on the level of functioning and on the psycho-
pathological proﬁle of patients during the early phase of the disease.
Methods: 225 EP subjects aged 18-35 were followed-up prospec-
tively over 36 months. Patients who had faced at least one experi-
ence of abuse or neglect were classiﬁed according to age at the time
of ﬁrst exposure (Early-Trauma: before age 12; Late-Trauma:
between age 12 and 16), and then compared with unexposed
patients (Non-Trauma). The level of symptoms was assessed using
the Positive and Negative Syndrome Scale, The Young Mania Rating
Scale, and the Montgomery-Asberg Depression Rating Scale. The
level of functioning was assessed with the Global Assessment of
Functioning.
Results: Comparisons over the 3 years of treatment with the Non-
Trauma patients revealed that (i) Early-Trauma patients showed con-
sistently higher levels of positive (p = 0.006) depressive (p = 0.001),
manic (p = 0.006) and negative (p = 0.029) symptoms and had
poorer functional level (p = 0.025) (ii) Late-Trauma patients only
showed more negative symptoms (p = 0.029).
Conclusions: The age at the time of exposure to trauma has a modu-
lating effect on its impact on symptoms and functional impairment in
EP patients. Various biological and psychological hypotheses can be
proposed to explain this observation, and they need to be investi-
gated in experimental setting in order to develop therapeutic
avenues.
Talk 3
Early-Life Insults Impair Parvalbumin Interneurons
via Oxidative Stress: Prevention and Reversal by
N-Acetylcysteine and Environmental Enrichment
Daniella Dwir, Jan-Harry Cabungcal, Pascal Steullet, Michel Cuenod,
Kim Q Do
Center for Psychiatric Neuroscience, Department of Psychiatry,
University Hospital of Lausanne, Switzerland
Purpose: A hallmark of the pathophysiology of schizophrenia is a dys-
function of parvalbumin-expressing fast-spiking interneurons (PVI),
which are essential for neuronal synchrony during sensory and cogni-
tive processing. Oxidative stress as observed in schizophrenia affects
PVI. Some schizophrenia patients have decreased brain glutathione
(GSH) levels due to genetic and functional origin. GSH dysregulation,
by increasing vulnerability to oxidative stress, could lead to cortical
circuit anomalies during speciﬁc developmental windows.
Methods: We used mice with impaired synthesis of glutathione
(Gclm knockout [KO]) to investigate the effect of redox dysregulation
and additional insults at various periods of postnatal development on
maturation and long-term integrity of PVI in the anterior cingulate
cortex.
Results: A redox dysregulation, as in Gclm KO mice, renders PVI vul-
nerable to exhibit oxidative stress. A glutathione deﬁcit delays PVI
maturation and their perineuronal net. An additional oxidative
challenge in young, but not adult KO mice, reduces the number of
PV-immunoreactive interneurons. The effect of early-life insults on
PVI can be prevented with N-acetylcysteine (NAC) treatment from
pregnancy until pubertal. Early-life insults have long-term conse-
quences on PVI, which can also be reversed with combined NAC
treatment and Environmental Enrichment during childhood and
adolescent.
Discussion: In analogy, individuals carrying genetic risks to redox dys-
regulation potentially vulnerable to early-life insults could beneﬁt
from a combined pharmacological and psycho-social therapy. These
data support the need to develop novel therapeutic approaches
based on antioxidant and redox regulator compounds, which could be
used in combination with cognitive behavioural therapy, as preven-
tive treatment in young at-risk subjects.
Talk 4
Childhood Trauma is Associated with Increased
Brain Responses to Emotionally Negative as
Compared to Positive Faces in Patients with
Psychotic Disorders
Monica Aas1, Christine L Brandt1, Karolina Kauppi1, Martin Tesli1,
Tobias Kaufmann1, Nils E Steen2, Lars T Westyle1,3, Ingrid Agartz1,4,
Ole A Andreassen1, Ingrid Melle1
1NORMENT K.G Jebsen Centre for Psychosis Research, Institute of
Clinical Medicine, University of Oslo, and Division of Mental Health and
Addiction, Oslo University Hospital, Oslo, Norway, 2Drammen
Outpatient Clinic, Clinic of Mental Health and Addiction, Vestre Viken
Hospital Trust, Drammen, Norway, 3Department of Psychology,
University of Oslo, Norway, 4Department of Psychiatric Research,
Diakonhjemmet Hospital, Oslo, Norway
Background: Childhood trauma increases risk of developing psycho-
sis. However the mechanisms are elusive. Here, we tested the associ-
ation between childhood trauma and brain activation during a face
processing task in patients diagnosed with psychosis continuum dis-
orders. We also tested if the high trauma group rated negative faces
as more negative and positive faces as less positive than the group
with no or low trauma.
Methods: We included 101 patients with a DSM-schizophrenia spec-
trum or bipolar spectrum diagnosis. History of childhood trauma was
obtained using the Childhood Trauma Questionnaire (CTQ). Brain
activation was measured with functional MRI during processing of
faces with negative or positive emotional expressions. After the scan-
ner session, patients rated how negative or positive they experienced
the faces on a rating scale.
Results: Compared to patients with no or low levels of childhood
trauma, patients with high levels had higher BOLD signal for negative
than positive faces in the inferior frontal gyrus, right middle frontal
gyrus, right cerebellum, the inferior/superior parietal and occipital
lobe, with moderate to large effect sizes (Cohen’s d = 0.70-0.93).
The largest effect was observed for the parietal lobe and the supra-
marginal gyrus. In patients with schizophrenia, childhood trauma was
also associated with reporting negative faces as more negative, and
positive faces as less positive (Cohen’s d > 0.8).
Conclusions: Along with the observed negativity bias in the assess-
ment of emotional valence of faces, our data suggest increased brain
responses to negative faces and reduced responses to positive faces





The PRONIA Study: An Integrated European
Multidisciplinary Approach to Prevent Psychosis at
Individual Level
Chair: Nikolaos Koutsouleris1, Co-Chair: Paolo Brambilla2
Speakers: Stephan Ruhrmann, J Kambeitz, H Pesonen, E Meisenzhal
1University of Munich, Munich, Germany, 2University of Milan, Milan,
Italy
The PRONIA (grant agreement n. 602152) is an EU-funded project
aiming at classifying the risk to develop psychosis and depression by
integrating multimodal (clinical, imaging, cognitive, genetic) data and
by using machine learning techniques. Six European centres are cur-
rently participating (Munich, Cologne, Basel, Milan, Turku, Birming-
ham) and about 900 subjects have been recruited so far. In this
symposium we will present the general framework of the study with
particular regards to clinical, imaging and genetic data in the context
of personalised medicine. First, the relationship between functional
domains and clinical variables will be elucidate in high risk and psy-
chotic patients. Then, new imaging ﬁndings using the BrainAGE
approach will be presented including genetic and environmental fac-
tors. Successively, machine learning classiﬁcation of modelling clinical
heterogeneity of psychosis and depression will be debated. Finally,
strategies of early recognition services through broadly available tele-
medical applications will be presented in the framework of PRONIA’s
dataset. PRONIA consortium is indeed developing an eHealth proto-
type providing telepsychiatric services for an accurate prediction of
mental health related disabilities in young help-seeking persons; diag-
nostic tools and medical device technologies in personalised medicine
will be presented. This symposium will therefore provide preliminary
and fascinating results on an ongoing European multicenter study
which will be of great help in the next few years to disentangle the
pathophysiology of psychosis and depression, ultimately helping in
planning innovative and personalised approaches to prevent and early
recognise psychosis and depression.
Talk 1
Functional Deterioration and Its Clinical Predictors
in Subjects Clinically at High Risk of Psychosis and
Patients with a Recent Onset Psychosis
Stephan Ruhrmann1, M Rosen1, N Kaiser1, T Haidl1,
F Schultze-Lutter1, S Borgwardt2, P Brambilla3, C Pantelis4,
R Salokangas5, E Meisenzhal6, S Wood7, N Koutsouleris6
1University of Cologne, Köln, Germany, 2University of Basel, Switzerland,
3University of Milan, Italy, 4University of Melbourne, Australia,
5University of Turku, Finland, 6University of Munich, Germany,
7University of Birmingham, UK
Background: Functional deterioration has become an important topic
in research on clinical high risk states as social and role performance
proofed to be markedly impaired already in this early, putatively
prodromal condition. Furthermore, despite remission of symptomatic
risk indicators, functional decline persists in a considerable amount of
CHR subjects. A better understanding of composition and determi-
nants of functional impairment is therefore essential, particularly, as
current interventions can prevent a transition to psychosis, but do
not equally well improve social and role performance.
Method: PRONIA (’Personalized Prognostic Tools for Early Psychosis
Management’) is a prospective collaboration project funded by the
European Union under the 7th Framework Programme (grant agree-
ment n 602152). Seven university centres in ﬁve European countries
and in Australia participate in the evaluation of three clinical groups
(subjects clinically at high risk of developing a psychosis [CHR],
patients with a recent onset psychosis [ROP] and patients with a
recent onset depression [ROD]) as well as healthy controls. Function-
ing is not only measured by global scales of functioning, but also by
the Functional Remission in General Schizophrenia Scale (FROGS),
comprising ﬁve domains.
Results: In all patient groups, functioning was impaired. In a prelimi-
nary interim analysis, the FROGS, but none of the more global mea-
sures differentiated between CHR and ROD in two domains, where
the CHR had a position in-between ROP and ROD. Discussion: We
will further elucidate these results and present an analysis of the rela-
tionship between functional domains and clinical variables in CHR
and ROP.
Talk 2
BrainAGE Approach: Investigating Ageing-related
Patterns of Brain Maturation in the Context of
Psychosis
J Kambeitz1, C Cabral1, L Kambeitz-Ilankovic1, M Re2, S Borgwardt3,
S Ruhrmann4, R Salokangas5, S Wood6, E Meisenzhal1, P Brambilla2,
N Koutsouleris1
1University of Munich, Germany, 2University of Milan, Italy, 3University
of Basel, Switzerland, 4University of Cologne, Köln, Germany, 5University
of Turku, Finland, 6University of Birmingham, UK
There is evidence from multiple lines of research indicating altera-
tions in brain structure and function in patients with psychiatric disor-
ders such as schizophrenia or major depressive disorder. The
pathophysiological mechanisms underlying these changes remain
largely unknown until today. The current debate is focused on the
time of onset of brain alterations (perinatal vs. prodromal vs. illness-
onset) and their trajectory (progressive vs. non-progressive). The Brai-
nAGE approach (Brain ‘Age Gap Estimation’) represents a statistical
modelling framework that allows the conceptualisation of functional
or structural brain alterations in individuals as deviations from a nor-
mative trajectory of maturational/ageing-related patterns. Using mul-
tivariate statistical methods, BrainAGE has successfully been applied
to different psychiatric populations. New ﬁndings from the PRONIA
study using the BrainAGE approach will be presented including the
extension of the approach to further neuroimaging-modalities as well
as the validation using genetic and environmental factors.
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Talk 3
Improving Machine-learning Based Predictive
Psychiatry via Subgroup-Sensitised Classiﬁcation
Methods: Results of the PRONIA Project
H Pesonen1, R Salokangas1, S Borgwardt2, S Ruhrmann3, P Brambilla4,
S Wood5, C Pantelis6, E Meisenzhal7, N Koutsouleris7
1University of Turku, Finland, 2University of Basel, Switzerland,
3University of Cologne, Köln, Germany, 4University of Milan, Italy,
5University of Birmingham, UK, 6University of Melbourne, Australia,
7University of Munich, Germany
Purpose: In recent years, machine learning has arisen as one of the
most interesting new approaches for early identiﬁcation of at-risk
mental states of psychosis. However, the biological heterogeneity
within all clinical groups such as clinical high-risk subjects, healthy
controls, subjects with recent onset of psychosis make it difﬁcult to
achieve great classiﬁcation accuracy if this multi-modal heterogeneity
within the populations is not explicitly modelled. Material and
Methods: In the Personalised Prognostic Tools for Early Psychosis
Management study (PRONIA) we explore techniques that decompose
the heterogeneous population into homogeneous subgroups and use
the attained clustering information to sensitise the classiﬁers to
achieve better performance when separating subjects with recent
onset of psychosis, clinical high risk subjects and healthy control
populations from each other based various clinical and neurobiologi-
cal data-modalities.
Results: Using premorbid, baseline clinical and neuroimaging (struc-
tural and functional MRI) data, we were able to separate patients
with recent onset psychosis and clinical high-risk to psychosis from
healthy controls reasonably well.
Conclusions: The suggested method of modelling heterogeneity of
clinical disorders and using this information with machine learning
classiﬁcation seem to be promising approach to enhance classiﬁcation
of heterogeneous clinical disorders.
Talk 4
Diagnostic Tools and Medical Device Technologies
in Personalised Medicine: Big Data Market Analysis
of Medical Neuroscience
E Meisenzhal1, P Brambilla2, N Koutsouleris1, C Pantelis3,
S Ruhrmann4, R Salokangas5, S Wood6, S Borgwardt7, A Stellbrink1
1University of Munich, Germany, 2University of Milan, Italy, 3University
of Melbourne, Australia, 4University of Colone, Germany, 5University of
Turku, Finland, 6University of Birmingham, UK, 7University of Basel,
Switzerland
The PRONIA consortium is developing an eHealth prototype provid-
ing telepsychiatric services for an accurate prediction of mental
health related disabilities in young help-seeking persons. This eHealth
prototype will become available within the next ﬁve years and will
pave the way for accurate, personalized diagnostics for persons at
risk that can be implemented all over the world. PRONIA’s ultimate
goal is to achieve/realise licensing, commercialisation and sustained
engineering strategies of its early recognition services through
broadly available telemedical applications. The digitalization of infor-
mation and communication processes as well as general computing
advances over the last 15 years triggered a highly dynamic industrial
revolution leading to the development of robots and artiﬁcial intelli-
gence among other advances. In contrast, international health sectors
have fallen behind with the implementation of IT solutions. The pros-
pect of further global population increase, and thus further increase
in chronic diseases, leads to rising costs due to increasing worldwide
healthcare expenditure. In the presentation, the ﬁeld of eHealth and
the development of chronic diseases are deﬁned. It provides an over-
view of the current state of eHealth diagnostic tools and eHealth
applications in medical neuroscience. Using the strategy of big data
analytics, opportunities and prospects of the eHealth market in
diagnostics and mobile health technology are evaluated, and will be
discussed together with global medical technology landscape.
Question and Answer Period




Schizotypy in Youths: Stress, Cognition and
Relationships with Transition to Psychosis
Chair: Martin Debbané1, Co-Chair: Frauke Schultze-Lutter2
Speakers: Neus Barrantes-Vidal, Maude Schneider, Eduardo Fonseca-
Pedrero, Rahel Flückiger
1University of Geneva, Switzerland, 2University of Bern, Switzerland
The assessment of schizotypy during adolescence and young adult-
hood bears crucial information on developmental interactions ante-
dating the onset of psychotic disorders. Examining schizotypy along
with key risk factors can thus critically inform early intervention pro-
grams seeking to delay or avoid transition to psychosis. A number of
studies currently examine the early interactions between stress and
schizotypy in exacerbating the ﬁrst signs of risk for psychosis. Impor-
tantly, genetic factors appear to play a key role linking stress to early
signs of schizotypy. In this symposium, two presentations will address
the genetic-stress diathesis in at-risk populations. First, Dr Barrantes-
Vidal will present a dataset combining experience sampling to genetic
analyses on stress sensitivity genes to understand the contributions
of childhood adversity on psychosis expression, in both non-clinical
subjects rating high on schizotypy and subjects diagnosed with at-risk
mental states for psychosis. Next, Dr Schneider will present original
research on the impact of stressful life events in exacerbating the
expression of schizotypy in youth with 22q11.2 deletion syndrome, a
condition associated with a 30% prevalence of psychotic disorders.
Following these two presentations, Dr Fonseca Pedrero will focus on
the relationship between cognition and schizotypy in determining the
expression of signiﬁcant schizotypal manifestations in community
youths. Finally, Dr Flückiger will present how schizotypy can inform
the question of conversion from clinical high risk states to psychosis,
through the analysis of longitudinal data. Together, these presenta-
tions harbour the methods and results that are starting to uncover
the key developmental interactions sustaining risk for psychosis.
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Talk 1
Impact of Childhood Adversity, Genetic Variation,
and their Interaction on Psychotic-like Symptoms
and Stress Reactivity in Psychometric and Clinical
High Risk Samples
Neus Barrantes-Vidal1,2,3,4, Paula Cristóbal-Narváez1,
Tamara Tamara1, Marta de Castro-Català5, Manel Monsonet1,
Lídia Hinojosa1, Anna Racioppi1, Tecelli Domínguez-Martínez6,
Elionora Peña5, Sergi Ballespí1, Araceli Rosa4,5, Thomas Kwapil2
1Universitat Autònoma de Barcelona, Barcelona, Spain, 2University of
North Carolina at Greensboro, USA, 3Sant Pere Claver – Fundació
Sanitària, Barcelona, Spain, 4Centre for Biomedical Research Network on
Mental Health, 5Universitat de Barcelona, Barcelona, Spain, 6Cátedras-
CONACyT/INPRF, Mexico
Purpose: This study examined whether childhood adversity, genetic
variation, and their interaction play a role in stress reactivity and the
expression of psychotic-like symptoms in daily life.
Materials and Methods: The Experience Sampling Method was used
with 206 nonclinical young adults (oversampled for schizotypy) and
50 ARMS patients during one week to assess momentary negative
affect, psychotic phenomena, and stress appraisals. Participants com-
pleted measures of childhood adversity and were genotyped for
SNPs in relevant psychosis and stress-sensitivity genes (COMT,
FKPB5 and OXTR).
Results: Both distal adversity and momentary situational and social
stress appraisals were associated with the real-world expression of
psychotic-like symptoms in both samples. In addition, childhood
adversity was associated with increased stress reactivity. Overall, var-
iability on COMT, FKPB5 and OXTR was scarcely associated with
psychotic experiences and stress-reactivity. In nonclinical participants,
the FKPB5 haplotype, number of COMT Met alleles and number of
OXTR G alleles interacted with childhood adversity in the expression
of stress reactivity. Analyses in the ARMS sample (so far completed
for COMT) indicated that adversity increased psychotic-like symp-
toms only in Met carriers.
Conclusion: Findings concur with and extend prior research by sup-
porting (i) the role of distal adversity in sensitizing individuals to
momentary stress and how this impacts on psychotic reactivity in
daily life, and (ii) the moderating effect of genetic variability across
levels of psychosis risk. Investigating the interplay of adversity, genes,
and current context seems relevant for uncovering mechanistic path-
ways to psychosis and should inform the development of ecologically
valid intervention strategies.
Talk 2
Stressful Life Events Modulates the Expression of
Positive Schizotypy in 22q11.2 Deletion Syndrome
Maude Schneider1,2, Marco Armando1,2, Martin Debbané1,2,
Stephan Eliez1,2
1University of Geneva, Geneva, Switzerland, 2Ofﬁce Médico-
Pédagogique, Geneva, Switzerland
Objective: 22q11.2 deletion syndrome (22q11DS) is recognized as a
model for schizophrenia. In patients with 22q11DS, attenuated psy-
chotic symptoms are often present as a trait marker and predict tran-
sition to psychosis, in accordance with the schizotypy framework.
However, little is known about the factors modulating the phenotypic
expression of schizotypal traits in this population. In this study, we
examined the contribution of stressful life events and expected to
observe signiﬁcant associations with positive schizotypy.
Method: 56 participants with 22q11DS (M = 20.53; SD = 6.27) and
30 healthy controls (M = 17.88; SD = 4.39) completed the Schizo-
typal Personality Questionnaire and the Coddington Life Event Scale.
The number and stress load for recent (0-6 months) and less recent
(6-12 months) events were computed for each participant.
Results: 73.2% of patients and 86.7% of controls reported at least one
stressful life event during the previous year (χ2 = 2.054, p = 0.152). In
patients who reported at least one stressful event, stress load for
recent events was signiﬁcantly associated with positive schizotypy
(r = 0.325, p = 0.038), especially suspiciousness (r = 0.432, p = 0.005),
but not with the other schizoypy dimensions. The number of
events and stress load of less recent events were unrelated to
schizotypy level. In controls, all the associations were statistically
non-signiﬁcant.
Conclusions: This study suggests that the interaction between a
genetic liability trait and environmental stress contributes to explain
increased risk for psychosis in this population. Implications concern-
ing risk to transition will be discussed.
Talk 3
Schizotypal Traits and Neurocognitive Functioning
in a Community-Derived Sample of Adolescents
Eduardo Fonseca-Pedrero1,2,3, Javier Ortuño-Sierra1, Alicia Pérez
de Albeniz1, Rebeca Aritio-Solana1, Laura Pérez-Gutiérrez1
1Department of Educational Sciences, University of La Rioja, Spain,
2Prevention Program for Psychosis (P3), Spain, 3Center for Biomedical
Research in the Mental Health Network (CIBERSAM), Spain
The previous literature asks for further work to establish the ideal
latent proﬁle of schizotypal features in samples of the general popula-
tion. Likewise, there has been no in-depth examination about the
relationship between schizotypal latent proﬁles and its relationship
with neurocognitive functioning. The main goal of the present study
was to explore the latent structure of schizotypal traits in a
community-derived sample of adolescents. Moreover, associations
with neurocognitive functioning were compared across different
latent classes of schizotypal traits. The present study included one
thousand students between the ages of 12 and 19. The Oviedo
Schizotypy Assessment Questionnaire (ESQUIZO-Q) and the Univer-
sity of Pennsylvania Computerized Neuropsychological Test Battery
for children were used. The 1-hour computerized neurocognitive bat-
tery included 14 tasks assessing ﬁve neurobehavioral domains (execu-
tive functions, episodic memory, complex cognition, social cognition,
and sensorimotor speed). Using latent proﬁle analysis four latent
classes of schizotypal traits were identiﬁed. Furthermore, schizotypal
traits were associated with neurocognitive domains. Across schizo-
typal latent proﬁles different neurocognitive deﬁcits were found, sim-
ilar to those found in patients with psychosis. The assessment of
schizotypal traits, in community settings, and its associations with
neurocognitive performance, may help us to enhance the possibility
of an early identiﬁcation of adolescents potentially at risk for psycho-
sis and mental health problems.
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Talk 4
Prediction of Psychosis in a Clinical High Risk
Sample: Value of Self-Reported Schizotypy Scales
Rahel Flückiger1, Stephan Ruhrmann2, Martin Debbané3,4,
Chantal Michel1, Daniela Hubl1, Benno G. Schimmelmann1,
Joachim Klosterkötter2, Frauke Schultze-Lutter1
1University of Bern, Switzerland, 2University of Cologne, Germany,
3University of Geneva, Switzerland, 4University College London, UK
Schizotypy is considered an indicator of psychosis-proneness and,
therefore, a precursor to schizophrenia-spectrum psychosis. In early
detection of psychosis, the widely used ultra-high risk criteria refer to
the positive features of schizotypy and schizotypal personality disor-
ders (SPD). In clinical high risk (CHR) samples, self-reported or clini-
cally assessed SPD, notably lack of close friends, was suggested to
facilitate prediction of psychosis. In community samples, self-reported
schizotypy was mainly psychometrically assessed using the four Wis-
consin Schizotypy Scales (WSS), and, especially, the positive schizo-
typy dimension was consistently predictive of psychosis.
Psychometrically assessed schizotypy, however, has not yet been
studied as a potential predictor of psychosis in CHR samples. To
bridge this gap, we studied the psychosis-predictive value of three
WSS and their association with a CHR state in a clinical sample. One-
hundred and twenty-eight patients (23 ± 7 years; 81% considered at
CHR) of two early detection services were followed up for 12–101
months. Within 48 months, 36 (28.1%) converted to psychosis. Only
“Physical Anhedonia” was associated with a CHR state, and high
scores of “Physical Anhedonia” were predictive of conversion in con-
junction with a CHR state. “Physical Anhedonia” rather than positive
schizotypy scales might separate future converters from non-
converters in clinical samples phenomenologically already presenting
a more extreme range of the psychosis continuum. Thus, given their
reported psychosis-predictive value in non-clinical samples psycho-
metric schizotypy measures in general might be useful for initial
screening of psychosis-proneness in the community, while “Physical
Anhedonia” might be particularly useful in CHR samples.
Symposium Session 30
Saturday, October 22,
2:45–4:15 p.m., Washington A
The Use of Virtual Reality and Phone Apps in the
Assessment and Treatment of Psychosis
Chair: Lucia Valmaggia1
Speakers: Maria Rus-Calafell, Mark van der Gaag, Lucia Valmaggia,
Roos Pot-Kolder
1King’s College London, Institute of Psychiatry, Psychology and
Neuroscience, London, UK
The symposium will present recent evidence of the use of Virtual
Reality (VR) and Apps for psychosis research and treatment. Dr Rus-
Calafell will discuss how matching the voice of the avatar to mimic
auditory hallucinations can help people who hear voices to learn stra-
tegies that can generalize to voices in daily life. Prof van der Gaag will
talk about the use of TemStem, an App designed to help people cope
distressing auditory hallucinations in daily life. Dr Valmaggia will pres-
ent a new VR English Pub environment designed to help people with
psychosis who feel anxious and paranoid in social situations. Finally,
Dr Pot-Kolder will show the results of a novel study exploring the
effectiveness of VR assisted therapy for the treatment of psychosis.
Talk 1
Examining the Role of Presence in the AVATAR
Therapy
Maria Rus-Calafell1,2, Tom Ward1,2, Philippa Garety1,2,
Thomas Craig1,2
1King’s College London, Institute of Psychiatry, Psychology and
Neuroscience, London, UK, 2South London and Maudsley NHS Trust, UK
AVATAR therapy is a computer-based intervention which aims to
reduce the frequency and severity of auditory verbal hallucinations
(AVH). AVATAR uses a Virtual Reality (VR) platform to create and dis-
play a human/non-human identity to the patient in order to facilitate
a real-time voice “trialogue” between the participant, a computerised
representation of their voice and the therapist. This virtual embodi-
ment of the experience is fully achieved by matching the voice of the
avatar to the current AVH. This adds even more realism to the expe-
rience and seems to be a key aspect of the therapy. We have incor-
porated an adapted version of the Sense of Presence Questionnaire
(Slater, Usoh and Steed, 1995) in order to evaluate the degree of ver-
isimilitude of the experience, the participant’s sense of “hearing the
voice” and the participant’s perception of the avatar as a “voice talk-
ing to me”. It is hypothesised that strategies developed in therapy
may be more likely to generalize to voices in daily life when the cre-
ated avatar is high in ecological validity. Data on hallucinations, sense
of presence and paranoia in relation to therapy engagement, partici-
pant’s persecutory thoughts about the avatar and anxiety reduction
will be presented and discussed considering previous literature about
the relevance of sense of presence in VR interventions for psychosis,
but also in relation to speciﬁc phenomenological aspects of the AVH.
Talk 2
Reducing Distress and Dysfunction Caused by
Auditory Verbal Hallucinations via a Smartphone
Application (Temstem)
Mark van der Gaag1,2, David van den Berg2, Alyssa Jongneel2,
Dorien Scheffers2
1VU University and EMGO+ Institute for Health and Care Research,
Amsterdam, The Netherlands, 2Parnassia Psychiatric Institute, The
Hague, Netherlands
Temstem is a Smartphone app aimed to reduce distress by persistent
auditory verbal hallucinations. Temstem is making use of three
evidence-based interventions: (1) by a verbal task the verbal working
memory phonological loop is addressed and this blocks the hearing of
voices (behavioural incompatible behaviour); (2) the app reinforces
results with compliments that are incompatible with the self-reported
themes of the negative self-esteem that the patient has (as in com-
petitive memory training); (3) taxing the auditory working memory
during recall of negative auditory memories of the voices who elicit
negative emotions, reduces emotionality that is associated to the
memories that the voices elicit (as in Eye Movement and Desensitiza-
tion and Reprocessing therapy). A RCT is now conducted in six sites
to examine the effect of the app on distress and dysfunction. Second-
ary objectives are to investigate the effect of Temstem on frequency
and severity of AVH, to determine working mechanisms, to identify
predictors and mediators of effects, and to test the usability of Tem-
stem. Preliminary results will be presented.
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Talk 3
Come to My Party! Using Virtual Reality to Improve
the Assessment and Treatment of Social
Performance
Lucia Valmaggia1,2, Mar Rus-Calafell1,2, SImon Riches1,2,
Thomas Craig1,2, Philippa Garety1,2
1King’s College London, Institute of Psychiatry, Psychology and
Neuroscience, London, UK, 2South London and Maudsley NHS Trust,
London, UK
Building on previous evidence we wanted to investigate whether
cognitive (fear of negative evaluation), affective (social distress) and
behavioural (social avoidance) components of social performance
(CSP) are associated with increased paranoid ideations in a VR social
environment. A large general population online survey (N = 609)
investigated how trait paranoia relates to CSP and mood. Participants
who scored higher (N = 44) and lower (N = 44) in trait paranoia
entered a VR party in an English Pub to evaluate the acceptability of
the new VR paradigm and the relationship between paranoia and
CSP. As hypothesised, trait paranoia was associated with CSP and
higher trait paranoia participants reported higher state paranoia and
greater negative CSP in VR. The assessment and treatment applica-
tions of this new environment for people with psychosis will be
presented.
Talk 4
The Effect of Cognitive Behavior Therapy
Augmented with Virtual Reality Exposure Therapy
on Social Participation in Patients with a Psychotic
Disorder (VRETp)
Roos Pot-Kolder1,2, Wim Veling2,3,4, Chris Geraets3,
Philippe Delespaul4,5, Mark van der Gaag1,2
1Parnassia Psychiatric Institute, The Hague, The Netherlands, 2VU
University and EMGO+ Institute for Health and Care Research,
Amsterdam, The Netherlands, 3University of Groningen, The Netherlands,
4Maastricht University, The Netherlands, 5Mondriaan Psychiatric
Institute, Maastricht, The Netherlands
Several patients in (partial) remission of a psychotic disorder still
avoid social situations because of distrust and anxiety. Avoidance
behaviours are an important factor in sustaining social isolation and it
can be hard to motivate patients to omit these behaviours in real life.
Cognitive Behavior Therapy augmented with Virtual Reality Exposure
Therapy (VRETp) has the potential to be an affordable and accessible
form of treatment to enhance social participation and wellbeing for
patients suffering from paranoia and social withdrawal. The study
design is a single blind randomized clinical trial with three-month
follow-up. The VRETp treatment consists of sixteen treatment ses-
sions of sixty minutes each, within an eight-week timeframe. Social
participation was measured with the PsyMate Experience Sampling
Method. One hundred and sixteen participants were included in the
study. Fifty-eight participant participants received the VRETp treat-
ment in addition to treatment as usual (TAU). The other ﬁfty-eight
participant received only TAU during the study. Preliminary results
show feelings of paranoia in daily life social situations were signiﬁ-
cantly reduced for participants that received the VRETp treatment.
More results will be ready for IEPA in October. VRETp appears to be
an effective treatment for reducing feelings of paranoia in social
situations for patients with a psychotic disorder. Limitations of the
results and the study will be discussed.
Question and Answer Period
Discussant: Wim Veling, University of Groningen, The Netherlands
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Individual Placement and Support: The Importance
of Integrating Supported Education in Early
Intervention
Chair: Luana R Turner1
Speakers: Eóin Killackey, Jaap van Weeghel, Wenche ten Velden
Hegelstad, Luana R Turner
1Department of Psychiatry and Biobehavioral Sciences, Semel Institute
for Neuroscience and Human Behavior, University of California, Los
Angeles, CA, USA
The goal of gaining and maintaining independence lies at the core of
every individual’s identity and self-esteem. A key component of this
dynamic is employment, however education is innately tied to this
process. The most evidenced-based model of supported employment
is the Individual Placement and Support Model (IPS); though little
research has been conducted on the integration and value of an IPS
ﬁdelity scale that includes supported education. This symposium will
explore the importance of an integrated scale, and how this scale can
assist in identifying the challenges, needs, and accommodations of cli-
ents early on to improve the likelihood of academic and employment
success. The symposium will also report on the results of using an
adapted IPS ﬁdelity scale (AIPSFS) in two randomized controlled trials
(RCT’s) across 9 early intervention teams in the Netherlands and
2 teams in Norway. This symposium will describe how researchers
from Australia, the Netherlands, Norway, and the U. S. have created
an AIPSFS integrating supported education, the process of coordinat-
ing these efforts across continents, and how the systems in each
country contribute to the diversity of the adapted scale. Furthermore,
this symposium aims to demonstrate the need for an adapted ﬁdelity
scale that utilizes the existing IPS scale as the foundation, and that
IPS workers should be trained to deliver supported education and
employment as integrated services to their clients. In summary,
empirical ﬁndings and clinical issues regarding the need for an
adapted IPS ﬁdelity scale integrating supported education in early
intervention will be discussed.
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Talk 1
Starting Fires, Not Filling Buckets: The Importance
of Education in the Vocational Recovery of Young
People with First Episodes Psychosis
Eóin Killackey1,2
1Orygen, The National Centre of Excellence in Youth Mental Health,
Parkville, VIC, Australia, 2Centre for Youth Mental Health, The University
of Melbourne, Australia
Psychosis inﬂicts much harm on those who experience it. Of these,
vocational disability that can accrue to individuals is particularly costly,
personally, societally and economically. The last 25 years has seen the
development of evidence based vocational recovery interventions for
people with psychotic illness, particularly the Individual Placement and
Support (IPS) form of Supported Employment. However, the majority of
the development of these interventions has been in populations with
long-standing illness. Consequently, most of the outcomes sought have
been employment related. Over the last 10 years there has been a
growing application of IPS to young people with ﬁrst episode psychosis.
For these young people educational outcomes are as valued as employ-
ment outcomes. This is for two key reasons. Firstly, for this group
whose vocational aspirations are as yet undiminished by their illness,
the completion of education and training gives the greatest chance of
engaging with a hoped-for career instead of just getting a job. Secondly,
increased levels of education will be protective against the increasing
automation of entry-level jobs. Reviews show however, that IPS is as
yet not producing the same advantages in educational outcomes that it
produces for employment outcomes. One reason for this may be that
IPS and the IPS ﬁdelity scale is a priori directed to employment. This
presentation will discuss education in the context of vocational recov-
ery, adaptations to IPS that are required to more effectively promote
education and the need to more accurately measure the ﬁdelity of
aspects of IPS targeted to educational outcomes.
Talk 2
Adding a Supported Education Fidelity Scale to
Individual Placement and Support (IPS) Practices for
Persons with a First Episode of Psychosis in The
Netherlands
Jaap van Weeghel1,2, Isis van Soest1, Daniëlle van Duin1
1Kenniscentrum Phrenos, 2Tilburg University, The Netherlands
Objective: In The Netherlands IPS services of ﬁrst episode psychosis
programs have increasingly included Supported Education (SEd). The
objective of this research project is a) to develop a complementary
SEd scale for IPS practices serving persons with early psychosis and
b) to integrate this scale addressing education supports with the
existing IPS ﬁdelity scale addressing employment supports.
Methods: A preliminary IPS SEd ﬁdelity scale is developed by means
of studying the literature on SEd and IPS model ﬁdelity, consulting
Dutch experts on this subject, and conducting a focus group of IPS
practitioners and IPS trainers. Within the context of a multisite RCT
on IPS practices in nine early intervention teams, each serving 100-
150 clients, the IPS SEd scale is administered at baseline and at one-
year follow up. IPS trainers and practitioners are interviewed discuss-
ing the validity and feasibility of the scale.
Results: At baseline (September 2015) eight teams scored ‘fair ﬁdel-
ity’ and one team ‘good ﬁdelity’ on the integrated IPS ﬁdelity scale.
No systematic differences were found between scores on the
employment and education items.
Discussion: At baseline, the participating teams had just started
implementing IPS. It is yet to be seen whether these teams, according
to the ﬁdelity assessment at one-year follow-up (September 2016),
will have made progress on the employment part, the education part,
or on both parts of their IPS practices. Also the feasibility and validity
of the SEd scale will be discussed, based on the experiences of the
IPS practitioners, trainers and researchers.
Talk 3
Earning and Learning: Two Sides of the Same Coin.
Testing of an Integrated IPS Fidelity Scale for
Education and Employment in Norway
Wenche ten Velden Hegelstad1, Kristin Hatløy1, Lena Heitmann2,
Jan Olav Johannessen1
1Stavanger University Hospital, Regional Centre for Clinical Research in
Psychosis, Norway, 2Stavanger University Hospital, Division of
Psychiatry, Job Prescription/ School Prescription, Norway
Purpose: Finishing school is important for social participation and
later employment, but may be impeded by mental illness. An IPS
intervention for employment was expanded to help young people
with severe mental illness or ultra high-risk states maintain or gain
education. The purposes of the presented project were to test the
utility of an adapted and integrated ﬁdelity scale for supported edu-
cation and employment, and to evaluate the integrated intervention.
Material and methods: A multi-site international work group (USA,
Australia, UK, the Netherlands, Norway) adapted the IPS ﬁdelity scale
by Bond et al(1) to integrate supported employment and education.
An external expert rated the intervention using observations of client
contacts and methods of work, and interviews with staff, organization
leadership, and collaborators in vocational and educational services.
Re-testing will be conducted in April 2017, and Scandinavian sites
invited to participate.
Results: Fidelity ratings will be presented. Preliminary results indicate
satisfactory ﬁdelity. There are however some discrepancies from
standard IPS: 1) The IPS workers do not serve clients from designated
mental health care teams exclusively 2) Frequency of contacts with
educational services are ﬂexible as opposed to ﬁxed. Strengths are
rapid enrolment and start of collaboration with educational/employ-
ment facilities, close collaboration with treating clinicians, and inte-
gration with mental health care.
Conclusion: The integrated scale is promising as a tool for ensuring
high-quality delivery of an integrated education/employment inter-
vention. Assisting young people with severe mental illness pursue
educational goals provides an opportunity to prevent later unemploy-
ment and social exclusion.
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Talk 4
Supported Education as a Key Early Intervention:
The Path Toward Integration of Services
Luana R Turner
Department of Psychiatry and Biobehavioral Sciences, Semel Institute for
Neuroscience and Human Behavior, University of California, Los
Angeles, USA
Supported employment has become an integral and poignant compo-
nent of recovery. However, supported education services are often
viewed as a separate intervention. As the mental health ﬁeld con-
tinues to appropriately increase focus on early interventions, it is
important to view supported education as a natural expansion of the
supported employment intervention. The Individual Placement and
Support (IPS) model offers excellent ﬁdelity as a solid base to inte-
grate educational services. This presentation will report on these
topics, current supported education services, programs that adapted
IPS for supported education, and the development of the adapted
IPS ﬁdelity scale (AIPSFS). Furthermore, this presentation will explore
the beneﬁts of using supported education with ﬁrst-episode clients
as well as prodromal populations and children under the age of 18.
This presentation will also report on the advantages of utilizing a
ﬁdelity scale that distinguishes the differences between the interven-
tions of supported education and employment, yet still provides for
an integrative scoring system. Lastly, this presentation will discuss
the process of the AIPSFS project, including the beneﬁts and chal-
lenges of working with colleagues across the globe, and conceptualiz-
ing a model that meets the diversity of the different educational
systems around the world.
Question and Answer Period
Discussant: Luana R Turner, Department of Psychiatry and Biobeha-
vioral Sciences, Semel Institute for Neuroscience and Human Behavior,




The US Generation of Early Psychosis Intervention
Services: What is Coordinated Specialty Care and
How Does It Compare to Other International
Initiatives?
Chair: Piper Meyer-Kalos1
Speakers: Piper Meyer-Kalos, Iruma Bello, Tamara Sale, Merete Nor-
dentoft
1University of Minnesota, Minnesota Center for Chemical and Mental
Health, MN, USA
Purpose: The US has developed a new model of care to support the
development of early psychosis treatment programs across the coun-
try. This new model is called Coordinated Specialty Care (CSC). CSC
includes low doses of antipsychotic medications, cognitive-
behavioural and recovery-oriented psychotherapy, family education
and support, and vocational and educational rehabilitation to promote
clinical and functional recovery and prevent disability among persons
with ﬁrst episode psychosis. The National Institute of Mental Health
(NIMH) funded the development and testing of CSC programs across
the US. Findings from the two Recovery After Initial Schizophrenia
Episode (RAISE) research initiatives have suggested that these pro-
grams can be implemented in routine US mental health settings.
While there are many shared CSC components in US and interna-
tional ﬁrst episode programs, the lack of a national health system has
had a signiﬁcant impact on the dissemination and uptake of these
programs in the US.
Methods: This symposium will describe three major CSC models cur-
rently being implemented in the US: NAVIGATE, OnTrackNY, and
Early Assessment and Support Alliance (EASA). Each presentation will
discuss how each program incorporates the core components of the
team based, multi-component CSC model and current efforts to
disseminate CSC.
Results: Each program will review results from the dissemination and
training efforts and describe the challenges of dissemination in
the US.
Conclusion: The CSC model presentations will conclude with a dis-
cussion panel of four international experts who will respond to the
US experience of developing early intervention services in compari-
son to international efforts.
Talk 1
NAVIGATE: An Overview of the Implementation
and Dissemination Strategies in Routine Settings
for a Team-Based, Comprehensive Intervention for
First Episode Psychosis
Piper Meyer-Kalos1, Shirley Glynn2, Susan Gingerich3, Kim Mueser4
1Minnesota Center for Chemical and Mental Health, University of
Minnesota, MN, USA, 2Research Psychologist at Semel Institute of
Neuroscience and Human Behavior University of California, Los Angeles,
USA, 3NAVIGATE Training Coordinator, 4Center for Psychiatric
Rehabilitation, Boston University, MA, USA
Purpose: NAVIGATE is an example of an evidence-based coordinated
specialty care (CSC) model. The NAVIGATE team works together to
provide four core services: individualized medication management,
family education (FE), individual resiliency training (IRT), and sup-
ported employment and education (SEE). In NAVIGATE, treatment is
guided by three conceptual frameworks that include the recovery
model, the stress-vulnerability model, and the ﬁeld of psychiatric
rehabilitation.
Methods: Since the RAISE-ETP study has concluded, the NAVIGATE
model has been disseminated as part of a national effort to increase
early intervention services. The training and dissemination model for
NAVIGATE is designed to foster the development of the core skills
utilized in all treatment components including shared decision mak-
ing, strengths and resiliency, psychoeducation, and collaboration with
natural supports.
Results: In this presentation we will describe the NAVIGATE program
and discuss our training and implementation model. We will present
results from the dissemination of NAVIGATE in 11 programs in
8 states and include recommendations for dissemination in the
US. To date, team training has been done in-person and followed up
by regular role-speciﬁc consultation calls for at least one year.
Conclusion: In NAVIGATE, we provide a ﬂexible and supportive
approach to training and implementation that addresses readiness to
start a ﬁrst episode program, development of expertise in treatment
for ﬁrst episode psychosis, and skill development for each role on the
team as well as promoting the sustainability of services.
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Talk 2
OnTrackNY: Training Strategy for Implementing a
Coordinated Specialty Care Service Model in
the USA
Iruma Bello1,2, Lisa Dixon1,2, Liza Watkins1, Tom Smith1, Ruﬁna Lee3,
Gary Scannevin1, Ilana Nossel1,2, Lloyd Sederer4
1New York State Psychiatric Institute, New York, NY, USA, 2Columbia
University Medical Center, New York, NY, USA, 3Silberman School of
Social Work at Hunter College, City University of New York, NY, USA,
4Ofﬁce of Mental Health, New York, NY, USA
Purpose: This presentation will discuss OnTrackNY’s training strategy
for implementing coordinated specialty care services. OnTrackNY ‘s
consultation activities begin with pre-implementation planning
(e.g., embedding a team within an agency, mapping existing policies
and procedures, addressing challenges across child/adult service
divides, hiring staff ) and continue through model implementation.
Methods: Training consists of a ﬂexible strategy delivered by a cen-
tralized team of experts. A three-day in person training introduces
providers to the service model and its component parts. Technical
assistance is continued through collaborative role-based calls,
monthly care consultation calls, and special topics requested by trai-
nees (e.g., violence risk, LGBT issues). This is combined with a web-
based learning management system that allows for self-paced learn-
ing through webinars and supplementary materials. New York based
teams receive a robust and continuous training package. The intensity
of training activities for other states is varied and lasts at least
one year.
Results: Twelve teams have been trained across diverse communities
in New York. The state’s effort is currently expanding to train 8 addi-
tional teams. Across the US, 12 states have been trained (22 teams)
in addition to Puerto Rico and the Paciﬁc Jurisdictions. A majority of
feedback forms (74%-93%, n = 485) submitted by for the in-person
training sessions reﬂect that trainees strongly agreed that the mate-
rial presented was useful and was presented in an engaging manner
by knowledgeable and skilful presenters.
Conclusion: OnTrackNY’s comprehensive and adaptive training strat-
egy has been successful in training providers across varied demo-
graphic settings enabling the effective implementation of coordinated
specialty care services.
Talk 3
Integrating Coordinated Specialty Care in the U.S.:
Oregon’s Experience
Tamara Sale1, Ryan Melton1, Katherine Hayden-Lewis1,
Craigan Usher2
1Portland State University, Portland, Oregon, 2Oregon Health & Science
University, Portland, Oregon
Purpose: Oregon’s early leadership in integrating preventive and
evidence-based strategies into health care reform resulted in the ﬁrst
systematic adoption of early psychosis intervention within the U.-
S. public mental health system in 2001.
Methods: Statewide dissemination of Oregon’s Early Assessment and
Support Alliance (EASA) began in 2008 and attempted to realign
ﬁnancial incentives toward population-based early psychosis services.
Results: Local EASA teams provide all of the elements of Coordinated
Specialty Care to residents regardless of insurance coverage, serving
over 400 individuals and families per year. EASA’s early implementa-
tion evolved under a governance structure consisting of providers,
service participants and funders, who deﬁned the purpose and under-
lying problems.
Conclusion: As a result, EASA’s implementation framework integrates
the perspective of individuals with lived experience of psychosis as
well as strategic and operational concerns, and attempts to maximize
the impact of evolving research on systems and participant wellbeing
while recognizing the limitations of research. The EASA Center for
Excellence facilitates a National Learning Collaborative representing
ﬁfteen diverse states, works with RAISE consultants and other
national trainers, and participates in the development of the EPINET
“learning healthcare system” focused on early psychosis. EASA
focuses on developing and supporting leadership, organizational
capacity, and clinical capacity to implement Coordinated
Specialty Care.
Talk 4
Panel Discussion from International Experts in
Response to the US Experience Disseminating
Treatment for First Episode Psychosis
Merete Nordentoft1, Eóin Kilackey2, Max Birchwood3,
Donald Addington4
1Professor, chief Psychiatrist, University of Copenhagen, Mental Health
Centre Copenhagen, Denmark, 2Orygen, The National Centre of
Excellence in Youth Mental Health Centre for Youth Mental Health; The
University of Melbourne, Parkville, VIC, Australia, 3School of Psychology,
University of Birmingham, Professor of Youth Mental Health Clinical
Director, YouthSpace Mental Health Service, Birmingham and Solihull
Mental Health Foundation Trust, 4Professor Department of Psychiatry,
Member Mathison Centre for Mental Health Research and Education,
University of Calgary, Alberta, Canada
Purpose: This panel discussion will focus on comparing and contrast-
ing the US experience with training and dissemination of a coordi-
nated specialty care (CSC) model for ﬁrst episode psychosis
treatment with the international experience of developing early inter-
vention services.
Methods: Four international experts in early intervention services will
share their feedback in response to the descriptions of the three US
programs: NAVIGATE, OnTrackNY, and Early Assessment and Sup-
port Alliance (EASA).
Results: Experts will describe the similarities and differences to the
development of ﬁrst episode programs outside of a national health
system. Experts will also respond to the common challenges in train-
ing and dissemination across the US ﬁrst episode training programs.
Conclusion: The development of ﬁrst episode psychosis programs in
the US is uniquely different from many other international programs.
Sharing information about the training and dissemination efforts may
enhance the sustainability of ﬁrst episode psychosis programs and






Oxidative Stress in Early Psychosis, from
Mechanisms to Interventions
Chair: Arjen Sutterland1, Co-Chair: Philipp Baumann2
Speakers: Daniella Dwir, Arjen L. Sutterland, Marie-Odile Krebs, Phil-
lipp Baumann
1University of Amsterdam, The Netherlands, 2Lausanne University
Hospital (CHUV), Switzerland
In this symposium the role of oxidative stress in early psychosis will
be highlighted, with latest results from several studies. Different
approaches will be presented, whereby the relation of oxidative
stress with neuroinﬂammation, advanced glycation endproducts and
common pathological ﬁndings in psychosis is demonstrated. Firstly,
Daniella Dwir will introduce the concept of oxidative stress and the
role of the receptor for advanced glycation endproducts in the inter-
action between oxidative stress and neuroinﬂammation. Data indi-
cates that redox dysregulation can be a potential trigger of structural
and morphological impairments in the adult brain similar to schizo-
phrenia. Next, Arjen Sutterland will elucidate how measuring accumu-
lation of advanced glycation endproducts non-invasively in early
psychosis subjects can be an indication for increased oxidative stress.
Correlations with clinical variables, cardiovascular risk factors and
peripheral markers of inﬂammation and oxidative stress are pre-
sented. Consequences for current treatment strategies are discussed.
Then, Marie-Odile Krebs will demonstrate that subjects with ultra
high risk for psychosis who convert to psychosis differ from non-
converters in methylation patterns of their DNA. The epigenetic
changes in converters occur in pathways relevant for psychosis,
including oxidative stress regulation, axon guidance and inﬂammatory
pathways. Lastly, Phillipp Baumann will present the relation of oxida-
tive stress with neuropathological ﬁndings in vivo in psychosis,
whereby the integrity of the fornix-hippocampus circuits is studied
with neuroimaging, showing that it’s impairment is linked to periph-
eral redox dysregulation in early psychosis. Lieuwe de Haan will dis-
cuss the implications for clinical practise, possibilities for stratiﬁcation
and its relevance to future interventions.
Talk 1
Involvement of the Receptor for Advanced
Glycation End-product (RAGE) in the Interaction
Between Redox Dysregulation and
Neuroinﬂammation: Relevance for Schizophrenia
Daniella Dwir, Jan-Harry Cabungcal, Pascal Steullet, Michel Cuénod,
Kim Q Do
Lausanne University Hospital (CHUV), Switzerland
Growing bodies of evidences show the involvement of a redox and
inﬂammatory dysregulation in the pathophysiology of schizophrenia
(SZ). For instance, decreased glutathione (GSH) levels, an important
redox regulator, have repeatedly been demonstrated. It has been sug-
gested that oxidative stress and inﬂammation occurring at a critical
period may affect neurons vulnerable to elevated oxidative insults,
such as parvalbumin-expressing interneurons (PVI), which circuit is
impaired in SZ. While several mechanisms have been proposed for
oxidative stress and inﬂammation interaction, we focus on the role of
the Receptor for Advanced Glycation End-product (RAGE). RAGE is a
promising candidate as its ligands are produced in both oxidative
stress and inﬂammatory conditions. RAGE activation leads to further
reactive oxygen species production and inﬂammatory pathway acti-
vation. Interestingly, AGEs and S100B, two major ligands of RAGE
were shown to be increased in SZ patients. Our results showed that
RAGE shedding by MMP9 was involved in maintaining a vicious cycle
of oxidative stress and inﬂammation in early development in a mouse
model of GSH deﬁcit that shows SZ related phenotype. These mice
show decreased PVI/PNN, increased oxidative stress and microglia
activation in anterior cingulate cortex in adulthood after an additional
oxidative stress in early postnatal days, which could be reversed by
RAGE shedding inhibition. We propose that an interaction between
redox dysregulation and pro-inﬂammatory condition via RAGE and
MMP9 in early developmental stages is a potential trigger of struc-
tural and morphological impairments in adult brain. Therefore, RAGE/
MMP9 pathway could be a new promising target for drug
development.
Talk 2
Advanced Glycation Endproducts and
Cardiovascular Risk in Relation to Inﬂammation and
Oxidative Stress in Recent Onset Psychosis
Arjen L. Sutterland1, Julia M. Hagen1, Maarten Koeter1, Rene Lutter1,
Dan Cohen2, Lieuwe de Haan1
1University of Amsterdam, The Netherlands, 2Mental Health Service
North-Holland North, The Netherlands
Profoundly increased mortality rates in schizophrenia, largely caused
by a higher risk and earlier onset of cardiovascular disease, remain a
major challenge. During human life Advanced Glycation Endproducts
(AGEs) accumulate, of which the concentration is strongly linked to
cardiovascular mortality. AGEs accumulation can be increased by sev-
eral pathways, including inﬂammation and oxidative stress. A case
control study was performed including 111 patients with a recent
onset psychosis, 135 controls from a validation cohort and a group of
321 healthy controls. Main outcome parameters were levels of AGEs
measured through skin autoﬂuorescence. AGEs were compared with
healthy controls controlling for age, gender and smoking. Correlations
of AGEs with well-known cardiovascular risk factors, clinical variables,
as well as inﬂammatory factors and level of oxidative stress measured
in plasma were analysed by hierarchical linear regression analyses. An
AGE measurement was possible in 77.4%. AGEs were elevated by
15.1% in recent onset psychosis compared to healthy controls
(P < .001), corresponding to an increased accumulation of AGEs nor-
mally occurring in over 10 years. Duration of disease, duration of
antipsychotic treatment and cumulative exposure to antipsychotics
correlated with AGE levels (p = 0.008, 0.009 and 0.023 respectively).
Correlations with inﬂammatory and oxidative stress markers will be
presented.We conclude that in patients suffering from recent onset
psychosis increased AGE levels compared with healthy controls are
already present. These ﬁndings argue for an earlier treatment of car-
diovascular risk factors and possibly conservative dosing strategies of
antipsychotics in schizophrenia. Mechanisms how AGEs accumulation
is raised in psychosis needs to be explored further.
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Talk 3
Methylomic Changes During Conversion to
Psychosis
Marie-Odile Krebs1,2, Oussama Kebir1,2, Boris Chaumette1,2,
Fabrice Rivollier1,2, Federico Miozzo3, Sylvie Provost4,
Marion Plaze1,2, The ICAAR Team, Raphaël Gaillard1,2,
Valérie Mezger3, Marie-Pierre Dube4
1Université Paris Descartes, France, 2Centre Hospitalier Sainte-Anne,
Paris, France, 3Université Paris Diderot, France, 4Université de Montréal,
Canada
The onset of psychosis is the consequence of complex interactions
between genetic vulnerability to psychosis and response to environ-
mental and/or maturational changes. Epigenetics is hypothesized to
mediate the interplay between genes and environment leading to the
onset of psychosis. We believe we performed the ﬁrst longitudinal
prospective study of genomic DNA methylation during psychotic
transition in help-seeking young individuals referred to a specialized
outpatient unit for early detection of psychosis and enrolled in a 1-
year follow-up. We used Inﬁnium HumanMethylation450 BeadChip
array after bisulﬁte conversion and analyzed longitudinal variations in
methylation at 411 947 cytosine-phosphate-guanine (CpG) sites.
Conversion to psychosis was associated with speciﬁc methylation
changes. Changes in DNA methylation were signiﬁcantly different
between converters and non-converters in two regions: one located
in 1q21.1 and a cluster of six CpG located in GSTM5 gene promoter.
Methylation data were conﬁrmed by pyrosequencing in the same
population. The 100 top CpGs associated with conversion to psycho-
sis were subjected to exploratory analyses. Cluster analysis showed
that the top CpG sites correctly distinguished between converters
and non-converters. In this ﬁrst study of methylation during conver-
sion to psychosis, we found that alterations preferentially occurred in
gene promoters and pathways relevant for psychosis, including oxida-
tive stress regulation, axon guidance and inﬂammatory pathways.
Although independent replications are warranted to reach deﬁnitive
conclusions, these results already support that longitudinal variations
in DNA methylation may reﬂect the biological mechanisms that pre-
cipitate some prodromal individuals into full-blown psychosis, under
the inﬂuence of environmental factors and maturational processes at
adolescence.
Talk 4
Impaired Fornix-hippocampus Integrity is Linked to
Peripheral Glutathione Peroxidase in Early
Psychosis
Phillipp Baumann1, Alessandra Griffa1,2, Margot Fournier1,
Philippe Golay1, Carina Ferrari1, Alameda Luis1, Michel Cuenod1,
Jean-Philippe Thiran1,2, Patric Hagmann1,2, Kim Q. Do1,
Philippe Conus1
1Lausanne University Hospital (CHUV), Switzerland, 2Signal Processing
Laboratory (LTS5) Lausanne, Switzerland
Different lines of evidence implicate the fornix-hippocampus circuit
in schizophrenia. Given that this circuit has not been extensively
investigated in early phase psychosis, the underlying mechanisms
affecting the circuit remain unknown. The hippocampus and fornix
are vulnerable to oxidative stress at peripuberty in a glutathione
(GSH; main non-protein antioxidant) deﬁcient animal model (Corcoba
et al., 2015; Steullet et al., 2010). The purposes of the current study
were to assess the integrity of the fornix-hippocampus circuit in early
psychosis patients (EP), and to study its relationship with peripheral
redox markers. 42 EP patients (age 25.0 ± 5.4) having met threshold
criteria for psychosis, as deﬁned by the CAARMS were recruited from
TIPP, an integrated early psychosis program in Switzerland. 42 gender
and age-matched healthy controls were also recruited. Diffusion
Spectrum Imaging and T1-weighted Magnetic Resonance Imaging
(MRI) were used to assess fornix and hippocampus. Generalized
fractional anisotropy (gFA) and volumetric properties were used to
measure fornix and hippocampal integrity respectively. Correlation
analysis was used to quantify the relationship of gFA in the fornix
and hippocampal volume, with blood GSH levels and glutathione per-
oxidase (GPx) activity. Patients compared to controls exhibited lower
gFA in the fornix as well as smaller volume in the hippocampus. In EP
but not in controls, smaller hippocampal volume was associated with
high GPx activity. Disruption of the fornix-hippocampus circuit is
already present in the early stages of psychosis. Higher blood GPx
activity is associated with smaller hippocampal volume, which may
support a role of oxidative stress in disease mechanisms.
Question and Answer Period





A Cautionary Tale or Breach of Promise? The Ups
and Downs of Resourcing, Development,
Dissemination and Sustaining of Early Intervention
Teams in Australia & The UK & Canada
Chair: Alan Rosen1, Co-Chair: Peter Byrne2
Speakers: Alan Rosen, Patrick D. McGorry, Roger Gurr, Peter Byrne
1Brain & Mind Centre University of Sydney, Illawarra Institute of Mental
Health University of Wollongong, Australia, 2Royal College of
Psychiatrists UK, Homerton University Hospital London, UK
Australia’s research, clinical and affected community have been suc-
cessful until recently in nationally innovating and disseminating Early
Intervention services for young people with Psychosis and other psy-
chiatric disorders. Youth friendly "headspace" centres provide a one-
stop-shop approach to assessment of troubled young people, then
connecting them with a range of mental health, substance use and
physical health services. They are now widespread and they have
been the launching pad of a pilot program in needy regions in each
state and territory of speciﬁc formerly "headspace" managed young
people with psychosis early intervention (hYEPP) teams.These highly
evidence based teams were brought in on the basis of bipartisan pol-
icy only a few years ago. They are now being told they face a step-
wise dismantling by the Australian Conservative Federal government,
without giving them a proper chance to develop and bloom, and dem-
onstrate the expected positive outcomes. This will lead to many sack-
ings of committed and skilled team staff and a dashing of the much
more hopeful expectations of many young individuals and their
families. Similar processes have been observed internationally, partic-
ularly in the UK in the wake of the shrinkage of the NHS on the
watch of the current Conservative government.A discussion will
ensue regarding how we can better anticipate, prevent, or ameliorate
these cycles of innovation, rigorous outcome research, nationally
widespread piloting and then wholesale political undoing, and how to
ensure that EIP teams have adequate opportunities to become stabi-




Introductory Narrative: The Story So Far
Alan Rosen
University of Sydney, Sydney, Australia
A national network of highly evidence based teams, piloting early
intervention in psychosis in each state were implemented on the
basis of bipartisan policy only a few years ago. Such teams have been
demonstrated to be highly cost-effective over medium to long-term
studies. They have also been national pioneers in extending continu-
ity of care in an EIP team for up to 5 years, employing of mental
health clinicians and peer workers in NGO sector-run teams, demon-
strating the diversifying of the provider market, and planning multi-
site trials of potentially synergistic approaches such as Open Dia-
logue. They now are to be dismantled stepwise by the Australian
Conservative Federal Government, without giving them any chance
to develop, stabilize, and demonstrate the expected positive out-
comes. The existing resources will be sprinkled lightly over 31 Primary
Health Networks, which will redeploy them variably, as they have no
experience in this ﬁeld, and very different priorities. Inevitably, these
resources will be absorbed for other purposes, and shrunk even fur-
ther, with the Government shifting the blame to the PHN’s, and none
of these coherent EIP services will remain. This will destroy the ﬁdel-
ity to the evidence based EIP model, which relies on a manageable
geographical catchment area for 7 day home visiting, and expert team
staff, who will lose their jobs. Several hundreds of very troubled
young people and their families will have expectations of more inten-
sive and appropriate care dashed, dumped onto the underfunded
local state services, which will be unable to serve them effectively.
Talk 2
International Comparisons in Disseminating and
Stabilizing Early Intervention in Psychosis
Patrick D. McGorry, M.D., Ph.D.
Orygen Youth Mental Health & University of Melbourne, Parkville, VIC,
Australia
A contextual analysis of the way this happened and the way forward
for government, mental health services, primary health networks etc.
and whether a pre-election campaign and an effective Federal oppo-
sition was able to make a difference. How should we set the balance
between early intervention of psychosis and other disorders? What
level of resourcing will it really require? What sequencing should
occur between completing model development and pilots in each
state jurisdiction and widespread dissemination? How do we stop this
political lurching and destabilization happening again? Similar pro-
cesses have been observed internationally, particularly in the UK in
the wake of the shrinkage of the NHS on the watch of the current
Conservative government. What has been achieved and what have
Government and NHS administrations undone? What can be done
from here and what are the lessons? At the same time, more coun-
tries are demonstrating very good outcomes in national networks of
local services eg RAISE study in USA, Scandinavia, Canada, Nether-
lands, Ireland etc.
Talk 3
Working with Governments, Public, Private and
NGO Sectors
Roger Gurr
Western Sydney University, Sydney, Australia
How has it been possible to successfully combine the efforts of pub-
lic, not-for-proﬁt (NGO) and fee-for? service sectors in the common
enterprise of establishing regional services for Early Intervention in
Psychosis. They combine an ultra-high-risk monitoring, therapy and
support team, an acute 7 day mobile outreach team and an assertive
community outreach team for persistent psychoses in young people?
At The Macro Level: How can we create an optimal governmental
and commissioning environment for piloting, regionally disseminating
and sustaining cost-effective evidence based components such as
Early Intervention in Psychosis teams?Can a federated, or even uni-
tary, national system succeed in supporting and stabilizing such men-
tal health reforms? Or for mental health services are such pressing
needs easily turned into political footballs, kicking the responsibility
and the blame for the failure to systemize them between different
political complexions, levels of government and funding bodies? How




London Hospital, London, UK
Service users’ high preferences for all three services were not enough
to save assertive outreach teams from cuts that followed the 2008
global economic crisis. By virtue of expediency, in the face of sus-
tained cuts to the number of inpatient beds available, home treat-
ment teams have survived across England: the levels of risk they
assume are reﬂected in falling inpatient suicide rates but rising death
rates among their clients. Having shown the most evidence of efﬁ-
cacy, the smartest economic modelling and sustained ﬂexibility EIP
services have mostly held on to their funding in a climate where Eng-
land’s MH services have lost 8% in real terms. There is a growing
national awareness of MH stigma and its need for "parity of esteem"
with physical healthcare services. This has mostly led to a cross-party
consensus that MH innovative services like EIP should be protected.
But an ideological drive towards competition between services
(as opposed to competition to ﬁght misery or deliver the best out-
comes for people) may pitch younger people’s services against EIP
that has come to mean 18-36 services. The onus is on all of us to
keep helping our service users and carers, proving the best outcomes,
and advocating for EI services.
Question and Answer Period
Discussant: Katherine Boydell, Black Dog Institute University of New
South Wales Australia, and University of Toronto, Canada
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